WO2020162020A1 - Drug supply device - Google Patents
Drug supply device Download PDFInfo
- Publication number
- WO2020162020A1 WO2020162020A1 PCT/JP2019/047821 JP2019047821W WO2020162020A1 WO 2020162020 A1 WO2020162020 A1 WO 2020162020A1 JP 2019047821 W JP2019047821 W JP 2019047821W WO 2020162020 A1 WO2020162020 A1 WO 2020162020A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- drug
- medicine
- unit
- control unit
- detection
- Prior art date
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
Definitions
- the present invention relates to a drug supply device.
- Patent Document 1 As a prior document disclosing the configuration of the drug supply device, there is International Publication No. 2016/013553 (Patent Document 1).
- the drug supply device described in Patent Document 1 includes a drug delivery unit including a first rotating body, a second rotating body, and a guide member.
- the first rotating body has a circular surface that is rotatably arranged in a state of being inclined with respect to the horizontal plane.
- the second rotating body is rotatably arranged on the outer peripheral side of the first rotating body and has an annular surface arranged on the horizontal plane.
- the guide member is disposed above the circular surface of the first rotating body, extends in the radial direction with respect to the circular surface, and is located on the downstream side in the rotational direction of the first rotating body as it extends outward in the radial direction. It has a guide surface with which the medicine placed on the first rotating body can come into contact with the rotation of the one rotating body.
- the drug supply device further includes a drug replenishment unit that replenishes the drug delivery unit with a drug.
- the medicine replenishing unit can replenish the medicine based on the medicine replenishment status in the medicine delivering unit.
- the drug supply device is required to reduce the time required to supply the drug.
- the present invention has been made in view of the above problems, and an object of the present invention is to provide a drug supply device capable of shortening the time required to supply a drug.
- the drug supply device includes a drug supply unit, a drug replenishment unit, a drug detection unit, and a control unit.
- the medicine supply unit has a medicine receiving position for receiving the replenished medicine, conveys the medicine while aligning the medicine from the medicine receiving position, and supplies the medicines one by one from the top.
- the medicine replenishing unit replenishes the medicine at the medicine receiving position.
- the drug detection unit detects the presence or absence of a drug at the drug receiving position and outputs a drug detection signal.
- the control unit controls the drug supplement unit.
- the control unit receives the drug detection signal from the drug detection unit and controls the drug replenishment unit according to the drug detection signal.
- the medicine detection unit has a first detection state in which the medicine is present at the medicine receiving position and a second detection state in which there is no medicine at the medicine receiving position.
- the control unit causes the drug replenishment unit to stop replenishment of the drug when the drug detection unit is in the first detection state, and causes the drug replenishment unit to replenish the drug when the drug detection unit is in the second detection state.
- control unit causes the drug replenishment unit to replenish the drug after a waiting time has elapsed from the time when the drug detection unit changed from the first detection state to the second detection state.
- a drug information signal having drug information related to the shape of the drug is input to the control unit.
- the control unit sets the waiting time according to the drug information.
- control unit stops the replenishment of the drug by the drug replenishment unit when the drug detection unit changes from the second detection state to the first detection state, and the operation amount of the drug supply unit from that time point. Exceeds the set value, and the drug detection unit switches from the first detection state to the second detection state at a later time, the drug replenishment unit restarts replenishing the drug.
- a drug information signal having drug information related to the shape of the drug is input to the control unit.
- the control unit sets the set value according to the drug information.
- the time required to supply a drug can be shortened.
- FIG. 7 is a perspective view showing a state in which the opening/closing section is rotated upward and the discharge section is opened in the medicine supply unit included in the medicine supply device according to the embodiment of the present invention. It is a perspective view showing composition of a medicine storage container of a medicine replenishment part with which a medicine supply device concerning one embodiment of the present invention is provided.
- FIG. 3 is a vertical cross-sectional view showing a state in which a lid is removed, in a drug container of a drug replenishing unit included in a drug supply device according to an embodiment of the present invention.
- FIG. 3 is a partial perspective view showing the shape of the medicine replenishing unit included in the medicine supply device according to the embodiment of the present invention on the side of the opening of the medicine container. It is a partial perspective view which shows the structure of the base part with which the chemical
- FIG. 4 is a front view showing a state in which a cover of a part of the base part is removed in a state where the drug supply part and the drug container are attached to the base part included in the drug supply device according to the embodiment of the present invention. It is a front side perspective view showing the state where a medicine storage container and a part of cover of a base part were removed from a medicine supply device concerning one embodiment of the present invention.
- FIG. 1 is a perspective view showing the external appearance of a medicine packaging device according to an embodiment of the present invention.
- FIG. 2 is a vertical cross-sectional view showing the configuration of the medicine packaging device according to the embodiment of the present invention.
- FIG. 3 is a plan view of the medicine packaging device of FIG. 2 seen from the direction of arrow III. Note that FIG. 1 illustrates a state in which the door of the housing is open and the manual cassette is slid to the front side of the housing. In FIG. 3, the ceiling part of the medicine packaging apparatus is seen through.
- a medicine packing apparatus 400 includes a medicine supply device unit, a housing 410, a rotating drum 420, a hopper 430, and a medicine packaging device unit 440. It has and.
- the medicine packaging device 400 further includes a control device unit described later.
- the drug supply device unit has a plurality of drug supply devices for supplying a drug.
- the drug supply device unit includes a plurality of first drug supply devices 10, a plurality of second drug supply devices 20, and a third drug supply device 30.
- Each of the plurality of second drug supply devices 20 accommodates a plurality of drugs and is configured to be able to supply the required number of drugs.
- the second medicine supply device 20 is an automatic medicine supply cassette.
- the third medicine supply device 30 is a manual medicine supply cassette.
- the hand-delivered medicine supply cassette has compartments arranged in a matrix, and each compartment accommodates one package of medicine.
- Each of the plurality of first drug supply devices 10 can supply the drug in place of the second drug supply device 20 of the plurality of second drug supply devices 20, which is empty of the drug. Further, each of the plurality of first drug supply devices 10 can supply another drug different from the drug contained in each of the plurality of second drug supply devices 20.
- the drug supply device unit supplies the drug one by one from the drug supply device selected from the plurality of drug supply devices.
- the medicine packaging device unit 440 packages the medicines supplied from the medicine supply device unit one by one.
- the control device unit controls each of the medicine supply device unit and the medicine packaging device unit.
- the housing 410 accommodates a drug supply device unit, a rotary drum 420, a hopper 430, and a drug packaging device unit 440.
- the housing 410 has a door that can be opened and closed.
- the operation panel 50 is provided on the front surface of the housing 410.
- the rotary drum 420 is rotatably supported around the axis 4 in the housing 410.
- a plurality of first drug supply devices 10 and a plurality of second drug supply devices 20 are attached to the rotary drum 420. That is, the first drug supply device 10 is housed in the housing 410 in a movable state.
- the rotary drum 420 is provided with a drug delivery path 421.
- the medicine transport path 421 is located above the hopper 430.
- the first drug supply device 10 and the second drug supply device 20 are annularly arranged side by side on the outer peripheral side of the rotary drum 420.
- the first drug supply device 10 and the second drug supply device 20 are arranged side by side in the vertical direction.
- Each of the first drug supply device 10 and the second drug supply device 20 is connected to the drug delivery path 421.
- the medicine supplied from each of the first medicine supply device 10 and the second medicine supply device 20 passes through the medicine conveyance path 421 and is put into the hopper 430.
- the medicine supplied from the third medicine supply device 30 is put into the hopper 430.
- the medicine put into the hopper 430 is packed in the medicine packing device unit 440.
- each of the first drug supply device 10 and the second drug supply device 20 may be attached to a slidable rack instead of the rotating drum 420.
- each of the first drug supply device 10 and the second drug supply device 20 can be moved to the outside of the casing 410 by pulling out the rack to the outside of the casing 410.
- the sliding direction of the rack may be the front-rear direction of the housing 410 or the left-right direction of the housing 410.
- the door of the housing 410 may have a double-door structure.
- FIG. 4 is a front view showing the configuration of the drug supply device according to the embodiment of the present invention.
- the first drug supply device 10 according to an embodiment of the present invention includes a drug supply module 100, which is a drug supply unit, and a drug replenishment unit 12.
- the first medicine supply device 10 further includes a base unit 200.
- a display unit 250 and a stop switch 238 are provided on the front surface of the base unit 200.
- the medicine replenishing unit 12 includes a medicine storage container 300 that stores a medicine.
- Each of the drug supply module 100 and the drug container 300 can be separately attached to and detached from the base unit 200.
- FIG. 5 is a perspective view showing a configuration of a drug supply unit included in the drug supply device according to the embodiment of the present invention.
- FIG. 6 is a plan view of the medicine supply unit of FIG. 5 viewed from the direction of arrow VI.
- FIG. 7 is a perspective view of the medicine supply unit of FIG. 5 viewed from the arrow VII direction.
- FIG. 8 is a diagram of the medicine supply unit of FIG. 5 viewed from the direction of arrow VIII.
- FIG. 9 is a view of the medicine supply unit of FIG. 5 viewed from the arrow IX direction.
- FIGS. 6 and 7 a lid portion described later is shown in a see-through manner.
- a lid member and an opening/closing member which will be described later are not shown.
- the lid portion is shown in a see-through manner, and the support portion described later is not shown.
- a drug supply module 100 which is a drug supply unit included in the first drug supply device 10 according to an embodiment of the present invention, includes a rotating body 110, a peripheral wall part, and a discharge part 131. Equipped with.
- the drug supply module 100 further includes a support part 150, a lid part 126, and an opening/closing part 141.
- the drug supply module 100 has a drug receiving position and a discharging unit 131 for receiving the refilled drug, and conveys the drugs while aligning the drugs in a line from the drug receiving position to the discharging unit 131, and the discharging unit. It functions as a drug supply unit that sequentially discharges and supplies the drugs one by one from 131.
- the drug supply module 100 is integrally configured by including the rotating body 110, the peripheral wall portion, the discharging portion 131, and the opening/closing portion 141.
- the opening/closing unit 141 does not necessarily have to be provided. That is, the medicine supply module 100 may be integrally configured by including the rotating body 110, the peripheral wall portion, and the discharging portion 131.
- FIG. 10 is a side view showing the configuration of the rotating body included in the drug supply unit included in the drug supply device according to the embodiment of the present invention.
- the rotating body is shown when viewed from the same direction as in FIG. 9.
- the rotating body 110 rotates about an axis 1 that extends in the vertical direction, and is coaxial with the axis 1 that is inclined downward as it goes radially outward about the axis 1. It has a conical slope 110s.
- the rotating body 110 includes a first rotating portion 111 and a second rotating portion 112 that are coaxially arranged.
- the second rotating portion 112 is located below the first rotating portion 111.
- the side surface of the first rotating portion 111 and the side surface of the second rotating portion 112 form an inclined surface 110s.
- Each of the first rotating unit 111 and the second rotating unit 112 is rotatably provided separately from each other. As shown in FIGS. 8 to 10, the first rotating portion 111 is connected to the first driven gear 111g.
- the second rotating portion 112 is connected to the second driven gear 112g.
- the slope 110s of the rotating body 110 is provided with a rolling prevention unit that prevents the medicine from rolling.
- the rolling prevention portion is composed of a concave streak portion radially provided from the apex of the slope 110s.
- the rolling prevention portion is composed of a first groove portion 111c provided on the first rotating portion 111 and a second groove portion 112c provided on the second rotating portion 112.
- the rolling prevention unit does not necessarily have to be provided.
- the rotating body 110 is rotatably supported by the supporting portion 150 located below the rotating body 110.
- the rotating body 110 is provided so as to be attachable to and detachable from the supporting unit 150.
- the support portion 150 includes a substantially circular horizontal plane portion 151, an upright portion 152 that stands up from the edge of the horizontal plane portion 151 in a substantially cylindrical shape, and a substantially cylindrical shape below the horizontal plane portion 151.
- Each of the first driven gear 111g and the second driven gear 112g is located on the inner peripheral side of the base portion 153.
- the drug supply module 100 includes a plurality of peripheral wall portions.
- the medicine supply module 100 includes a first peripheral wall portion 121, a second peripheral wall portion 122, and a third peripheral wall portion 123.
- the number of peripheral wall portions included in the drug supply module 100 is not limited to three and may be one or more.
- each of the first peripheral wall portion 121, the second peripheral wall portion 122, and the third peripheral wall portion 123 extends in an arc shape along the circumferential direction about the axis 1 above the slope 110s. ing.
- Each of the 1st peripheral wall part 121, the 2nd peripheral wall part 122, and the 3rd peripheral wall part 123 supports the chemical
- the 1st peripheral wall part 121, the 2nd peripheral wall part 122, and the 3rd peripheral wall part 123 are located in a line with each other in the rotation direction 2 of the rotating body 110, and the peripheral wall part located in the downstream of the rotation direction 2 has the said radial direction. It is located outside and below.
- the second peripheral wall portion 122 is located on the downstream side in the rotation direction 2 with respect to the first peripheral wall portion 121, and is radially outward and downward with respect to the first peripheral wall portion 121. Is located in.
- the third peripheral wall portion 123 is located on the downstream side in the rotation direction 2 with respect to the second peripheral wall portion 122, and is located outside and below in the radial direction with respect to the second peripheral wall portion 122. ..
- Each of the first peripheral wall portion 121 and the second peripheral wall portion 122 is located above the first rotating portion 111.
- the third peripheral wall portion 123 is located above the second rotating portion 112. Therefore, the 1st rotation part 111 conveys the chemical
- the first rotating unit 111 conveys the drug supported by the second peripheral wall 122 along the second peripheral wall 122.
- the second rotating portion 112 conveys the medicine supported by the third peripheral wall portion 123 along the third peripheral wall portion 123.
- each of the first peripheral wall portion 121, the second peripheral wall portion 122, and the third peripheral wall portion 123 is separated from the slope 110s.
- each of the first peripheral wall portion 121, the second peripheral wall portion 122, and the third peripheral wall portion 123 has a slope 110 s within a range in which the medicine supplied onto the slope 110 s can be supported from the outside in the radial direction. Separated from each other.
- the peripheral wall portions that are adjacent to each other in the rotational direction 2 are located on the downstream side in the rotational direction 2.
- the end portion is separated from the slope 110s as it goes downstream in the rotation direction 2.
- downstream end of the first peripheral wall portion 121 in the rotation direction 2 is separated from the slope 110s as it goes to the downstream side in the rotation direction 2.
- downstream end of the second peripheral wall portion 122 in the rotation direction 2 is separated from the slope 110 s as it goes downstream in the rotation direction 2.
- the peripheral wall portions adjacent to each other in the rotation direction 2 extend outward in the radial direction as they go downstream in the rotation direction 2. They are connected to each other by a slanted wall portion that descends.
- the inclined wall portion does not necessarily have to be provided.
- first peripheral wall portion 121 and the second peripheral wall portion 122 are connected to each other by the first inclined wall portion 124.
- the second peripheral wall portion 122 and the third peripheral wall portion 123 are connected to each other by the second inclined wall portion 125.
- each of the first inclined wall portion 124 and the second inclined wall portion 125 inclines toward the downstream side in the rotational direction 2 as it goes away from the slope 110s. Therefore, each of the boundary line between the first peripheral wall portion 121 and the first inclined wall portion 124 and the boundary line between the second peripheral wall portion 122 and the first inclined wall portion 124 increases with increasing distance from the slope 110s. , Is inclined to the downstream side in the rotation direction 2. Similarly, each of the boundary line between the second peripheral wall portion 122 and the second inclined wall portion 125 and the boundary line between the third peripheral wall portion 123 and the second inclined wall portion 125 is separated upward from the slope 110s. Therefore, it is inclined to the downstream side in the rotation direction 2.
- each of the first peripheral wall portion 121, the second peripheral wall portion 122 and the third peripheral wall portion 123 is configured integrally with the lid portion 126. ..
- Each of the first peripheral wall 121, the second peripheral wall 122, and the third peripheral wall 123 extends downward from the lower surface of the lid 126.
- the lid 126 does not necessarily have to be provided, and the peripheral wall may be provided above the slope 110s.
- Each of the first inclined wall portion 124 and the second inclined wall portion 125 is configured integrally with the lid portion 126. Each of the first inclined wall portion 124 and the second inclined wall portion 125 extends downward from the lower surface of the lid portion 126.
- the lid 126 covers the slope 110s from above.
- the lid 126 is provided so that the slope 110s can be opened upward.
- the lid 126 is arranged on the support 150. Specifically, the lid 126 is provided on the lid member 120.
- Each of the first peripheral wall portion 121, the second peripheral wall portion 122, and the third peripheral wall portion 123 is provided on the lid member 120.
- Each of the first inclined wall portion 124 and the second inclined wall portion 125 is provided on the lid member 120.
- the lid member 120 is detachably mounted on the support portion 150 with respect to the support portion 150.
- a cushioning member 170 is provided between the lid 126 and the support 150.
- the lid member 120 is placed on the horizontal surface portion 151 of the support portion 150 via the buffer member 170 having an arc shape.
- the cushioning member 170 is made of an elastic body such as rubber.
- the buffer member 170 does not necessarily have to be provided.
- the lid member 120 is made of a transparent member. Therefore, each of the lid 126, the first peripheral wall 121, the second peripheral wall 122, and the third peripheral wall 123 is made of a transparent member. Thereby, the inside of the lid member 120 can be visually recognized from the outside of the lid member 120.
- the lid member 120 may be made of a non-transparent member.
- FIG. 11 is a perspective view showing an external appearance of a lid member included in a drug supply unit included in the drug supply device according to the embodiment of the present invention.
- FIG. 12 is a view of the lid member of FIG. 11 viewed from the arrow XII direction.
- FIG. 13 is a diagram of the lid member of FIG. 12 viewed from the arrow XIII direction.
- FIG. 14 is a view of the lid member of FIG. 13 viewed from the arrow XIV direction.
- FIG. 15 is a view of the lid member of FIG. 13 viewed from the arrow XV direction.
- 11 and 12 show a state in which a later-described vibration transmission plate is removed from the lid member 120.
- the lid member 120 is provided with the medicine supply hole 127, the cutout portion 128, and the attachment portion 129. Specifically, each of the medicine supply hole 127 and the attachment portion 129 is provided on the top surface of the lid member 120.
- the cutout 128 is provided on the peripheral edge of the lid member 120 on the lower end side.
- the drug supply hole 127 is provided to supply a drug from the outside of the lid member 120 to the inside of the lid member 120.
- the cutout portion 128 is provided for disposing a discharge member, which will be described later, on the support portion 150.
- the attachment portion 129 is provided to attach a vibration transmission plate, which will be described later, to the lid member 120.
- the first peripheral wall portion 121 is located below the drug supply hole 127, and the first inclined wall portion 124 is located adjacent to the first peripheral wall portion 121. Then, the second peripheral wall portion 122 is positioned adjacent to the first inclined wall portion 124, the second inclined wall portion 125 is positioned adjacent to the second peripheral wall portion 122, and the second inclined wall portion 125 is adjacent.
- the third peripheral wall portion 123 is located, and the cutout portion 128 is located adjacent to the third peripheral wall portion 123.
- the mounting portion 129 is provided with a screw hole.
- the vibration transmission plate 160 is fixed to the mounting portion 129 by screws.
- the vibration transmission plate 160 constitutes a part of the lid 126.
- the vibration transmission plate 160 is made of a magnetic material.
- the vibration transmission plate 160 may be made of a non-magnetic material.
- the vibration transmission plate 160 does not necessarily have to be provided.
- a discharge member 130 is provided on the support portion 150 so as to be fitted into the cutout portion 128.
- the discharge member 130 has an outer shape corresponding to the shape of the cutout 128.
- a slight gap is provided between the discharge member 130 and the lid member 120.
- the discharging member 130 discharges the medicine, which is sequentially conveyed along each of the first peripheral wall portion 121, the second peripheral wall portion 122, and the third peripheral wall portion 123, by the rotation of the rotating body 110 from the slope 110s. Is provided.
- the discharge member 130 is provided with a standing wall portion 132. That is, the standing wall portion 132 is configured as a member different from the peripheral wall portion.
- the standing wall portion 132 is provided between the third peripheral wall portion 123 and the discharge portion 131, and supports the medicine from the outside in the radial direction.
- the standing wall portion 132 extends in an arc shape along the circumferential direction around the axis 1.
- the third peripheral wall portion 123, the standing wall portion 132, and the discharge portion 131 are arranged along the circumferential direction centered on the axis 1.
- the standing wall portion 132 does not necessarily have to be provided.
- the discharge member 130 is provided with a pair of bearings 130b that supports a rotating shaft 140s that rotates the opening/closing part 141.
- the pair of bearings 130b is erected at a position above the discharge part 131.
- the opening/closing part 141 is configured to be able to open/close the discharging part 131 by being rotated by the rotating shaft 140s.
- the opening/closing part 141 is connected to the biasing member 140t and is biased in the direction of closing the discharging part 131.
- the biasing member 140t is composed of a torsion spring, but is not limited to the torsion spring.
- the urging member 140t does not necessarily have to be provided.
- the base unit 200 is provided with an open/close sensor 237 which will be described later and detects the open/closed state of the open/close unit 141.
- the drug supply module 100 further includes a drug stopper 142.
- the medicine stopping portion 142 is adjacent to the discharging portion 131 while extending in the radial direction along the slope 110s on the upstream side in the rotation direction 2 of the rotating body 110 with respect to the discharging portion 131.
- the medicine stopper 142 is provided so as to be able to come into contact with and separate from the slope 110s.
- the medicine stopping portion 142 is configured integrally with the opening/closing portion 141.
- the medicine stopper 142 does not necessarily have to be provided.
- FIG. 16 is a perspective view showing the outer appearance of the opening/closing member included in the drug supply unit included in the drug supply device according to the embodiment of the present invention.
- FIG. 17 is a view of the opening/closing member of FIG. 16 seen from the direction of arrow XVII.
- the opening/closing member 140 is provided with an opening/closing portion 141, a drug stopping portion 142, and a pair of engagement holes 140b.
- the medicine stopping portion 142 projects from one edge in the width direction of the substantially flat plate-shaped opening/closing portion 141 so as to be orthogonal to the opening/closing portion 141.
- the pair of engagement holes 140b are erected at a position above the opening/closing portion 141.
- Each of the pair of engagement holes 140b has a D-shaped inner peripheral surface in a side view.
- Each of the pair of engagement holes 140b engages with a portion of the rotating shaft 140s having a D-shaped cross section.
- FIG. 18 is a perspective view showing a state in which the opening/closing section pivots upward and the discharge section is opened in the medicine supply unit included in the medicine supply device according to the embodiment of the present invention.
- the medicine supply module 100 is illustrated when viewed from the same direction as FIG. 5.
- the opening/closing member 140 rotates around the rotating shaft 140s, and the discharging portion 131 closed by the opening/closing portion 141 is opened. Then, the medicine stopper 142 is separated from the slope 110s.
- the opening/closing member 140 rotates about the rotating shaft 140s, and the opening/closing part 141 closes the discharge part 131 and the medicine stopping part. 142 approaches the slope 110s.
- FIG. 19 is a perspective view showing a configuration of a drug container of a drug replenishing unit included in the drug supply device according to the embodiment of the present invention.
- FIG. 20 is a perspective view showing a state in which the outer lid is removed in the medicine container of the medicine replenishing unit included in the medicine supply device according to the embodiment of the present invention.
- FIG. 21 is a perspective view showing a state in which the lid is removed in the medicine container of the medicine replenishing unit included in the medicine supply device according to the embodiment of the present invention.
- FIG. 22 is a side view showing a state in which the lid is removed in the medicine container of the medicine replenishing unit included in the medicine supply device according to the embodiment of the present invention.
- FIG. 20 is a perspective view showing a state in which the outer lid is removed in the medicine container of the medicine replenishing unit included in the medicine supply device according to the embodiment of the present invention.
- FIG. 21 is a perspective view showing a state in which the lid is removed in the medicine container of the medicine replenishing unit included in the
- FIG. 23 is a plan view showing a state in which the lid is removed in the drug container of the drug replenishing unit included in the drug feeding device according to the embodiment of the present invention.
- FIG. 24 is a bottom view showing a state in which the lid is removed in the medicine container of the medicine replenishing unit included in the medicine supply device according to the embodiment of the present invention.
- FIG. 25 is a vertical cross-sectional view showing a state in which the lid is removed in the medicine container of the medicine replenishing unit included in the medicine supply device according to the embodiment of the present invention.
- the drug storage container 300 of the drug replenishing unit 12 included in the first drug supply device 10 has a bottomed cylindrical shape including a bottom and an opening. It also has a spiral groove formed on the inner peripheral surface thereof.
- the drug container 300 includes a main body cylinder 310, a cylindrical portion 320, a bottom portion 330, and a lid portion 340.
- the main body cylinder 310 has a spiral groove 312 formed on the inner peripheral surface thereof.
- the main body cylinder 310 has a first opening 313 at one end and a second opening 314 at the other end.
- the central axis of the main body cylinder 310 is located on the axis 3 of the medicine container 300. In FIG. 25, a vertical line 4 perpendicular to the axis 3 is shown.
- the angle ⁇ formed by the perpendicular line 4 and the wall surface located on the side of the first opening 313 on the pair of wall surfaces facing each other of the spiral groove 312 formed on the inner peripheral surface of the main body cylinder 310 is
- FIG. 26 is a partial perspective view showing the shape of the medicine replenishing section of the medicine supply device according to the embodiment of the present invention on the side of the opening of the medicine container. In FIG. 26, the state where the cylindrical portion 320 is removed from the main body cylinder 310 is shown.
- the spiral groove 312 is formed on the inner peripheral surface of the main body cylinder 310 so as to continue until it reaches the first opening 313 of the main body cylinder 310.
- a terminal end 312e of the spiral groove 312 on the first opening 313 side has a shape cut along the end surface of the main body cylinder 310 on the first opening 313 side.
- the spiral groove 312 is formed on the inner peripheral surface of the main body cylinder 310 so as to continue to a position before reaching the second opening 314 of the main body cylinder 310.
- the end of the spiral groove 312 on the second opening 314 side is connected to a circumferential groove 315 extending in the circumferential direction around the axis 3. Therefore, the groove width does not become narrow even in the vicinity of the second opening 314 of the main body cylinder 310. Therefore, it is possible to prevent the medicine from being clogged in the groove.
- the cylindrical portion 320 is attached to the outer periphery of the main body cylinder 310 on the side of the first opening 313.
- a male screw for attaching the lid 340 is formed on the outer circumference of the end of the cylindrical portion 320 on the side of the first opening 313 in the direction of the axis 3.
- the bottom portion 330 is attached to the outer periphery of the main body cylinder 310 on the second opening 314 side.
- the bottom portion 330 has a bottom surface 330b that closes the second opening 314.
- the bottom surface 330b is curved in a convex shape on the side away from the second opening 314 in the axis 3 direction. That is, the inner bottom surface of the medicine container 300 has a convex curved surface shape on the outside of the medicine container 300.
- the bottom portion 330 further has an annular portion 330c that protrudes annularly outward from the peripheral edge of the bottom surface 330b.
- the identifier 331 is arranged in the space defined by the bottom surface 330b and the annular portion 330c.
- the bottom portion 330 further includes a disc portion 332 that closes a space defined by the bottom surface 330b and the annular portion 330c.
- the disc portion 332 is fixed to the bottom surface 330b with a screw.
- the identifier 331 is sandwiched between the bottom surface 330b and the disc portion 332.
- the identifier 331 is a permanent magnet.
- the identifier 331 is formed so as to be different from each other in each of the plurality of drug storage containers 300. That is, each of the plurality of drug storage containers 300 has an identifier 331 that can identify each other.
- the identifier 331 is not limited to the permanent magnet, and may be another magnetic body. Moreover, the identifier 331 does not necessarily have to be provided.
- the lid 340 can close the first opening 313.
- the lid portion 340 is composed of an outer lid 341 and an inner lid 342.
- the outer lid 341 is rotatably provided with respect to the inner lid 342.
- the outer lid 341 is provided with an arm portion 341a having a pair of engagement holes 341h.
- a rotary shaft portion 342p having a pair of engagement protrusions 342s is provided on a side portion of the inner lid 342.
- the pair of engagement holes 341h and the pair of engagement protrusions 342s are engaged with each other, whereby the arm portion 341a is supported rotatably around the rotation shaft portion 342p.
- the outer lid 341 becomes rotatable with respect to the inner lid 342.
- a plurality of openings 342h are formed on the inner lid surface 342c of the inner lid 342.
- a space is formed between the outer lid 341 and the inner lid surface 342c for inserting the ear of a PTP (Press-Through-Package) packaging sheet of a desiccant or a medicine.
- PTP Pressure-Through-Package
- FIG. 27 is a partial perspective view showing the configuration of the base portion included in the drug supply device according to the embodiment of the present invention.
- FIG. 28 is a partial rear view showing the configuration of the base portion included in the drug supply device according to the embodiment of the present invention.
- FIG. 29 is a partial perspective view showing a state in which the drug supply unit included in the drug supply device according to the embodiment of the present invention is mounted on the base unit.
- the base unit 200 includes a first drive shaft 210, a second drive shaft 240, a discharge chute 220, a first sensor 231 which is a first detection unit, and a second detection unit which is a second detection unit.
- Two sensors 232, a drug detection sensor 235 which is a drug detection unit, and a vibration unit 260 are provided.
- the base unit 200 is provided with a first motor that is a first drive source that drives the rotating body 110 and a second motor that is a second drive source that drives the opening/closing unit 141.
- Each of the first sensor 231, the second sensor 232, the drug detection sensor 235, and the vibrating section 260 may not necessarily be provided.
- the first drive shaft 210 is connected to the first motor.
- the first drive shaft 210 extends upward from the bottom portion of the base portion 200.
- a first drive gear 211g and a second drive gear 212g are provided at the tip of the first drive shaft 210.
- the first drive gear 211g engages with the first driven gear 111g.
- the second drive gear 212g engages with the second driven gear 112g.
- the first rotating portion 111 rotates via the first drive gear 211g and the first driven gear 111g, and the second drive gear 212g and the second drive gear 212g.
- the second rotating portion 112 rotates via the driven gear 112g. That is, each of the first rotating unit 111 and the second rotating unit 112 is driven by the common drive source.
- the rotation speed of the second rotation unit 112 is higher than the rotation speed of the first rotation unit 111.
- the number of teeth of each of the first drive gear 211g, the second drive gear 212g, the first driven gear 111g, and the second driven gear 112g is such that the rotation speed of the second rotating portion 112 is equal to that of the first rotating portion 111. It is set to be higher than the rotation speed.
- the second drive shaft 240 is connected to the second motor.
- the second drive shaft 240 extends substantially horizontally from one side portion of the base portion 200 toward the other side portion.
- the tip of the second drive shaft 240 engages with the rotating shaft 140s.
- the second motor drives and the second drive shaft 240 rotates, so that the opening/closing member 140 rotates together with the rotating shaft 140s.
- each of the opening/closing unit 141 and the medicine stopping unit 142 also rotates about the rotation shaft 140s. In this way, each of the opening/closing section 141 and the medicine stopping section 142 is driven by the common drive source.
- the discharge chute 220 guides the medicine discharged from the discharge part 131 to the outside of the base part 200.
- the inlet of the discharge chute 220 faces the discharge part 131.
- the first sensor 231 is arranged adjacent to the discharging unit 131.
- a second sensor 232 is arranged on the discharge chute 220. The second sensor 232 is located farther from the discharge unit 131 than the first sensor 231.
- the first sensor 231 detects that the medicine on the slope 110s has been discharged from the discharge portion 131.
- the first sensor 231 outputs a first detection signal when detecting that the medicine has reached the first detection position outside the discharging unit 131.
- the first sensor 231 is composed of a photoelectric sensor and has a light projecting unit and a light receiving unit which are arranged so as to sandwich the region immediately downstream of the discharge unit 131 between them. The arrival of the drug discharged from the discharge unit 131 is detected by detecting that the optical axis between the light projecting unit and the light receiving unit is blocked by the drug.
- the second sensor 232 detects the drug discharged from the discharge unit 131.
- the second sensor 232 outputs a second detection signal when it is detected that the medicine has passed a second detection position which is far from the medicine supply module 100 from the first detection position.
- the second sensor 232 is composed of a photoelectric sensor and has a light projecting unit and a light receiving unit which are arranged so as to sandwich the drug passage defined by the discharge chute 220 therebetween.
- the passage of the medicine discharged from the discharging portion 131 is detected by detecting that the optical axis between the light projecting portion and the light receiving portion has returned from the state blocked by the medicine to the original opened state.
- the drug detection sensor 235 detects the presence or absence of a drug at the drug receiving position on the slope 110s of the drug supply module 100 and outputs a drug detection signal.
- the drug detection sensor 235 is composed of a photoelectric sensor and has a light projecting unit and a light receiving unit which are arranged so as to sandwich the region below the drug supply hole 127 between them. That is, the region located below the drug supply hole 127 on the slope 110s is the drug receiving position for receiving the refilled drug.
- the drug detection sensor 235 detects the presence or absence of a drug at the drug receiving position by detecting whether or not the optical axis between the light projecting unit and the light receiving unit is blocked by the drug.
- the drug detection sensor 235 has a first detection state in which it is detected that there is a drug at the drug receiving position, and a second detection state in which it is detected that there is no drug at the drug receiving position.
- the lid member 120 at least a portion on the optical axis is transparent.
- the vibrating section 260 vibrates each of the first peripheral wall section 121, the second peripheral wall section 122, and the third peripheral wall section 123.
- the vibrating section 260 vibrates each of the first peripheral wall section 121, the second peripheral wall section 122, and the third peripheral wall section 123 via the lid section 126.
- the vibration unit 260 is provided so as to be located directly above the vibration transmission plate 160.
- the vibrating section 260 is provided with a permanent magnet (not shown).
- the vibration transmission plate 160 is made of a magnetic material.
- the vibrating section 260 and the vibration transmitting plate 160 are attracted to each other by the magnetic force of the permanent magnet. That is, the contact portions of the vibrating portion 260 and the lid portion 126 are attracted to each other by the magnetic force.
- the vibration of the vibrating section 260 propagates to each of the first peripheral wall section 121, the second peripheral wall section 122, and the third peripheral wall section 123 through the lid section 126.
- the vibrating section 260 vibrates in a direction inclined with respect to the horizontal plane.
- the vibrating section 260 is driven by an eccentric motor 273 described later in which the motor shaft is arranged so as to be inclined with respect to the horizontal plane.
- the vibration is generated.
- the vibration caused by the portion 260 does not directly propagate to the standing wall portion 132.
- a cushioning member may be provided at the connection between the vibrating section 260 and the base section 200 to suppress the vibration from the vibrating section 260 from propagating to the base section 200. Accordingly, it is possible to suppress the vibration from the vibrating section 260 from propagating to the standing wall section 132 through the base section 200 and the supporting section 150.
- the vibration part 260 is provided in the base part 200, and the lid part 126 is provided in the drug supply module 100, so that the vibration is generated.
- the part 260 can be brought into and out of contact with the lid part 126.
- the base unit 200 is provided with a module detection sensor 236 which will be described later and detects that the medicine supply module 100 is attached.
- FIG. 30 is a front view showing a state in which a cover of a part of the base part is removed in a state where each of the drug supply part and the drug storage container is attached to the base part included in the drug supply device according to the embodiment of the present invention. It is a figure.
- FIG. 31 is a front side perspective view showing a state in which the medicine container and the partial cover of the base portion are removed from the medicine supply device according to the embodiment of the present invention.
- FIG. 32 is a rear perspective view showing a state in which the other part of the cover of the base part is removed from the drug supply device according to the embodiment of the present invention.
- the drug container 300 is attached to the base part 200 with the lid part 340 removed.
- the medicine container 300 attached to the base portion 200 is located above the medicine supply module 100.
- the axis 3 of the medicine container 300 is inclined with respect to the horizontal plane.
- the axis 3 of the medicine container 300 is inclined by 20° with respect to the horizontal plane.
- the base portion 200 is provided with four roller portions that support the medicine container 300 so as to be rotatable about the axis 3.
- the base portion 200 is provided with a pair of rotating shafts.
- a pair of roller portions 281 are attached to one of the pair of rotating shafts with a space therebetween.
- a pair of roller portions 282 are attached to the other of the pair of rotating shafts with a space therebetween.
- the base unit 200 is provided with a container detection sensor 233 that detects that the medicine container 300 is attached.
- a path 290 is provided in the base part 200.
- the base unit 200 is provided with an identification sensor 234 that recognizes the identifier 331 of the drug container 300.
- the identification sensor 234 is a magnetic sensor.
- the identification sensor 234 is not limited to the magnetic sensor and may be any sensor that can recognize the identifier 331. Further, the identification sensor 234 does not necessarily have to be provided.
- the first motor 270 which is the first drive source for driving the rotating body 110 and the second motor source 270 which is the second drive source for driving the opening/closing unit 141 are provided.
- a motor 271 is provided.
- the base portion 200 is provided with a third motor 272 that is a third drive source that drives the other of the pair of rotating shafts.
- the drug replenishing unit 12 shown in FIGS. 4 and 30 includes a drug container 300, the above-mentioned pair of rotary shafts, a pair of roller units 281, a pair of roller units 282, a third motor 272, a container detection sensor 233, and An identification sensor 234 is included.
- the drug storage container 300 stores a drug and is driven to refill the drug receiving position of the drug supply module 100 with the drug. That is, the medicine replenishing unit 12 replenishes the medicine at the medicine receiving position.
- a display unit 250 is provided on the front surface of the base unit 200.
- the display unit 250 selectively emits light of one color from a plurality of colors. Further, the display unit 250 can also emit blinking light.
- the light emission pattern of the display unit 250 can indicate the state of the first medicine supply device 10.
- FIG. 33 is a block diagram showing a connection system of the medicine packaging device according to the embodiment of the present invention.
- the medicine packaging device 400 according to the embodiment of the present invention includes a main control unit 41.
- the main controller 41 is electrically connected to each of the medicine packaging device unit 440, the medicine supply device unit 450, and the operation panel 50.
- the main controller 41 is electrically connected to a prescription information receiving device 90 that receives prescription information via the operation panel 50.
- FIG. 34 is a block diagram showing a connection system of the drug supply device according to the embodiment of the present invention.
- the first drug supply device 10 according to one embodiment of the present invention has a control unit 11 that controls each of the drug supply module 100, which is a drug supply unit, and the drug replenishment unit 12. ..
- the control unit 11 is provided in the base unit 200.
- the control unit 11 includes the first sensor 231, the second sensor 232, the container detection sensor 233, the identification sensor 234, the drug detection sensor 235, the module detection sensor 236, the open/close sensor 237, the stop switch 238, the display unit 250, and the first motor 270.
- the second motor 271, the third motor 272, and the eccentric motor 273 are electrically connected.
- the control unit 11 is electrically connected to the main control unit 41.
- a control device unit 460 is configured by the control unit 11 of each of the plurality of first drug supply devices 10 and the main control unit 41.
- the medicine packaging device 400 includes the control device unit 460.
- the operation of the first drug supply device 10 according to the embodiment of the present invention will be described below. First, the operation of the drug supply module 100, which is a drug supply unit, will be described.
- the medicine supplied from the medicine supply hole 127 to the inside of the lid member 120 is received at the medicine receiving position on the slope 110s and is supported by the first peripheral wall portion 121.
- Each of the first rotating unit 111 and the second rotating unit 112 is driven by the first motor 270.
- the medicine supported by the first peripheral wall portion 121 is conveyed along the first peripheral wall portion 121.
- the medicines supported by the first peripheral wall portion 121 are aligned along the first peripheral wall portion 121 while being transported along the first peripheral wall portion 121.
- the medicine supported by the first peripheral wall portion 121 sequentially moves downward from the medicine located on the leading side in the rotation direction 2 along the first inclined wall portion 124 and moves outward in the radial direction around the axis 1. By doing so, it is supported by the second peripheral wall portion 122.
- the medicine that descends along the first inclined wall portion 124 is accelerated by gravity, and thus has a higher moving speed than the medicine that is conveyed along the first peripheral wall portion 121. As a result, the distance between the medicine that has descended along the first inclined wall portion 124 and the medicine that has not yet descended along the first inclined wall portion 124 becomes wider.
- the medicine supported by the second peripheral wall portion 122 is conveyed along the second peripheral wall portion 122.
- the medicine supported by the second peripheral wall portion 122 sequentially moves downward from the medicine located on the leading side in the rotation direction 2 along the second inclined wall portion 125 and moves to the outer side in the radial direction, thereby the third medicine. It is supported by the peripheral wall portion 123.
- the medicine that descends along the second inclined wall portion 125 is accelerated by gravity, and therefore has a higher moving speed than the medicine that is conveyed along the second peripheral wall portion 122. As a result, the interval between the medicine that has descended along the second inclined wall portion 125 and the medicine that has not yet descended along the second inclined wall portion 125 becomes wider.
- the medicine supported by the third peripheral wall portion 123 is conveyed along the third peripheral wall portion 123. Since the rotation speed of the second rotating portion 112 is higher than the rotation speed of the first rotating portion 111, the distance between the medicine supported by the third peripheral wall portion 123 and the medicine supported by the second peripheral wall portion 122 is small. Get wider
- the medicines supported by the third peripheral wall 123 are sequentially supported by the standing wall 132 from the medicine located on the leading side in the rotation direction 2.
- the medicine supported by the standing wall portion 132 is conveyed along the standing wall portion 132.
- the medicine stopping portion 142 When the medicine stopping portion 142 is close to the slope 110s, the medicine conveyed along the standing wall portion 132 is prevented from moving to the discharging portion 131. Therefore, the rotation shaft 140s is rotated by the second motor 271.
- the opening/closing member 140 When the rotating shaft 140s is rotated to one side, the opening/closing member 140 is rotated around the rotating shaft 140s, the discharging portion 131 closed by the opening/closing portion 141 is opened, and the medicine stopping portion 142 is opened. It is separated from the slope 110s. As a result, among the medicines supported by the standing wall portion 132, the medicines located on the leading side in the rotation direction 2 are discharged one by one from the discharge portion 131.
- the first sensor 231 detects that the medicine on the slope 110s is discharged from the discharge portion 131.
- the second sensor 232 detects the drug discharged from the discharging unit 131.
- the rotating shaft 140s is rotated to the other side, whereby the opening/closing member 140 is rotated around the rotating shaft 140s, and the discharge portion 131 is closed by the opening/closing portion 141.
- the drug stopper 142 approaches the slope 110s.
- the medicine supported by the upright wall portion 132 is prevented from moving to the discharging portion 131 by the medicine stopping portion 142, and is prevented from being discharged from the discharging portion 131 by the opening/closing portion 141.
- the opening/closing unit 141 is in the open state when the drug is supplied from the drug supply unit, and is in the closed state when the drug is not supplied from the drug supply unit.
- the medicine supply unit moves with respect to the housing 410, the medicine supply unit is stopped and the opening/closing unit 141 is closed, and then the movement of the medicine supply unit is started. In this case, it is possible to suppress the discharge of the undesired drug from the discharge unit 131 during the movement of the drug supply unit.
- the opening/closing unit 141 When resuming the supply of the drug from the drug supply unit, the opening/closing unit 141 is opened and the drug supply unit is restarted. In this case, the drug can be discharged from the discharge unit 131 immediately after the drug supply unit is restarted.
- the medicine replenishing unit 12 By rotating the pair of roller portions 282 by the third motor 272, the medicine container 300 is rotationally driven around the axis 3.
- the medicine in the medicine container 300 is conveyed from the bottom 330 side of the medicine container 300 to the first opening 313 side by the spiral groove 312, and the first opening 313 is formed. It is discharged from the section 313.
- the medicine discharged from the first opening 313 passes through the connection conduit 290 of the base 200 and is supplied into the medicine supply hole 127 of the lid member 120.
- the medicines supplied into the medicine supply holes 127 of the lid member 120 are discharged one by one from the discharge portion 131 of the medicine supply module 100.
- the base portion 200 is attached with one medicine container 300 selected in sequence from a plurality of medicine containers 300.
- Each of the plurality of drug storage containers 300 is driven under different drive conditions set based on the identifier 331.
- the drug supply unit is driven corresponding to each of the plurality of drug storage containers 300.
- drugs there are two types of drugs: general drugs, which are small tablets, and special drugs, such as capsules, long and thin tablets, spherical tablets, and triangular column tablets.
- a general medicine or a special medicine is stored in each of the plurality of medicine storage containers 300.
- the control unit 11 to which the detection signal of the identifier 331 from the identification sensor 234 is input is housed inside the medicine container 300 attached to the base unit 200.
- Determine the type of drug present That is, the control unit 11 is input with a drug information signal including drug information regarding the shape of the drug, which is included in the detection signal of the identifier 331 from the identification sensor 234.
- FIG. 35 is a time chart when the medicine packaging device according to an aspect of the present invention operates according to prescription information.
- FIG. 36 is a diagram for explaining prescription information and packaging information.
- prescription information is input to the prescription information reception device 90.
- the prescription information includes information such as the type of drug, time of administration, number of days of administration, daily dose, and dose at each time of administration.
- the drug for 3 days is prescribed in one prescription
- the required number of drug A in one prescription is 9
- the required number of drug B in one prescription is 6 Is.
- the required number of drug A is one after breakfast, after lunch, and after dinner.
- the required number of B drugs is 0 after breakfast and after dinner, and 2 after lunch.
- one packaging information is created based on one prescription information.
- one prescription corresponds to one packaging information based on one prescription information.
- multiple packaging information may be created based on one prescription information.
- one prescription information includes three kinds of medicines
- first packaging information is created for two kinds of the three kinds of medicines
- second packaging information for the remaining one kind. May be created.
- each of the created plurality of packaging information corresponds to one prescription here.
- one packaging information may be created based on a part of one prescription information. For example, when one prescription information includes three kinds of medicines, one packaging information may be created for two kinds of the three kinds of medicines and the packaging information may not be created for the remaining one kind of medicines. is there. In this case, one piece of created packaging information corresponds to one prescription here.
- the prescription information reception device 90 inputs the packaging information according to the input prescription information into the operation panel 50.
- the packaging information includes information for packaging the medicine according to the prescription information.
- a packing instruction for causing the medicine packing apparatus 400 to start the packing operation is input from the input unit provided on the operation panel 50.
- the packing information including the selection information is input from the operation panel 50 to the main control unit 41.
- the main control unit 41 to which the packaging information including the selection information is input, inputs the required number of drugs in one prescription to the control unit 11 of the first drug supply device 10 selected by the selection information.
- the packaging information signal having the packaging information of the medicine is input to the control device unit 460 including the control unit 11 and the main control unit 41 of each of the plurality of first drug supply devices 10.
- the required number of medicines in one package and the supply instruction for starting the supply operation are sequentially input from the main control unit 41 to the control unit 11 at appropriate timing.
- the control unit 11 executes the supply operation for one package.
- a notification of the completion is input from the control unit 11 to the main control unit 41.
- FIG. 37 is a flow chart for explaining the operation of the control unit of the drug supply device, in which the required number of drugs in one prescription is input from the main control unit.
- the drug storage container 300 is identified by the input signal from the identification sensor 234. (Step S11).
- the control unit 11 that has identified the medicine container 300 causes the medicine replenishment unit 12 to start replenishment of the medicine (step S12).
- FIG. 38 is a flow chart for explaining the operation of the control unit when the medicine is replenished by the medicine replenishing unit.
- the control unit 11 determines whether the supply number is less than the required number of medicines in one prescription after starting the medicine replenishment by the medicine replenishment unit 12 (step S12) (step S12). S21).
- the control unit 11 of the first drug supply device 10 in which the drug storage container 300 that stores the A drug is mounted indicates that the supply number of the A drug is It is determined whether the required number is less than 9.
- the control unit 11 of the first drug supply device 10 in which the drug storage container 300 containing the B drug is mounted determines whether the number of supplies of the B drug is less than the required number of 6.
- the control unit 11 determines from the medicine detection signal whether the medicine detection sensor 235, which is a medicine detection unit, detects that there is a medicine at the medicine receiving position. (Step S22).
- the control unit 11 stops the third motor 272, which is a replenishing motor, when the medicine detection sensor 235 is in the first detection state in which the medicine is detected at the medicine receiving position (step S23). That is, the control unit 11 causes the drug replenishment unit 12 to stop refilling the drug when the drug detection unit is in the first detection state. After that, the control unit 11 returns to step S21.
- the third motor 272 which is a replenishing motor
- the control unit 11 rotates the third motor 272 in the forward rotation direction in the second detection state in which the medicine detection sensor 235 detects that there is no medicine at the medicine receiving position (step S24). That is, the control unit 11 causes the drug replenishment unit 12 to replenish the drug when the drug detection unit is in the second detection state. After that, the control unit 11 returns to step S21.
- control unit 11 receives the drug detection signal from the drug detection unit and controls the drug replenishment unit 12 according to the drug detection signal.
- the control unit 11 may be configured to cause the drug replenishment unit 12 to replenish the drug after a waiting time has elapsed from the time when the drug detection unit changed from the first detection state to the second detection state.
- the control unit 11 receives the drug information signal including the drug information regarding the shape of the drug, which is included in the detection signal of the identifier 331 from the identification sensor 234.
- the control unit 11 sets the waiting time according to the drug information.
- the control unit 11 rotates the third motor 272 in the reverse direction (step S25). Thereby, the medicine contained in the medicine container 300 can be returned to the inside of the medicine container 300 from the first opening 313 side.
- the control unit 11 stops the third motor 272 after a lapse of a certain time after rotating the third motor 272 in the reverse direction (step S26).
- control unit 11 causes the drug replenishment unit 12 to replenish the drug when the drug detection unit changes from the second detection state to the first detection state in a state where the number of supplies is less than the required number of drugs in one prescription. It is the later one of the time when the operation amount of the drug supply unit exceeds the set value from the time of stopping and the first detection state and the time when the drug detection unit changes from the first detection state to the second detection state.
- the medicine replenishment unit 12 may be configured to restart the medicine replenishment at the time point. In this case, the control unit 11 sets the set value according to the drug information.
- the operation amount of the drug supply unit is the cumulative rotation angle of the first rotation unit 111 in the rotation direction 2 of the drug supply unit from the time when the first detection state is reached, or the rotation of the first rotation unit 111. It is the cumulative drive time in the direction 2.
- the set value of the cumulative rotation angle is, for example, 60°.
- the set value of the cumulative drive time is a drive time required for the cumulative rotation angle to be, for example, 60°.
- the above replenishment operation is performed at any time in each of the plurality of first drug supply devices 10 that supplies the drug necessary for one prescription.
- the control device unit 460 in the first drug supply device 10 that supplies the drug next to the first drug supply device 10 that is supplying the drug, according to the packaging information, the drug supply unit.
- the medicine replenishment unit 12 starts replenishment of the medicine before the first operation start time.
- the control unit 11 of the first medicine supply apparatus 10 causes the medicine replenishment unit 12 to start replenishment of the medicine when the required number of medicines in one prescription is input from the main control unit 41.
- the control unit 11 of the first medicine supply apparatus 10 causes the medicine replenishment unit 12 to start replenishment of medicines even if the supply instruction is not input from the main control unit 41.
- the control device unit 460 for example, the first medicine supply device 10 that supplies the medicine A has 3 days from the first day to the third day after breakfast. While supplying the drug A for the package, the first drug supply device 10 for supplying the drug B for the three packages from the first day to the third day after lunch is next tested.
- the medicine replenishment unit 12 starts the medicine replenishment before the time when the 1-motor 270 starts driving.
- the medicine replenishing unit 12 has completed the first replenishment at the time when the first medicine supplying apparatus 10 that supplies the medicine next starts to supply the medicine, and the medicine is in the medicine receiving position. Has become.
- the control device unit 460 stops the drug replenishment by the drug replenishment unit 12 sequentially from the first drug supply device 10 which has finished supplying the required number of drugs in one prescription according to the packaging information.
- the control device unit 460 finishes the supply of the B medicine necessary for the three packages from the first day to the third day after lunch,
- the replenishment of the B medicine by the medicine replenishing unit 12 of the first medicine supplying apparatus 10 which has finished supplying the required number of B medicines in the prescription is stopped.
- the controller unit 460 then completes the supply of the A drug necessary for the 3 packages from the first day to the third day after dinner, and then supplies the necessary number of A drugs in one prescription.
- the replenishment of the medicine A by the medicine replenishing unit 12 of the supply device 10 is stopped.
- FIG. 39 is a flowchart for explaining the operation of the control unit of the drug supply device, which is input with the required number of drugs and the supply instruction of the drug from the main control unit.
- the discharge unit that is blocked by the opening/closing unit 141. 131 is opened (step S31).
- the control unit 11 After opening the discharge unit 131, the control unit 11 causes the drug supply module 100, which is a drug supply unit, to start supplying the drug in one package (S32). After starting the supply of the medicine by the medicine supply module 100 (step S32), the control unit 11 counts the medicines supplied from the medicine supply module 100 (step S33). When the number of medicines supplied exceeds the necessary number of medicines in one package, the medicine supply by the medicine supply module 100 is terminated (step S34).
- the control unit 11 determines whether or not the number of medicines supplied is equal to or larger than the necessary number of medicines in one prescription (step S35). When the supply number is more than the required number of medicines in one prescription, the opening/closing section 141 closes the discharge section 131 (step S36). When the supply number is less than the required number of medicines in one prescription, the control unit 11 ends the operation of supplying one package of medicine while maintaining the discharge unit 131 in an open state.
- FIG. 40 is a flow chart for explaining the operation of the control unit when a drug is supplied by the drug supply unit. As shown in FIG. 40, the control unit 11 determines whether the supply number is less than the required number of drugs in one package after starting the supply of the drug by the drug supply module 100 (step S32) (step S32). S41).
- the first drug supply device 10 in which the drug container 300 containing the drug A is mounted determines whether the supply number of the A medicine is less than the required number of 1.
- the control unit 11 of the first drug supply device 10 in which the drug storage container 300 that stores the B drug is mounted determines whether the supply number of the B drug is less than the required number of 2.
- the control unit 11 drives the first motor 270, which is a supply motor, in the forward rotation direction, and also drives the eccentric motor 273, which is a vibration motor ( Step S42). As a result, each of the first rotating portion 111 and the second rotating portion 112 rotates in the forward rotation direction and the vibrating portion 260 vibrates.
- control unit 11 determines whether or not the first sensor 231 which is the first detection unit has detected the drug based on the presence or absence of the input of the first detection signal from the first sensor 231 (step S43).
- the control unit 11 stops the first motor 270 and the eccentric motor 273 (step S44). As described above, when the first detection signal is input, the control unit 11 temporarily stops the drug delivery by the drug supply unit.
- control unit 11 drives the first motor 270 in the reverse rotation direction by the set amount (step S45). In this way, when the first detection signal is input, the control unit 11 temporarily reverses the drug transport direction of the drug supply unit to the reverse direction.
- the control unit 11 drives the first motor 270 in the reverse rotation direction by the set amount, stops the first motor 270, and returns to step S41.
- control unit 11 terminates the supply operation of the medicines for one package (step S34).
- FIG. 41 is a flowchart illustrating the operation of the control unit when counting the medicines supplied by the medicine supply unit.
- the control unit 11 determines whether the first sensor 231 as the first detection unit has detected the drug. The determination is made based on the presence or absence of the input of the first detection signal from the first sensor 231 (step S51).
- the control unit 11 turns on the arrival flag (step S52).
- the control unit 11 leaves the arrival flag as it is.
- control unit 11 determines whether or not the second sensor 232, which is the second detection unit, has detected the drug based on the presence or absence of the input of the second detection signal from the second sensor 232 (step S53).
- step S53 when the second sensor 232 is detecting the drug, the drug blocks the optical axis between the light projecting unit and the light receiving unit that configure the second sensor 232.
- step S53 the control unit 11 determines whether the second sensor 232, which is the second detection unit, detects the drug as a second detection signal from the second sensor 232. It is determined whether or not there is an input (step S54).
- step S54 in the state where the second sensor 232 is not detecting the medicine, the medicine passes through the optical axis between the light projecting section and the light receiving section which constitute the second sensor 232, and the optical axis concerned. Is the state in which it has returned to the original open state.
- the control unit 11 returns to step S51.
- step S54 the control unit 11 confirms whether the arrival flag is on (step S55). When the second sensor 232 does not detect the drug in step S54, the control unit 11 returns to step S54.
- step S54 When the second sensor 232 does not detect the drug and the arrival flag is on in step S54, the control unit 11 increments the supply number by 1 (step S56) and turns off the arrival flag (step S56). Step S57).
- step S59 the control unit 11 determines that the drug is abnormal when the second detection signal is input a plurality of times during the input interval in which the first detection signal is input.
- step S58 the control unit 11 determines whether the supply number is equal to or more than the required number of medicines in one package. When the supply number is equal to or more than the required number of medicines in one package, the control unit 11 finishes counting the medicines. When the supply number is less than the required number of medicines in one package, the control unit 11 returns to step S51.
- control unit 11 receives the first detection signal from the first sensor 231, controls the medicine supply unit according to the first detection signal, and inputs the second detection signal from the second sensor 232. Then, the medicines supplied from the medicine supply unit are counted according to the second detection signal.
- the control unit 11 controls the drug supply unit according to the drug information. Specifically, when it is determined from the drug information that the drug contained in the drug container 300 is a general drug, the general drug is supplied for each rotation amount of the drug container 300. Since the amount discharged to the portion is large, the control unit 11 stops the rotation drive of the medicine container 300 immediately after the medicine detection sensor 235 detects that there is a medicine at the medicine receiving position. After this, when the drug is no longer detected by the drug detection sensor 235, the rotation of the drug container 300 is restarted. This can prevent the medicine from being excessively supplied to the medicine supply unit.
- the control unit 11 determines the time from the detection of the drug at the drug receiving position by the drug detection sensor 235 until the rotation drive of the drug container 300 is stopped in the case of a general drug. Make it longer than.
- the control unit 11 increases the rotation speed of the medicine container 300 as compared with a general medicine.
- the control unit 11 also increases the rotation speed of the rotating body 110 as compared with the case of a general medicine. By doing so, even in the case of a special drug that is difficult to be discharged by rotation drive, the time required for drug replenishment can be made closer to that of a general drug, and the drugs can be supplied one by one from the discharge unit 131.
- each of the rotating body 110 and the vibrating portion 260 is temporarily stopped, and the rotating body 110 is temporarily reversed. Then, the medicine discharged from the discharge portion 131 is held on the slope 110s.
- the vibrating portion 260 is temporarily stopped, the rotating body 110 is temporarily stopped, and then the medicine is discharged from the discharge portion 131.
- the medicine to be held may be held on the slope 110s.
- the control device unit 460 supplies the medicine next to the first medicine supplying apparatus 10 which supplies the medicine according to the packing information.
- the medicine replenishment unit 12 starts the medicine replenishment.
- the control device unit 460 sequentially supplies the required number of medicines in one prescription from the first medicine supplying device 10 in accordance with the packaging information, The replenishment of the medicine by the medicine replenishing unit 12 is stopped. As a result, it is possible to prevent the medicine replenishment unit 12 from replenishing the medicine supply module 100 with the medicine excessively.
- the control device unit 460 receives the medicine detection signal from the medicine detection sensor 235, and the medicine detection sensor 235 receives the medicine detection signal according to the first detection state.
- the drug detection sensor 235 is in the second detection state, the drug replenishment unit 12 is caused to replenish the drug.
- the medicine can be appropriately replenished from the medicine replenishing unit 12 to the medicine supply module 100 by a simple control.
- the control unit 11 receives the drug detection signal from the drug detection sensor 235 and controls the drug replenishment unit 12 according to the drug detection signal.
- the control unit 11 receives the drug detection signal from the drug detection sensor 235 and controls the drug replenishment unit 12 according to the drug detection signal.
- the control unit 11 stops the drug replenishment by the drug replenishment unit 12 when the drug detection sensor 235 is in the first detection state, and the drug detection sensor.
- the medicine replenishing unit is made to replenish the medicine.
- the medicine can be appropriately replenished from the medicine replenishing unit 12 to the medicine supply module 100 by a simple control.
- the control unit 11 controls the medicine replenishment unit after the waiting time has elapsed from the time when the medicine detection sensor 235 changes from the first detection state to the second detection state. Let 12 replenish the drug. As a result, it is possible to prevent the medicine replenishment unit 12 from replenishing the medicine supply module 100 with the medicine excessively.
- the control unit 11 sets the waiting time according to the medicine information. Thereby, the medicine can be appropriately replenished from the medicine replenishing unit 12 to the medicine supply module 100 according to the kind of the medicine.
- the control unit 11 causes the drug replenishment unit 12 to replenish the drug when the drug detection sensor 235 changes from the second detection state to the first detection state. Stop and stop the above-mentioned time, when the operation amount of the medicine supply module 100 exceeds the set value, and when the medicine detection sensor 235 changes from the first detection state to the second detection state, the medicine is replenished later. Replenishment of the medicine by the section 12 is restarted. As a result, it is possible to prevent the medicine replenishment unit 12 from replenishing the medicine supply module 100 with the medicine excessively.
- the control unit 11 sets the set value according to the drug information.
- the medicine can be appropriately replenished from the medicine replenishing unit 12 to the medicine supply module 100 according to the kind of the medicine.
- the control part 11 inputs the 1st detection signal from the 1st sensor 231, controls the chemical
- the second detection signal is input from the second sensor 232, and the medicine supplied from the medicine supply module 100 is counted according to the second detection signal. Accordingly, even when the first sensor 231 detects a plurality of medicines in an overlapping state, the second sensor 232 detects a plurality of medicines in a separated state, and thus the plurality of medicines from the discharge unit 131 are detected. It is possible to detect that is discharged at the same time.
- the control unit 11 when the first detection signal is input, temporarily causes the drug supply module 100 to reverse the drug transport direction. Accordingly, it is possible to prevent the plurality of medicines from being simultaneously discharged from the discharge unit 131.
- the control unit 11 temporarily stops the drug delivery by the drug supply module 100 when the first detection signal is input. Even in this case, it is possible to prevent the plurality of medicines from being simultaneously discharged from the discharge portion 131.
- the control unit 11 receives a drug information signal having drug information related to the shape of the drug.
- the control unit 11 controls the medicine supply module 100 according to the medicine information.
- the drug supply module 100 temporarily stops the drug transfer, or the drug supply module 100 temporarily reverses the drug transfer direction.
- the control unit 11 determines which of the above is selected according to the drug information.
- the control unit 11 determines the time to temporarily stop or the time to temporarily convey in the opposite direction according to the drug information. Accordingly, it is possible to prevent a plurality of drugs from being simultaneously discharged from the discharging unit 131 in a mode according to the type of the drug.
- the control part 11 will judge with an abnormality, if a 2nd detection signal is input in multiple times during the input interval which a 1st detection signal is input. .. Accordingly, it is possible to detect an abnormality in which a plurality of drugs are simultaneously discharged from the discharge unit 131.
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
Abstract
In the present invention, a drug supply unit comprises a drug reception position for receiving a refilled drug, lines up and conveys the drug from the drug reception position, and individually supplies the drug in order from the head of the line. A drug refill unit refills the drug to the drug reception position. A drug detection unit detects the absence/presence of the drug in the drug reception position and outputs a drug detection signal. A control unit controls the drug refill unit. The drug detection signal from the drug detection unit is input to the control unit, which controls the drug refill unit in response to the drug detection signal.
Description
本発明は、薬剤供給装置に関する。
The present invention relates to a drug supply device.
薬剤供給装置の構成を開示した先行文献として、国際公開第2016/013553号(特許文献1)がある。特許文献1に記載された薬剤供給装置は、第1回転体と第2回転体とガイド部材とを含む薬剤払出部を備える。第1回転体は、水平面に対して傾斜した状態で回転可能に配置される円形面を有する。第2回転体は、第1回転体の外周側に回転可能に配置され、上記水平面上に配置される環状面を有する。ガイド部材は、第1回転体の円形面の上方に配置され、上記円形面に対して径方向に延び、かつ、径方向外側に向かうに従って第1回転体の回転方向下流側に位置し、第1回転体の回転により第1回転体上に載置された薬剤が当接可能となるガイド面を有する。薬剤供給装置は、薬剤払出部に薬剤を補充する薬剤補充部をさらに備える。薬剤補充部は、薬剤払出部での薬剤の補充状況に基づいて薬剤を補充可能である。
As a prior document disclosing the configuration of the drug supply device, there is International Publication No. 2016/013553 (Patent Document 1). The drug supply device described in Patent Document 1 includes a drug delivery unit including a first rotating body, a second rotating body, and a guide member. The first rotating body has a circular surface that is rotatably arranged in a state of being inclined with respect to the horizontal plane. The second rotating body is rotatably arranged on the outer peripheral side of the first rotating body and has an annular surface arranged on the horizontal plane. The guide member is disposed above the circular surface of the first rotating body, extends in the radial direction with respect to the circular surface, and is located on the downstream side in the rotational direction of the first rotating body as it extends outward in the radial direction. It has a guide surface with which the medicine placed on the first rotating body can come into contact with the rotation of the one rotating body. The drug supply device further includes a drug replenishment unit that replenishes the drug delivery unit with a drug. The medicine replenishing unit can replenish the medicine based on the medicine replenishment status in the medicine delivering unit.
薬剤供給装置には、薬剤を供給するための所要時間を短縮することが求められている。
本発明は上記の問題点に鑑みてなされたものであって、薬剤を供給するための所要時間を短縮することができる、薬剤供給装置を提供することを目的とする。 The drug supply device is required to reduce the time required to supply the drug.
The present invention has been made in view of the above problems, and an object of the present invention is to provide a drug supply device capable of shortening the time required to supply a drug.
本発明は上記の問題点に鑑みてなされたものであって、薬剤を供給するための所要時間を短縮することができる、薬剤供給装置を提供することを目的とする。 The drug supply device is required to reduce the time required to supply the drug.
The present invention has been made in view of the above problems, and an object of the present invention is to provide a drug supply device capable of shortening the time required to supply a drug.
本発明に基づく薬剤供給装置は、薬剤供給部と、薬剤補充部と、薬剤検出部と、制御部とを備える。薬剤供給部は、補充された薬剤を受ける薬剤受け位置を有し、薬剤受け位置から薬剤を整列させつつ搬送し、薬剤を先頭から順に1つずつ供給する。薬剤補充部は、薬剤受け位置に薬剤を補充する。薬剤検出部は、薬剤受け位置における薬剤の有無を検出して薬剤検出信号を出力する。制御部は、薬剤補充部を制御する。制御部は、薬剤検出部から薬剤検出信号を入力され、薬剤検出信号に応じて薬剤補充部を制御する。
The drug supply device according to the present invention includes a drug supply unit, a drug replenishment unit, a drug detection unit, and a control unit. The medicine supply unit has a medicine receiving position for receiving the replenished medicine, conveys the medicine while aligning the medicine from the medicine receiving position, and supplies the medicines one by one from the top. The medicine replenishing unit replenishes the medicine at the medicine receiving position. The drug detection unit detects the presence or absence of a drug at the drug receiving position and outputs a drug detection signal. The control unit controls the drug supplement unit. The control unit receives the drug detection signal from the drug detection unit and controls the drug replenishment unit according to the drug detection signal.
本発明の一形態においては、薬剤検出部は、薬剤受け位置に薬剤が有ることを検出している第1検出状態と、薬剤受け位置に薬剤が無いことを検出している第2検出状態とを有する。制御部は、薬剤検出部が第1検出状態であるとき、薬剤補充部による薬剤の補充を停止させ、薬剤検出部が第2検出状態であるとき、薬剤補充部に薬剤を補充させる。
In one aspect of the present invention, the medicine detection unit has a first detection state in which the medicine is present at the medicine receiving position and a second detection state in which there is no medicine at the medicine receiving position. Have. The control unit causes the drug replenishment unit to stop replenishment of the drug when the drug detection unit is in the first detection state, and causes the drug replenishment unit to replenish the drug when the drug detection unit is in the second detection state.
本発明の一形態においては、制御部は、薬剤検出部が第1検出状態から第2検出状態になった時点から待機時間の経過後に、薬剤補充部に薬剤を補充させる。
In one aspect of the present invention, the control unit causes the drug replenishment unit to replenish the drug after a waiting time has elapsed from the time when the drug detection unit changed from the first detection state to the second detection state.
本発明の一形態においては、制御部には、薬剤の形状に関する薬剤情報を有する薬剤情報信号が入力される。制御部は、薬剤情報に応じて上記待機時間を設定する。
In one aspect of the present invention, a drug information signal having drug information related to the shape of the drug is input to the control unit. The control unit sets the waiting time according to the drug information.
本発明の一形態においては、制御部は、薬剤検出部が第2検出状態から第1検出状態になった時点で薬剤補充部による薬剤の補充を停止させ、上記時点から薬剤供給部の作動量が設定値を超えた時点、および、薬剤検出部が第1検出状態から第2検出状態になった時点、のうちの遅い時点で薬剤補充部による薬剤の補充を再開させる。
In one aspect of the present invention, the control unit stops the replenishment of the drug by the drug replenishment unit when the drug detection unit changes from the second detection state to the first detection state, and the operation amount of the drug supply unit from that time point. Exceeds the set value, and the drug detection unit switches from the first detection state to the second detection state at a later time, the drug replenishment unit restarts replenishing the drug.
本発明の一形態においては、制御部には、薬剤の形状に関する薬剤情報を有する薬剤情報信号が入力される。制御部は、薬剤情報に応じて上記設定値を設定する。
In one aspect of the present invention, a drug information signal having drug information related to the shape of the drug is input to the control unit. The control unit sets the set value according to the drug information.
本発明によれば、薬剤を供給するための所要時間を短縮することができる。
According to the present invention, the time required to supply a drug can be shortened.
以下、本発明の一実施形態に係る薬剤分包装置について図を参照して説明する。以下の実施形態の説明においては、図中の同一または相当部分には同一符号を付して、その説明は繰返さない。
Hereinafter, a medicine packaging apparatus according to an embodiment of the present invention will be described with reference to the drawings. In the following description of the embodiments, the same or corresponding parts in the drawings will be denoted by the same reference numerals, and the description thereof will not be repeated.
図1は、本発明の一実施形態に係る薬剤分包装置の外観を示す斜視図である。図2は、本発明の一実施形態に係る薬剤分包装置の構成を示す縦断面図である。図3は、図2の薬剤分包装置を矢印III方向から見た平面図である。なお、図1においては、筐体の扉が開いた状態、かつ、手撒きカセットが筐体の前側にスライド移動した状態を図示している。図3においては、薬剤分包装置の天井部を透視して図示している。
FIG. 1 is a perspective view showing the external appearance of a medicine packaging device according to an embodiment of the present invention. FIG. 2 is a vertical cross-sectional view showing the configuration of the medicine packaging device according to the embodiment of the present invention. FIG. 3 is a plan view of the medicine packaging device of FIG. 2 seen from the direction of arrow III. Note that FIG. 1 illustrates a state in which the door of the housing is open and the manual cassette is slid to the front side of the housing. In FIG. 3, the ceiling part of the medicine packaging apparatus is seen through.
図1~図3に示すように、本発明の一実施形態に係る薬剤分包装置400は、薬剤供給装置ユニットと、筐体410と、回転ドラム420と、ホッパ430と、薬剤包装装置ユニット440とを備えている。薬剤分包装置400は、後述する制御装置ユニットをさらに備える。
As shown in FIGS. 1 to 3, a medicine packing apparatus 400 according to an embodiment of the present invention includes a medicine supply device unit, a housing 410, a rotating drum 420, a hopper 430, and a medicine packaging device unit 440. It has and. The medicine packaging device 400 further includes a control device unit described later.
薬剤供給装置ユニットは、薬剤を供給する複数の薬剤供給装置を有している。具体的には、薬剤供給装置ユニットは、複数の第1薬剤供給装置10と、複数の第2薬剤供給装置20と、第3薬剤供給装置30とを有している。
The drug supply device unit has a plurality of drug supply devices for supplying a drug. Specifically, the drug supply device unit includes a plurality of first drug supply devices 10, a plurality of second drug supply devices 20, and a third drug supply device 30.
複数の第2薬剤供給装置20の各々は、複数の薬剤を収容しており、必要数の薬剤を供給可能に構成されている。第2薬剤供給装置20は、自動薬剤供給カセットである。第3薬剤供給装置30は、手撒き薬剤供給カセットである。手撒き薬剤供給カセットは、マトリクス状に配置された区画室を有し、各区画室に一包分の薬剤が収容される。
Each of the plurality of second drug supply devices 20 accommodates a plurality of drugs and is configured to be able to supply the required number of drugs. The second medicine supply device 20 is an automatic medicine supply cassette. The third medicine supply device 30 is a manual medicine supply cassette. The hand-delivered medicine supply cassette has compartments arranged in a matrix, and each compartment accommodates one package of medicine.
複数の第1薬剤供給装置10の各々は、複数の第2薬剤供給装置20のうちの薬剤が空になった第2薬剤供給装置20の代わりに、当該薬剤を供給することができる。また、複数の第1薬剤供給装置10の各々は、複数の第2薬剤供給装置20の各々に収容されている薬剤とは異なる他の薬剤を供給することができる。
Each of the plurality of first drug supply devices 10 can supply the drug in place of the second drug supply device 20 of the plurality of second drug supply devices 20, which is empty of the drug. Further, each of the plurality of first drug supply devices 10 can supply another drug different from the drug contained in each of the plurality of second drug supply devices 20.
薬剤供給装置ユニットは、複数の薬剤供給装置の中から選択された薬剤供給装置から薬剤を一包分ずつ供給する。薬剤包装装置ユニット440は、薬剤供給装置ユニットから供給された薬剤を一包分ずつ包装する。制御装置ユニットは、薬剤供給装置ユニットおよび薬剤包装装置ユニットの各々を制御する。
The drug supply device unit supplies the drug one by one from the drug supply device selected from the plurality of drug supply devices. The medicine packaging device unit 440 packages the medicines supplied from the medicine supply device unit one by one. The control device unit controls each of the medicine supply device unit and the medicine packaging device unit.
筐体410は、薬剤供給装置ユニットと、回転ドラム420と、ホッパ430と、薬剤包装装置ユニット440とを収容している。筐体410は、開閉可能な扉を有している。筐体410の正面に、操作パネル50が設けられている。
The housing 410 accommodates a drug supply device unit, a rotary drum 420, a hopper 430, and a drug packaging device unit 440. The housing 410 has a door that can be opened and closed. The operation panel 50 is provided on the front surface of the housing 410.
図2および図3に示すように、回転ドラム420は、筐体410内において、軸線4まわりに回転可能に支持されている。回転ドラム420には、複数の第1薬剤供給装置10および複数の第2薬剤供給装置20が取り付けられる。すなわち、第1薬剤供給装置10は、移動可能な状態で筐体410内に収容されている。
As shown in FIGS. 2 and 3, the rotary drum 420 is rotatably supported around the axis 4 in the housing 410. A plurality of first drug supply devices 10 and a plurality of second drug supply devices 20 are attached to the rotary drum 420. That is, the first drug supply device 10 is housed in the housing 410 in a movable state.
図2に示すように、回転ドラム420には、薬剤搬送路421が設けられている。薬剤搬送路421は、ホッパ430の上方に位置している。図3に示すように、回転ドラム420の外周側に、第1薬剤供給装置10および第2薬剤供給装置20が環状に並んで配置されている。図2に示すように、第1薬剤供給装置10および第2薬剤供給装置20の各々は、上下方向に並んで配置されている。第1薬剤供給装置10および第2薬剤供給装置20の各々は、薬剤搬送路421と接続されている。第1薬剤供給装置10および第2薬剤供給装置20の各々から供給された薬剤は、薬剤搬送路421を通過してホッパ430内に投入される。第3薬剤供給装置30から供給された薬剤は、ホッパ430内に投入される。ホッパ430内に投入された薬剤は、薬剤包装装置ユニット440にて包装される。
As shown in FIG. 2, the rotary drum 420 is provided with a drug delivery path 421. The medicine transport path 421 is located above the hopper 430. As shown in FIG. 3, the first drug supply device 10 and the second drug supply device 20 are annularly arranged side by side on the outer peripheral side of the rotary drum 420. As shown in FIG. 2, the first drug supply device 10 and the second drug supply device 20 are arranged side by side in the vertical direction. Each of the first drug supply device 10 and the second drug supply device 20 is connected to the drug delivery path 421. The medicine supplied from each of the first medicine supply device 10 and the second medicine supply device 20 passes through the medicine conveyance path 421 and is put into the hopper 430. The medicine supplied from the third medicine supply device 30 is put into the hopper 430. The medicine put into the hopper 430 is packed in the medicine packing device unit 440.
なお、薬剤分包装置400の構成は、上記に限られない。たとえば、第1薬剤供給装置10および第2薬剤供給装置20の各々が、回転ドラム420の代わりにスライド可能なラックに取り付けられていてもよい。この場合、ラックを筐体410の外側に引き出すことにより、第1薬剤供給装置10および第2薬剤供給装置20の各々を筐体410の外側に移動させることができる。なお、ラックのスライド方向は、筐体410の前後方向でもよいし、筐体410の左右方向でもよい。また、筐体410の扉が観音開きする構造であってもよい。
The configuration of the medicine packaging device 400 is not limited to the above. For example, each of the first drug supply device 10 and the second drug supply device 20 may be attached to a slidable rack instead of the rotating drum 420. In this case, each of the first drug supply device 10 and the second drug supply device 20 can be moved to the outside of the casing 410 by pulling out the rack to the outside of the casing 410. The sliding direction of the rack may be the front-rear direction of the housing 410 or the left-right direction of the housing 410. Further, the door of the housing 410 may have a double-door structure.
次に、本発明の一実施形態に係る薬剤供給装置について図を参照して説明する。図4は、本発明の一実施形態に係る薬剤供給装置の構成を示す正面図である。図4に示すように、本発明の一実施形態に係る第1薬剤供給装置10は、薬剤供給部である薬剤供給モジュール100と薬剤補充部12とを含む。第1薬剤供給装置10は、ベース部200をさらに含む。ベース部200の正面には、表示部250および停止スイッチ238が設けられている。薬剤補充部12は、薬剤を収容する薬剤収容容器300を含む。薬剤供給モジュール100および薬剤収容容器300の各々は、別々にベース部200に着脱可能である。
Next, a drug supply device according to an embodiment of the present invention will be described with reference to the drawings. FIG. 4 is a front view showing the configuration of the drug supply device according to the embodiment of the present invention. As shown in FIG. 4, the first drug supply device 10 according to an embodiment of the present invention includes a drug supply module 100, which is a drug supply unit, and a drug replenishment unit 12. The first medicine supply device 10 further includes a base unit 200. A display unit 250 and a stop switch 238 are provided on the front surface of the base unit 200. The medicine replenishing unit 12 includes a medicine storage container 300 that stores a medicine. Each of the drug supply module 100 and the drug container 300 can be separately attached to and detached from the base unit 200.
図5は、本発明の一実施形態に係る薬剤供給装置が備える薬剤供給部の構成を示す斜視図である。図6は、図5の薬剤供給部を矢印VI方向から見た平面図である。図7は、図5の薬剤供給部を矢印VII方向から見た斜視図である。図8は、図5の薬剤供給部を矢印VIII方向から見た図である。図9は、図5の薬剤供給部を矢印IX方向から見た図である。
FIG. 5 is a perspective view showing a configuration of a drug supply unit included in the drug supply device according to the embodiment of the present invention. FIG. 6 is a plan view of the medicine supply unit of FIG. 5 viewed from the direction of arrow VI. FIG. 7 is a perspective view of the medicine supply unit of FIG. 5 viewed from the arrow VII direction. FIG. 8 is a diagram of the medicine supply unit of FIG. 5 viewed from the direction of arrow VIII. FIG. 9 is a view of the medicine supply unit of FIG. 5 viewed from the arrow IX direction.
図6および図7においては、後述する蓋部を透視して図示している。図8においては、後述する蓋部材および開閉部材を図示していない。図9においては、蓋部を透視して図示しており、後述する支持部を図示していない。
In FIGS. 6 and 7, a lid portion described later is shown in a see-through manner. In FIG. 8, a lid member and an opening/closing member which will be described later are not shown. In FIG. 9, the lid portion is shown in a see-through manner, and the support portion described later is not shown.
図5~図9に示すように、本発明の一実施形態に係る第1薬剤供給装置10が備える薬剤供給部である薬剤供給モジュール100は、回転体110と、周壁部と、排出部131とを備える。本実施形態においては、薬剤供給モジュール100は、支持部150、蓋部126および開閉部141をさらに備える。後述するように、薬剤供給モジュール100は、補充された薬剤を受ける薬剤受け位置および排出部131を有し、薬剤受け位置から排出部131に向けて薬剤を一列に整列させつつ搬送し、排出部131から薬剤を先頭から順に1つずつ排出して供給する薬剤供給部として機能する。
As shown in FIGS. 5 to 9, a drug supply module 100, which is a drug supply unit included in the first drug supply device 10 according to an embodiment of the present invention, includes a rotating body 110, a peripheral wall part, and a discharge part 131. Equipped with. In the present embodiment, the drug supply module 100 further includes a support part 150, a lid part 126, and an opening/closing part 141. As will be described later, the drug supply module 100 has a drug receiving position and a discharging unit 131 for receiving the refilled drug, and conveys the drugs while aligning the drugs in a line from the drug receiving position to the discharging unit 131, and the discharging unit. It functions as a drug supply unit that sequentially discharges and supplies the drugs one by one from 131.
本実施形態においては、薬剤供給モジュール100は、回転体110と周壁部と排出部131と開閉部141とを含んで一体に構成されている。なお、開閉部141は、必ずしも設けられていなくてもよい。すなわち、薬剤供給モジュール100が、回転体110と周壁部と排出部131とを含んで一体に構成されていてもよい。
In the present embodiment, the drug supply module 100 is integrally configured by including the rotating body 110, the peripheral wall portion, the discharging portion 131, and the opening/closing portion 141. The opening/closing unit 141 does not necessarily have to be provided. That is, the medicine supply module 100 may be integrally configured by including the rotating body 110, the peripheral wall portion, and the discharging portion 131.
図10は、本発明の一実施形態に係る薬剤供給装置が備える薬剤供給部が含む回転体の構成を示す側面図である。図10においては、回転体を図9と同一方向から見て図示している。図8~図10に示すように、回転体110は、鉛直方向に延びる軸線1を中心として回転し、軸線1を中心とする径方向の外側に行くにしたがって下方に傾斜する軸線1と同軸の円錐面状の斜面110sを有する。
FIG. 10 is a side view showing the configuration of the rotating body included in the drug supply unit included in the drug supply device according to the embodiment of the present invention. In FIG. 10, the rotating body is shown when viewed from the same direction as in FIG. 9. As shown in FIGS. 8 to 10, the rotating body 110 rotates about an axis 1 that extends in the vertical direction, and is coaxial with the axis 1 that is inclined downward as it goes radially outward about the axis 1. It has a conical slope 110s.
回転体110は、互いに同軸配置された、第1回転部111および第2回転部112を含む。第2回転部112は、第1回転部111の下方に位置している。第1回転部111の側面と、第2回転部112の側面とで、斜面110sが構成されている。第1回転部111および第2回転部112の各々は、互いに別々に回転可能に設けられている。図8~図10に示すように、第1回転部111は、第1従動歯車111gと接続されている。第2回転部112は、第2従動歯車112gと接続されている。
The rotating body 110 includes a first rotating portion 111 and a second rotating portion 112 that are coaxially arranged. The second rotating portion 112 is located below the first rotating portion 111. The side surface of the first rotating portion 111 and the side surface of the second rotating portion 112 form an inclined surface 110s. Each of the first rotating unit 111 and the second rotating unit 112 is rotatably provided separately from each other. As shown in FIGS. 8 to 10, the first rotating portion 111 is connected to the first driven gear 111g. The second rotating portion 112 is connected to the second driven gear 112g.
本実施形態においては、回転体110の斜面110sには、薬剤の転動を防止する転動防止部が設けられている。転動防止部は、斜面110sの頂点部から放射状に設けられた凹条部で構成されている。具体的には、転動防止部は、第1回転部111に設けられた第1凹条部111cと、第2回転部112に設けられた第2凹条部112cとから構成されている。なお、転動防止部は、必ずしも設けられていなくてもよい。
In the present embodiment, the slope 110s of the rotating body 110 is provided with a rolling prevention unit that prevents the medicine from rolling. The rolling prevention portion is composed of a concave streak portion radially provided from the apex of the slope 110s. Specifically, the rolling prevention portion is composed of a first groove portion 111c provided on the first rotating portion 111 and a second groove portion 112c provided on the second rotating portion 112. The rolling prevention unit does not necessarily have to be provided.
図6~図8に示すように、回転体110は、回転体110の下方に位置する支持部150に、回転可能に支持されている。回転体110は、支持部150に対して着脱可能に設けられている。図8に示すように、支持部150は、略円形状の水平面部151と、水平面部151の縁から略円筒状に立設された立設部152と、水平面部151から下方に略円筒状に延在する台部153を含む。台部153の内周側に、第1従動歯車111gおよび第2従動歯車112gの各々が位置している。
As shown in FIGS. 6 to 8, the rotating body 110 is rotatably supported by the supporting portion 150 located below the rotating body 110. The rotating body 110 is provided so as to be attachable to and detachable from the supporting unit 150. As shown in FIG. 8, the support portion 150 includes a substantially circular horizontal plane portion 151, an upright portion 152 that stands up from the edge of the horizontal plane portion 151 in a substantially cylindrical shape, and a substantially cylindrical shape below the horizontal plane portion 151. Includes a base 153 extending to. Each of the first driven gear 111g and the second driven gear 112g is located on the inner peripheral side of the base portion 153.
図6~図9に示すように、本実施形態においては、薬剤供給モジュール100は、複数の周壁部を含んでいる。具体的には、薬剤供給モジュール100は、第1周壁部121、第2周壁部122および第3周壁部123を含んでいる。なお、薬剤供給モジュール100が含む周壁部の数は、3つに限られず、1つ以上であればよい。
As shown in FIGS. 6 to 9, in the present embodiment, the drug supply module 100 includes a plurality of peripheral wall portions. Specifically, the medicine supply module 100 includes a first peripheral wall portion 121, a second peripheral wall portion 122, and a third peripheral wall portion 123. The number of peripheral wall portions included in the drug supply module 100 is not limited to three and may be one or more.
図6に示すように、第1周壁部121、第2周壁部122および第3周壁部123の各々は、斜面110sの上方において軸線1を中心とする周方向に沿って円弧状に延在している。第1周壁部121、第2周壁部122および第3周壁部123の各々は、斜面110s上に供給された薬剤を上記径方向の外側から支持する。
As shown in FIG. 6, each of the first peripheral wall portion 121, the second peripheral wall portion 122, and the third peripheral wall portion 123 extends in an arc shape along the circumferential direction about the axis 1 above the slope 110s. ing. Each of the 1st peripheral wall part 121, the 2nd peripheral wall part 122, and the 3rd peripheral wall part 123 supports the chemical|medical agent supplied on 110 s of slopes from the outer side of the said radial direction.
第1周壁部121、第2周壁部122および第3周壁部123は、回転体110の回転方向2に互いに並んでおり、かつ、回転方向2の下流側に位置する周壁部ほど上記径方向の外側かつ下方に位置している。具体的には、第2周壁部122は、第1周壁部121に対して回転方向2の下流側に位置しており、かつ、第1周壁部121に対して、上記径方向の外側かつ下方に位置している。第3周壁部123は、第2周壁部122に対して回転方向2の下流側に位置しており、かつ、第2周壁部122に対して、上記径方向の外側かつ下方に位置している。
The 1st peripheral wall part 121, the 2nd peripheral wall part 122, and the 3rd peripheral wall part 123 are located in a line with each other in the rotation direction 2 of the rotating body 110, and the peripheral wall part located in the downstream of the rotation direction 2 has the said radial direction. It is located outside and below. Specifically, the second peripheral wall portion 122 is located on the downstream side in the rotation direction 2 with respect to the first peripheral wall portion 121, and is radially outward and downward with respect to the first peripheral wall portion 121. Is located in. The third peripheral wall portion 123 is located on the downstream side in the rotation direction 2 with respect to the second peripheral wall portion 122, and is located outside and below in the radial direction with respect to the second peripheral wall portion 122. ..
第1周壁部121および第2周壁部122の各々は、第1回転部111の上方に位置している。第3周壁部123は、第2回転部112の上方に位置している。よって、第1回転部111は、第1周壁部121によって支持されている薬剤を、第1周壁部121に沿って搬送する。第1回転部111は、第2周壁部122によって支持されている薬剤を、第2周壁部122に沿って搬送する。第2回転部112は、第3周壁部123によって支持されている薬剤を、第3周壁部123に沿って搬送する。
Each of the first peripheral wall portion 121 and the second peripheral wall portion 122 is located above the first rotating portion 111. The third peripheral wall portion 123 is located above the second rotating portion 112. Therefore, the 1st rotation part 111 conveys the chemical|medical agent supported by the 1st surrounding wall part 121 along the 1st surrounding wall part 121. The first rotating unit 111 conveys the drug supported by the second peripheral wall 122 along the second peripheral wall 122. The second rotating portion 112 conveys the medicine supported by the third peripheral wall portion 123 along the third peripheral wall portion 123.
図9に示すように、第1周壁部121、第2周壁部122および第3周壁部123の各々は、斜面110sに対して離間している。具体的には、第1周壁部121、第2周壁部122および第3周壁部123の各々は、斜面110s上に供給された薬剤を上記径方向の外側から支持可能な範囲で、斜面110sに対して離間している。
As shown in FIG. 9, each of the first peripheral wall portion 121, the second peripheral wall portion 122, and the third peripheral wall portion 123 is separated from the slope 110s. Specifically, each of the first peripheral wall portion 121, the second peripheral wall portion 122, and the third peripheral wall portion 123 has a slope 110 s within a range in which the medicine supplied onto the slope 110 s can be supported from the outside in the radial direction. Separated from each other.
図6、図7および図9に示すように、本実施形態においては、回転方向2に互いに隣り合う周壁部同士のうち回転方向2の上流側に位置する周壁部における回転方向2の下流側の端部は、回転方向2の下流側に行くにしたがって斜面110sから離れている。
As shown in FIGS. 6, 7 and 9, in the present embodiment, among the peripheral wall portions that are adjacent to each other in the rotational direction 2, the peripheral wall portions that are located on the upstream side in the rotational direction 2 are located on the downstream side in the rotational direction 2. The end portion is separated from the slope 110s as it goes downstream in the rotation direction 2.
具体的には、第1周壁部121における回転方向2の下流側の端部は、回転方向2の下流側に行くにしたがって斜面110sから離れている。同様に、第2周壁部122における回転方向2の下流側の端部は、回転方向2の下流側に行くにしたがって斜面110sから離れている。
Specifically, the downstream end of the first peripheral wall portion 121 in the rotation direction 2 is separated from the slope 110s as it goes to the downstream side in the rotation direction 2. Similarly, the downstream end of the second peripheral wall portion 122 in the rotation direction 2 is separated from the slope 110 s as it goes downstream in the rotation direction 2.
図6、図7および図9に示すように、本実施形態においては、回転方向2に互いに隣り合う周壁部同士は、回転方向2の下流側に行くにしたがって上記径方向の外側に延在しつつ下降する傾斜壁部にて互いに接続されている。なお、傾斜壁部は、必ずしも設けられていなくてもよい。
As shown in FIGS. 6, 7, and 9, in the present embodiment, the peripheral wall portions adjacent to each other in the rotation direction 2 extend outward in the radial direction as they go downstream in the rotation direction 2. They are connected to each other by a slanted wall portion that descends. The inclined wall portion does not necessarily have to be provided.
具体的には、第1周壁部121と第2周壁部122とは、第1傾斜壁部124にて互いに接続されている。第2周壁部122と第3周壁部123とは、第2傾斜壁部125にて互いに接続されている。
Specifically, the first peripheral wall portion 121 and the second peripheral wall portion 122 are connected to each other by the first inclined wall portion 124. The second peripheral wall portion 122 and the third peripheral wall portion 123 are connected to each other by the second inclined wall portion 125.
図7および図9に示すように、第1傾斜壁部124および第2傾斜壁部125の各々は、斜面110sから上方に離れるにしたがって、回転方向2の下流側に傾斜している。よって、第1周壁部121と第1傾斜壁部124との境界線、および、第2周壁部122と第1傾斜壁部124との境界線の、各々は、斜面110sから上方に離れるにしたがって、回転方向2の下流側に傾斜している。同様に、第2周壁部122と第2傾斜壁部125との境界線、および、第3周壁部123と第2傾斜壁部125との境界線の、各々は、斜面110sから上方に離れるにしたがって、回転方向2の下流側に傾斜している。
As shown in FIGS. 7 and 9, each of the first inclined wall portion 124 and the second inclined wall portion 125 inclines toward the downstream side in the rotational direction 2 as it goes away from the slope 110s. Therefore, each of the boundary line between the first peripheral wall portion 121 and the first inclined wall portion 124 and the boundary line between the second peripheral wall portion 122 and the first inclined wall portion 124 increases with increasing distance from the slope 110s. , Is inclined to the downstream side in the rotation direction 2. Similarly, each of the boundary line between the second peripheral wall portion 122 and the second inclined wall portion 125 and the boundary line between the third peripheral wall portion 123 and the second inclined wall portion 125 is separated upward from the slope 110s. Therefore, it is inclined to the downstream side in the rotation direction 2.
図5~図7および図9に示すように、本実施形態においては、第1周壁部121、第2周壁部122および第3周壁部123の各々は、蓋部126と一体で構成されている。第1周壁部121、第2周壁部122および第3周壁部123の各々は、蓋部126の下面から下方に延在している。なお、蓋部126は、必ずしも設けられていなくてもよく、周壁部が斜面110sの上方に配置されていればよい。
As shown in FIGS. 5 to 7 and 9, in the present embodiment, each of the first peripheral wall portion 121, the second peripheral wall portion 122 and the third peripheral wall portion 123 is configured integrally with the lid portion 126. .. Each of the first peripheral wall 121, the second peripheral wall 122, and the third peripheral wall 123 extends downward from the lower surface of the lid 126. The lid 126 does not necessarily have to be provided, and the peripheral wall may be provided above the slope 110s.
第1傾斜壁部124および第2傾斜壁部125の各々は、蓋部126と一体で構成されている。第1傾斜壁部124および第2傾斜壁部125の各々は、蓋部126の下面から下方に延在している。
Each of the first inclined wall portion 124 and the second inclined wall portion 125 is configured integrally with the lid portion 126. Each of the first inclined wall portion 124 and the second inclined wall portion 125 extends downward from the lower surface of the lid portion 126.
蓋部126は、斜面110sを上方から覆っている。蓋部126は、斜面110sを上方に開放可能に設けられている。蓋部126は、支持部150上に配置されている。具体的には、蓋部126は、蓋部材120に設けられている。第1周壁部121、第2周壁部122および第3周壁部123の各々は、蓋部材120に設けられている。第1傾斜壁部124および第2傾斜壁部125の各々は、蓋部材120に設けられている。
The lid 126 covers the slope 110s from above. The lid 126 is provided so that the slope 110s can be opened upward. The lid 126 is arranged on the support 150. Specifically, the lid 126 is provided on the lid member 120. Each of the first peripheral wall portion 121, the second peripheral wall portion 122, and the third peripheral wall portion 123 is provided on the lid member 120. Each of the first inclined wall portion 124 and the second inclined wall portion 125 is provided on the lid member 120.
蓋部材120は、支持部150に対して着脱可能に支持部150上に載置されている。本実施形態においては、図6に示すように、蓋部126と支持部150との間に、緩衝部材170が設けられている。具体的には、蓋部材120が、円弧形状を有する緩衝部材170を介して支持部150の水平面部151上に載置されている。緩衝部材170は、ゴムなどの弾性体で構成されている。なお、緩衝部材170は、必ずしも設けられていなくてもよい。
The lid member 120 is detachably mounted on the support portion 150 with respect to the support portion 150. In this embodiment, as shown in FIG. 6, a cushioning member 170 is provided between the lid 126 and the support 150. Specifically, the lid member 120 is placed on the horizontal surface portion 151 of the support portion 150 via the buffer member 170 having an arc shape. The cushioning member 170 is made of an elastic body such as rubber. The buffer member 170 does not necessarily have to be provided.
蓋部材120は、透明部材で構成されている。よって、蓋部126、第1周壁部121、第2周壁部122および第3周壁部123の各々は、透明部材で構成されている。これにより、蓋部材120の外側から蓋部材120の内側を視認可能となっている。ただし、蓋部材120は、非透明部材で構成されていてもよい。
The lid member 120 is made of a transparent member. Therefore, each of the lid 126, the first peripheral wall 121, the second peripheral wall 122, and the third peripheral wall 123 is made of a transparent member. Thereby, the inside of the lid member 120 can be visually recognized from the outside of the lid member 120. However, the lid member 120 may be made of a non-transparent member.
図11は、本発明の一実施形態に係る薬剤供給装置が備える薬剤供給部に含まれる蓋部材の外観を示す斜視図である。図12は、図11の蓋部材を矢印XII方向から見た図である。図13は、図12の蓋部材を矢印XIII方向から見た図である。図14は、図13の蓋部材を矢印XIV方向から見た図である。図15は、図13の蓋部材を矢印XV方向から見た図である。図11および図12においては、後述する振動伝達板が蓋部材120から取り外された状態を図示している。
FIG. 11 is a perspective view showing an external appearance of a lid member included in a drug supply unit included in the drug supply device according to the embodiment of the present invention. FIG. 12 is a view of the lid member of FIG. 11 viewed from the arrow XII direction. FIG. 13 is a diagram of the lid member of FIG. 12 viewed from the arrow XIII direction. FIG. 14 is a view of the lid member of FIG. 13 viewed from the arrow XIV direction. FIG. 15 is a view of the lid member of FIG. 13 viewed from the arrow XV direction. 11 and 12 show a state in which a later-described vibration transmission plate is removed from the lid member 120.
図11~図15に示すように、本実施形態においては、蓋部材120に、薬剤供給孔127、切欠部128および取付部129が設けられている。具体的には、薬剤供給孔127および取付部129の各々が、蓋部材120の天面に設けられている。切欠部128は、蓋部材120の下端側の周縁に設けられている。
As shown in FIGS. 11 to 15, in the present embodiment, the lid member 120 is provided with the medicine supply hole 127, the cutout portion 128, and the attachment portion 129. Specifically, each of the medicine supply hole 127 and the attachment portion 129 is provided on the top surface of the lid member 120. The cutout 128 is provided on the peripheral edge of the lid member 120 on the lower end side.
薬剤供給孔127は、蓋部材120の外側から蓋部材120の内側に薬剤を供給するために設けられている。切欠部128は、後述する排出部材を支持部150上に配置するために設けられている。取付部129は、後述する振動伝達板を蓋部材120に取り付けるために設けられている。
The drug supply hole 127 is provided to supply a drug from the outside of the lid member 120 to the inside of the lid member 120. The cutout portion 128 is provided for disposing a discharge member, which will be described later, on the support portion 150. The attachment portion 129 is provided to attach a vibration transmission plate, which will be described later, to the lid member 120.
図13~図15に示すように、蓋部材120においては、薬剤供給孔127の下側に第1周壁部121が位置し、第1周壁部121に隣接して第1傾斜壁部124が位置し、第1傾斜壁部124に隣接して第2周壁部122が位置し、第2周壁部122に隣接して第2傾斜壁部125が位置し、第2傾斜壁部125に隣接して第3周壁部123が位置し、第3周壁部123に隣接して切欠部128が位置している。
As shown in FIGS. 13 to 15, in the lid member 120, the first peripheral wall portion 121 is located below the drug supply hole 127, and the first inclined wall portion 124 is located adjacent to the first peripheral wall portion 121. Then, the second peripheral wall portion 122 is positioned adjacent to the first inclined wall portion 124, the second inclined wall portion 125 is positioned adjacent to the second peripheral wall portion 122, and the second inclined wall portion 125 is adjacent. The third peripheral wall portion 123 is located, and the cutout portion 128 is located adjacent to the third peripheral wall portion 123.
図11に示すように、取付部129には、ねじ孔が設けられている。図5~図7に示すように、取付部129には、振動伝達板160がねじによって固定されている。振動伝達板160は、蓋部126の一部を構成している。本実施形態においては、振動伝達板160は、磁性体で構成されている。なお、振動伝達板160は、非磁性体で構成されていてもよい。振動伝達板160は、必ずしも設けられていなくてもよい。
As shown in FIG. 11, the mounting portion 129 is provided with a screw hole. As shown in FIGS. 5 to 7, the vibration transmission plate 160 is fixed to the mounting portion 129 by screws. The vibration transmission plate 160 constitutes a part of the lid 126. In this embodiment, the vibration transmission plate 160 is made of a magnetic material. The vibration transmission plate 160 may be made of a non-magnetic material. The vibration transmission plate 160 does not necessarily have to be provided.
図5~図7および図9に示すように、切欠部128に嵌め込まれるように、排出部材130が支持部150上に設けられている。排出部材130は、切欠部128の形状に対応した外形を有している。排出部材130と蓋部材120との間には、僅かな隙間が設けられている。
As shown in FIGS. 5 to 7 and 9, a discharge member 130 is provided on the support portion 150 so as to be fitted into the cutout portion 128. The discharge member 130 has an outer shape corresponding to the shape of the cutout 128. A slight gap is provided between the discharge member 130 and the lid member 120.
排出部材130には、回転体110の回転により、第1周壁部121、第2周壁部122および第3周壁部123の各々に順次沿って搬送された薬剤を斜面110s上から排出する排出部131が設けられている。
The discharging member 130 discharges the medicine, which is sequentially conveyed along each of the first peripheral wall portion 121, the second peripheral wall portion 122, and the third peripheral wall portion 123, by the rotation of the rotating body 110 from the slope 110s. Is provided.
図7に示すように、排出部材130には、立壁部132が設けられている。すなわち、立壁部132は、周壁部とは別部材で構成されている。立壁部132は、第3周壁部123と排出部131との間に設けられ、薬剤を上記径方向の外側から支持する。立壁部132は、軸線1を中心とする周方向に沿って円弧状に延在している。本実施形態においては、第3周壁部123、立壁部132および排出部131は、軸線1を中心とする周方向に沿って並んでいる。なお、立壁部132は、必ずしも設けられていなくてもよい。
As shown in FIG. 7, the discharge member 130 is provided with a standing wall portion 132. That is, the standing wall portion 132 is configured as a member different from the peripheral wall portion. The standing wall portion 132 is provided between the third peripheral wall portion 123 and the discharge portion 131, and supports the medicine from the outside in the radial direction. The standing wall portion 132 extends in an arc shape along the circumferential direction around the axis 1. In the present embodiment, the third peripheral wall portion 123, the standing wall portion 132, and the discharge portion 131 are arranged along the circumferential direction centered on the axis 1. The standing wall portion 132 does not necessarily have to be provided.
排出部材130には、開閉部141を回動させる回動軸140sを支持する1対の軸受部130bが設けられている。1対の軸受部130bは、排出部131の上方の位置に立設されている。開閉部141は、回動軸140sによって回動させられることにより、排出部131を開閉可能に構成されている。
The discharge member 130 is provided with a pair of bearings 130b that supports a rotating shaft 140s that rotates the opening/closing part 141. The pair of bearings 130b is erected at a position above the discharge part 131. The opening/closing part 141 is configured to be able to open/close the discharging part 131 by being rotated by the rotating shaft 140s.
開閉部141は、付勢部材140tと接続されており、排出部131を閉じる方向に付勢されている。本実施形態においては、付勢部材140tは、トーションばねで構成されているが、トーションばねに限られない。なお、付勢部材140tは、必ずしも設けられていなくてもよい。ベース部200には、開閉部141の開閉状態を検出する、後述する開閉センサ237が設けられている。
The opening/closing part 141 is connected to the biasing member 140t and is biased in the direction of closing the discharging part 131. In the present embodiment, the biasing member 140t is composed of a torsion spring, but is not limited to the torsion spring. The urging member 140t does not necessarily have to be provided. The base unit 200 is provided with an open/close sensor 237 which will be described later and detects the open/closed state of the open/close unit 141.
図7および図9に示すように、本実施形態においては、薬剤供給モジュール100は、薬剤止め部142をさらに含む。薬剤止め部142は、排出部131に対して回転体110の回転方向2の上流側にて、斜面110sに沿って上記径方向に延在しつつ排出部131と隣接している。薬剤止め部142は、斜面110sに接離可能に設けられている。
As shown in FIGS. 7 and 9, in the present embodiment, the drug supply module 100 further includes a drug stopper 142. The medicine stopping portion 142 is adjacent to the discharging portion 131 while extending in the radial direction along the slope 110s on the upstream side in the rotation direction 2 of the rotating body 110 with respect to the discharging portion 131. The medicine stopper 142 is provided so as to be able to come into contact with and separate from the slope 110s.
薬剤止め部142が斜面110sに接近した状態において、薬剤は薬剤止め部142によって排出部131への移動が阻止され、薬剤止め部142が斜面110sから離間した状態において、薬剤は排出部131へ移動可能である。薬剤止め部142は、開閉部141と一体で構成されている。なお、薬剤止め部142は、必ずしも設けられていなくてもよい。
In the state where the medicine stopper 142 approaches the slope 110s, the medicine is prevented from moving to the discharge portion 131 by the medicine stopper 142, and the medicine moves to the discharge portion 131 in the state where the medicine stopper 142 is separated from the slope 110s. It is possible. The medicine stopping portion 142 is configured integrally with the opening/closing portion 141. The medicine stopper 142 does not necessarily have to be provided.
図16は、本発明の一実施形態に係る薬剤供給装置が備える薬剤供給部に含まれる開閉部材の外観を示す斜視図である。図17は、図16の開閉部材を矢印XVII方向から見た図である。
FIG. 16 is a perspective view showing the outer appearance of the opening/closing member included in the drug supply unit included in the drug supply device according to the embodiment of the present invention. FIG. 17 is a view of the opening/closing member of FIG. 16 seen from the direction of arrow XVII.
図5~図7、図9、図16および図17に示すように、開閉部材140に、開閉部141、薬剤止め部142、および、1対の係合孔140bが設けられている。具体的には、薬剤止め部142は、略平板状の開閉部141の幅方向の一方の縁から開閉部141に直交するように突出している。1対の係合孔140bは、開閉部141の上方の位置に立設されている。1対の係合孔140bの各々は、側面視にて、D字状の内周面を有している。1対の係合孔140bの各々は、回動軸140sにおいてD字状の横断面形状を有する部分と係合する。
As shown in FIGS. 5 to 7, FIG. 9, FIG. 16 and FIG. 17, the opening/closing member 140 is provided with an opening/closing portion 141, a drug stopping portion 142, and a pair of engagement holes 140b. Specifically, the medicine stopping portion 142 projects from one edge in the width direction of the substantially flat plate-shaped opening/closing portion 141 so as to be orthogonal to the opening/closing portion 141. The pair of engagement holes 140b are erected at a position above the opening/closing portion 141. Each of the pair of engagement holes 140b has a D-shaped inner peripheral surface in a side view. Each of the pair of engagement holes 140b engages with a portion of the rotating shaft 140s having a D-shaped cross section.
図18は、本発明の一実施形態に係る薬剤供給装置が備える薬剤供給部において、開閉部が上方に回動して排出部が開いた状態を示す斜視図である。図18においては、薬剤供給モジュール100を図5と同一方向から見て図示している。
FIG. 18 is a perspective view showing a state in which the opening/closing section pivots upward and the discharge section is opened in the medicine supply unit included in the medicine supply device according to the embodiment of the present invention. In FIG. 18, the medicine supply module 100 is illustrated when viewed from the same direction as FIG. 5.
回動軸140sが一方に回動させられることにより、図18に示すように、開閉部材140が回動軸140sを中心に回動し、開閉部141によって塞がれていた排出部131が開放され、薬剤止め部142が斜面110sから離間する。
As the rotating shaft 140s is rotated to one side, as shown in FIG. 18, the opening/closing member 140 rotates around the rotating shaft 140s, and the discharging portion 131 closed by the opening/closing portion 141 is opened. Then, the medicine stopper 142 is separated from the slope 110s.
回動軸140sが他方に回動させられることにより、図5に示すように、開閉部材140が回動軸140sを中心に回動し、開閉部141によって排出部131が閉鎖され、薬剤止め部142が斜面110sに接近する。
As the rotating shaft 140s is rotated to the other side, as shown in FIG. 5, the opening/closing member 140 rotates about the rotating shaft 140s, and the opening/closing part 141 closes the discharge part 131 and the medicine stopping part. 142 approaches the slope 110s.
図19は、本発明の一実施形態に係る薬剤供給装置が備える薬剤補充部の薬剤収容容器の構成を示す斜視図である。図20は、本発明の一実施形態に係る薬剤供給装置が備える薬剤補充部の薬剤収容容器において、外蓋を取り外した状態を示す斜視図である。図21は、本発明の一実施形態に係る薬剤供給装置が備える薬剤補充部の薬剤収容容器において、蓋部を取り外した状態を示す斜視図である。図22は、本発明の一実施形態に係る薬剤供給装置が備える薬剤補充部の薬剤収容容器において、蓋部を取り外した状態を示す側面図である。図23は、本発明の一実施形態に係る薬剤供給装置が備える薬剤補充部の薬剤収容容器において、蓋部を取り外した状態を示す平面図である。図24は、本発明の一実施形態に係る薬剤供給装置が備える薬剤補充部の薬剤収容容器において、蓋部を取り外した状態を示す底面図である。図25は、本発明の一実施形態に係る薬剤供給装置が備える薬剤補充部の薬剤収容容器において、蓋部を取り外した状態を示す縦断面図である。
FIG. 19 is a perspective view showing a configuration of a drug container of a drug replenishing unit included in the drug supply device according to the embodiment of the present invention. FIG. 20 is a perspective view showing a state in which the outer lid is removed in the medicine container of the medicine replenishing unit included in the medicine supply device according to the embodiment of the present invention. FIG. 21 is a perspective view showing a state in which the lid is removed in the medicine container of the medicine replenishing unit included in the medicine supply device according to the embodiment of the present invention. FIG. 22 is a side view showing a state in which the lid is removed in the medicine container of the medicine replenishing unit included in the medicine supply device according to the embodiment of the present invention. FIG. 23 is a plan view showing a state in which the lid is removed in the drug container of the drug replenishing unit included in the drug feeding device according to the embodiment of the present invention. FIG. 24 is a bottom view showing a state in which the lid is removed in the medicine container of the medicine replenishing unit included in the medicine supply device according to the embodiment of the present invention. FIG. 25 is a vertical cross-sectional view showing a state in which the lid is removed in the medicine container of the medicine replenishing unit included in the medicine supply device according to the embodiment of the present invention.
図19~図25に示すように、本発明の一実施形態に係る第1薬剤供給装置10が備える薬剤補充部12の薬剤収容容器300は、底部および開口部を含む有底円筒状の形状を有し、かつ、内周面に螺旋溝が形成されている。具体的には、薬剤収容容器300は、本体筒310、円筒部320、底部330、および、蓋部340を含んでいる。
As shown in FIGS. 19 to 25, the drug storage container 300 of the drug replenishing unit 12 included in the first drug supply device 10 according to the embodiment of the present invention has a bottomed cylindrical shape including a bottom and an opening. It also has a spiral groove formed on the inner peripheral surface thereof. Specifically, the drug container 300 includes a main body cylinder 310, a cylindrical portion 320, a bottom portion 330, and a lid portion 340.
本体筒310は、内周面に螺旋溝312が形成されている。本体筒310は、一方の端部に第1開口部313を有し、他方の端部に第2開口部314を有する。本体筒310の中心軸は、薬剤収容容器300の軸線3上に位置している。図25においては、軸線3と垂直な垂線4を図示している。
The main body cylinder 310 has a spiral groove 312 formed on the inner peripheral surface thereof. The main body cylinder 310 has a first opening 313 at one end and a second opening 314 at the other end. The central axis of the main body cylinder 310 is located on the axis 3 of the medicine container 300. In FIG. 25, a vertical line 4 perpendicular to the axis 3 is shown.
図25に示すように、本体筒310の内周面に形成されている螺旋溝312の相対する1対の壁面において、第1開口部313側に位置する壁面と垂線4とのなす角αは、第2開口部314側に位置する壁面と垂線4とのなす角βより大きい。たとえば、α=45°、β=10°である。
As shown in FIG. 25, the angle α formed by the perpendicular line 4 and the wall surface located on the side of the first opening 313 on the pair of wall surfaces facing each other of the spiral groove 312 formed on the inner peripheral surface of the main body cylinder 310 is The angle β between the wall surface located on the side of the second opening 314 and the perpendicular 4 is larger than β. For example, α=45° and β=10°.
図26は、本発明の一実施形態に係る薬剤供給装置が備える薬剤補充部の薬剤収容容器の開口部側の形状を示す部分斜視図である。図26においては、円筒部320を本体筒310から取り外した状態を図示している。
FIG. 26 is a partial perspective view showing the shape of the medicine replenishing section of the medicine supply device according to the embodiment of the present invention on the side of the opening of the medicine container. In FIG. 26, the state where the cylindrical portion 320 is removed from the main body cylinder 310 is shown.
図26に示すように、螺旋溝312は、本体筒310の第1開口部313に到達するまで続くように、本体筒310の内周面に形成されている。螺旋溝312の第1開口部313側の終端312eは、本体筒310の第1開口部313側の端面に沿って切断されたような形状となっている。
As shown in FIG. 26, the spiral groove 312 is formed on the inner peripheral surface of the main body cylinder 310 so as to continue until it reaches the first opening 313 of the main body cylinder 310. A terminal end 312e of the spiral groove 312 on the first opening 313 side has a shape cut along the end surface of the main body cylinder 310 on the first opening 313 side.
また、図25に示すように、螺旋溝312は、本体筒310の第2開口部314に到達する手前の位置まで続くように、本体筒310の内周面に形成されている。螺旋溝312の第2開口部314側の終端は、軸線3を中心とする周方向に延びる周方向溝315に接続されている。そのため、本体筒310の第2開口部314の近傍においても、溝幅が狭くならない。したがって、溝内に薬剤が詰まることを防止することができる。
Further, as shown in FIG. 25, the spiral groove 312 is formed on the inner peripheral surface of the main body cylinder 310 so as to continue to a position before reaching the second opening 314 of the main body cylinder 310. The end of the spiral groove 312 on the second opening 314 side is connected to a circumferential groove 315 extending in the circumferential direction around the axis 3. Therefore, the groove width does not become narrow even in the vicinity of the second opening 314 of the main body cylinder 310. Therefore, it is possible to prevent the medicine from being clogged in the groove.
円筒部320は、本体筒310の第1開口部313側の外周に取り付けられている。円筒部320の軸線3方向における第1開口部313側の端部の外周には、蓋部340を取り付けるための雄ねじが形成されている。
The cylindrical portion 320 is attached to the outer periphery of the main body cylinder 310 on the side of the first opening 313. A male screw for attaching the lid 340 is formed on the outer circumference of the end of the cylindrical portion 320 on the side of the first opening 313 in the direction of the axis 3.
底部330は、本体筒310の第2開口部314側の外周に取り付けられている。底部330は、第2開口部314を閉塞する底面330bを有している。底面330bは、軸線3方向において第2開口部314から離れる側に凸状に湾曲している。すなわち、薬剤収容容器300の内側の底面は、薬剤収容容器300の外側に凸状の曲面形状を有している。
The bottom portion 330 is attached to the outer periphery of the main body cylinder 310 on the second opening 314 side. The bottom portion 330 has a bottom surface 330b that closes the second opening 314. The bottom surface 330b is curved in a convex shape on the side away from the second opening 314 in the axis 3 direction. That is, the inner bottom surface of the medicine container 300 has a convex curved surface shape on the outside of the medicine container 300.
底部330は、底面330bの周縁から外側に円環状に突出した環状部330cをさらに有している。本実施形態においては、図25に示すように、底面330bと環状部330cとによって規定される空間に、識別子331が配置されている。底部330は、底面330bと環状部330cとによって規定される空間を閉塞する円板部332をさらに有している。円板部332は、ねじによって底面330bに対して固定されている。識別子331は、底面330bと円板部332との間に挟み込まれている。
The bottom portion 330 further has an annular portion 330c that protrudes annularly outward from the peripheral edge of the bottom surface 330b. In the present embodiment, as shown in FIG. 25, the identifier 331 is arranged in the space defined by the bottom surface 330b and the annular portion 330c. The bottom portion 330 further includes a disc portion 332 that closes a space defined by the bottom surface 330b and the annular portion 330c. The disc portion 332 is fixed to the bottom surface 330b with a screw. The identifier 331 is sandwiched between the bottom surface 330b and the disc portion 332.
本実施形態においては、識別子331は、永久磁石である。識別子331は、複数の薬剤収容容器300の各々において、互いに異なるように形成されている。すなわち、複数の薬剤収容容器300の各々は、互いに識別可能な識別子331を有している。なお、識別子331は、永久磁石に限られず、他の磁性体であってもよい。また、識別子331は、必ずしも設けられていなくてもよい。
In this embodiment, the identifier 331 is a permanent magnet. The identifier 331 is formed so as to be different from each other in each of the plurality of drug storage containers 300. That is, each of the plurality of drug storage containers 300 has an identifier 331 that can identify each other. The identifier 331 is not limited to the permanent magnet, and may be another magnetic body. Moreover, the identifier 331 does not necessarily have to be provided.
図19に示すように、蓋部340は、第1開口部313を閉塞可能である。図19および図20に示すように、蓋部340は、外蓋341と内蓋342とから構成されている。外蓋341は、内蓋342に対して回動可能に設けられている。具体的には、外蓋341に、1対の係合孔341hを有するアーム部341aが設けられている。内蓋342の側部に、1対の係合突起342sを有する回動軸部342pが設けられている。1対の係合孔341hと1対の係合突起342sとが互いに係合することにより、アーム部341aが回動軸部342pを中心に回動可能に支持される。その結果、外蓋341が内蓋342に対して回動可能となる。
As shown in FIG. 19, the lid 340 can close the first opening 313. As shown in FIGS. 19 and 20, the lid portion 340 is composed of an outer lid 341 and an inner lid 342. The outer lid 341 is rotatably provided with respect to the inner lid 342. Specifically, the outer lid 341 is provided with an arm portion 341a having a pair of engagement holes 341h. A rotary shaft portion 342p having a pair of engagement protrusions 342s is provided on a side portion of the inner lid 342. The pair of engagement holes 341h and the pair of engagement protrusions 342s are engaged with each other, whereby the arm portion 341a is supported rotatably around the rotation shaft portion 342p. As a result, the outer lid 341 becomes rotatable with respect to the inner lid 342.
内蓋342の内蓋面342cには、複数の開口部342hが形成されている。外蓋341が閉じた状態において、外蓋341と内蓋面342cとの間に、乾燥材または薬剤のPTP(Press-Through-Package)包装シートの耳などを入れるための空間が形成される。内蓋342の内周面に、円筒部320の雄ねじと螺合する雌ねじが形成されている。
A plurality of openings 342h are formed on the inner lid surface 342c of the inner lid 342. In a state where the outer lid 341 is closed, a space is formed between the outer lid 341 and the inner lid surface 342c for inserting the ear of a PTP (Press-Through-Package) packaging sheet of a desiccant or a medicine. On the inner peripheral surface of the inner lid 342, a female screw that is screwed with the male screw of the cylindrical portion 320 is formed.
図27は、本発明の一実施形態に係る薬剤供給装置が備えるベース部の構成を示す部分斜視図である。図28は、本発明の一実施形態に係る薬剤供給装置が備えるベース部の構成を示す部分背面図である。図29は、本発明の一実施形態に係る薬剤供給装置が備える薬剤供給部が、ベース部に装着された状態を示す部分斜視図である。
FIG. 27 is a partial perspective view showing the configuration of the base portion included in the drug supply device according to the embodiment of the present invention. FIG. 28 is a partial rear view showing the configuration of the base portion included in the drug supply device according to the embodiment of the present invention. FIG. 29 is a partial perspective view showing a state in which the drug supply unit included in the drug supply device according to the embodiment of the present invention is mounted on the base unit.
図27および図28に示すように、ベース部200には、第1駆動軸210、第2駆動軸240、排出シュート220、第1検出部である第1センサ231、第2検出部である第2センサ232、薬剤検出部である薬剤検出センサ235および振動部260が設けられている。ベース部200には、回転体110を駆動する第1駆動源である第1モータと、開閉部141を駆動する第2駆動源である第2モータとが設けられている。なお、第1センサ231、第2センサ232、薬剤検出センサ235および振動部260の各々は、必ずしも設けられていなくてもよい。
As shown in FIGS. 27 and 28, the base unit 200 includes a first drive shaft 210, a second drive shaft 240, a discharge chute 220, a first sensor 231 which is a first detection unit, and a second detection unit which is a second detection unit. Two sensors 232, a drug detection sensor 235 which is a drug detection unit, and a vibration unit 260 are provided. The base unit 200 is provided with a first motor that is a first drive source that drives the rotating body 110 and a second motor that is a second drive source that drives the opening/closing unit 141. Each of the first sensor 231, the second sensor 232, the drug detection sensor 235, and the vibrating section 260 may not necessarily be provided.
第1駆動軸210は、第1モータに接続されている。第1駆動軸210は、ベース部200の底部から上方に向けて延在している。第1駆動軸210の先端に、第1駆動歯車211gおよび第2駆動歯車212gが設けられている。第1駆動歯車211gは、第1従動歯車111gと係合する。第2駆動歯車212gは、第2従動歯車112gと係合する。
The first drive shaft 210 is connected to the first motor. The first drive shaft 210 extends upward from the bottom portion of the base portion 200. A first drive gear 211g and a second drive gear 212g are provided at the tip of the first drive shaft 210. The first drive gear 211g engages with the first driven gear 111g. The second drive gear 212g engages with the second driven gear 112g.
第1モータが駆動して第1駆動軸210が回転することにより、第1駆動歯車211gおよび第1従動歯車111gを介して第1回転部111が回転するとともに、第2駆動歯車212gおよび第2従動歯車112gを介して第2回転部112が回転する。すなわち、第1回転部111および第2回転部112の各々は、共通の駆動源によって駆動される。
When the first motor drives and the first drive shaft 210 rotates, the first rotating portion 111 rotates via the first drive gear 211g and the first driven gear 111g, and the second drive gear 212g and the second drive gear 212g. The second rotating portion 112 rotates via the driven gear 112g. That is, each of the first rotating unit 111 and the second rotating unit 112 is driven by the common drive source.
第2回転部112の回転速度は、第1回転部111の回転速度より高い。具体的には、第1駆動歯車211g、第2駆動歯車212g、第1従動歯車111gおよび第2従動歯車112gの各々の歯数が、第2回転部112の回転速度が第1回転部111の回転速度より高くなるように設定されている。
The rotation speed of the second rotation unit 112 is higher than the rotation speed of the first rotation unit 111. Specifically, the number of teeth of each of the first drive gear 211g, the second drive gear 212g, the first driven gear 111g, and the second driven gear 112g is such that the rotation speed of the second rotating portion 112 is equal to that of the first rotating portion 111. It is set to be higher than the rotation speed.
第2駆動軸240は、第2モータに接続されている。第2駆動軸240は、ベース部200の一方の側部から他方の側部に向けて略水平に延在している。第2駆動軸240の先端部は、回動軸140sと係合する。
The second drive shaft 240 is connected to the second motor. The second drive shaft 240 extends substantially horizontally from one side portion of the base portion 200 toward the other side portion. The tip of the second drive shaft 240 engages with the rotating shaft 140s.
第2モータが駆動して第2駆動軸240が回転することにより、回動軸140sとともに開閉部材140が回動する。開閉部材140が回動軸140sを中心に回動することにより、開閉部141および薬剤止め部142の各々も回動軸140sを中心に回動する。このように、開閉部141および薬剤止め部142の各々は、共通の駆動源によって駆動される。
The second motor drives and the second drive shaft 240 rotates, so that the opening/closing member 140 rotates together with the rotating shaft 140s. When the opening/closing member 140 rotates about the rotation shaft 140s, each of the opening/closing unit 141 and the medicine stopping unit 142 also rotates about the rotation shaft 140s. In this way, each of the opening/closing section 141 and the medicine stopping section 142 is driven by the common drive source.
排出シュート220は、排出部131から排出された薬剤をベース部200の外側に導く。排出シュート220の入口は、排出部131と対向している。排出部131に隣接して、第1センサ231が配置されている。排出シュート220には、第2センサ232が配置されている。第2センサ232は、第1センサ231よりも排出部131から離れて位置している。
The discharge chute 220 guides the medicine discharged from the discharge part 131 to the outside of the base part 200. The inlet of the discharge chute 220 faces the discharge part 131. The first sensor 231 is arranged adjacent to the discharging unit 131. A second sensor 232 is arranged on the discharge chute 220. The second sensor 232 is located farther from the discharge unit 131 than the first sensor 231.
第1センサ231は、斜面110s上の薬剤が排出部131から排出されたことを検出する。第1センサ231は、排出部131の外側の第1検出位置に薬剤が到達したことを検出したときに第1検出信号を出力する。本実施形態においては、第1センサ231は、光電センサで構成されており、排出部131のすぐ下流側の領域を互いの間に挟むように配置された投光部および受光部を有する。この投光部と受光部との間の光軸が薬剤によって遮られたことを検出することにより、排出部131から排出された薬剤の到達を検出する。
The first sensor 231 detects that the medicine on the slope 110s has been discharged from the discharge portion 131. The first sensor 231 outputs a first detection signal when detecting that the medicine has reached the first detection position outside the discharging unit 131. In the present embodiment, the first sensor 231 is composed of a photoelectric sensor and has a light projecting unit and a light receiving unit which are arranged so as to sandwich the region immediately downstream of the discharge unit 131 between them. The arrival of the drug discharged from the discharge unit 131 is detected by detecting that the optical axis between the light projecting unit and the light receiving unit is blocked by the drug.
第2センサ232は、排出部131から排出された薬剤を検出する。第2センサ232は、第1検出位置より薬剤供給モジュール100から離れた第2検出位置を薬剤が通過したことを検出したときに第2検出信号を出力する。本実施形態においては、第2センサ232は、光電センサで構成されており、排出シュート220によって規定される薬剤通路を互いの間に挟むように配置された投光部および受光部を有する。この投光部と受光部との間の光軸が薬剤によって遮られた状態から元の開通状態に戻ったことを検出することにより、排出部131から排出された薬剤の通過を検出する。
The second sensor 232 detects the drug discharged from the discharge unit 131. The second sensor 232 outputs a second detection signal when it is detected that the medicine has passed a second detection position which is far from the medicine supply module 100 from the first detection position. In the present embodiment, the second sensor 232 is composed of a photoelectric sensor and has a light projecting unit and a light receiving unit which are arranged so as to sandwich the drug passage defined by the discharge chute 220 therebetween. The passage of the medicine discharged from the discharging portion 131 is detected by detecting that the optical axis between the light projecting portion and the light receiving portion has returned from the state blocked by the medicine to the original opened state.
薬剤検出センサ235は、薬剤供給モジュール100の斜面110s上の薬剤受け位置における薬剤の有無を検出して薬剤検出信号を出力する。本実施形態においては、薬剤検出センサ235は、光電センサで構成されており、薬剤供給孔127の下方の領域を互いの間に挟むように配置された投光部および受光部を有する。すなわち、斜面110s上において薬剤供給孔127の下方に位置する領域が、補充された薬剤を受ける薬剤受け位置である。薬剤検出センサ235は、投光部と受光部との間の光軸が薬剤によって遮られているか否かを検出することにより、薬剤受け位置における薬剤の有無を検出する。すなわち、薬剤検出センサ235は、薬剤受け位置に薬剤があることを検出している第1検出状態と、薬剤受け位置に薬剤が無いことを検出している第2検出状態とを有する。なお、蓋部材120において、少なくとも上記光軸上の部分は、透明になっている。
The drug detection sensor 235 detects the presence or absence of a drug at the drug receiving position on the slope 110s of the drug supply module 100 and outputs a drug detection signal. In the present embodiment, the drug detection sensor 235 is composed of a photoelectric sensor and has a light projecting unit and a light receiving unit which are arranged so as to sandwich the region below the drug supply hole 127 between them. That is, the region located below the drug supply hole 127 on the slope 110s is the drug receiving position for receiving the refilled drug. The drug detection sensor 235 detects the presence or absence of a drug at the drug receiving position by detecting whether or not the optical axis between the light projecting unit and the light receiving unit is blocked by the drug. That is, the drug detection sensor 235 has a first detection state in which it is detected that there is a drug at the drug receiving position, and a second detection state in which it is detected that there is no drug at the drug receiving position. In addition, in the lid member 120, at least a portion on the optical axis is transparent.
振動部260は、第1周壁部121、第2周壁部122および第3周壁部123の各々を振動させる。本実施形態においては、振動部260は、蓋部126を介して第1周壁部121、第2周壁部122および第3周壁部123の各々を振動させる。
The vibrating section 260 vibrates each of the first peripheral wall section 121, the second peripheral wall section 122, and the third peripheral wall section 123. In the present embodiment, the vibrating section 260 vibrates each of the first peripheral wall section 121, the second peripheral wall section 122, and the third peripheral wall section 123 via the lid section 126.
具体的には、振動部260は、振動伝達板160の直上に位置するように設けられている。振動部260には、図示しない永久磁石が設けられている。振動伝達板160は、磁性体で構成されている。振動部260と振動伝達板160とは、永久磁石の磁力によって互いに引き合っている。すなわち、振動部260および蓋部126の各々の接触部は、磁力によって互いに引き合っている。振動部260の振動は、蓋部126を通じて、第1周壁部121、第2周壁部122および第3周壁部123の各々に伝播する。振動部260は、水平面に対して傾斜する方向に振動する。本実施形態においては、振動部260は、モータ軸が水平面に対して傾斜するように配置された後述する偏心モータ273によって駆動される。
Specifically, the vibration unit 260 is provided so as to be located directly above the vibration transmission plate 160. The vibrating section 260 is provided with a permanent magnet (not shown). The vibration transmission plate 160 is made of a magnetic material. The vibrating section 260 and the vibration transmitting plate 160 are attracted to each other by the magnetic force of the permanent magnet. That is, the contact portions of the vibrating portion 260 and the lid portion 126 are attracted to each other by the magnetic force. The vibration of the vibrating section 260 propagates to each of the first peripheral wall section 121, the second peripheral wall section 122, and the third peripheral wall section 123 through the lid section 126. The vibrating section 260 vibrates in a direction inclined with respect to the horizontal plane. In the present embodiment, the vibrating section 260 is driven by an eccentric motor 273 described later in which the motor shaft is arranged so as to be inclined with respect to the horizontal plane.
なお、上記のように、排出部材130と蓋部材120との間に僅かな隙間が設けられており、蓋部126と支持部150との間に、緩衝部材170が設けられているため、振動部260による振動は立壁部132には直接伝播しない。
Note that, as described above, since a slight gap is provided between the discharge member 130 and the lid member 120, and the cushioning member 170 is provided between the lid portion 126 and the support portion 150, the vibration is generated. The vibration caused by the portion 260 does not directly propagate to the standing wall portion 132.
振動部260とベース部200との接続部に、振動部260からの振動がベース部200に伝播することを抑制するための緩衝部材が設けられていてもよい。これにより、振動部260からの振動が、ベース部200および支持部150を通じて立壁部132に伝播することを抑制できる。
A cushioning member may be provided at the connection between the vibrating section 260 and the base section 200 to suppress the vibration from the vibrating section 260 from propagating to the base section 200. Accordingly, it is possible to suppress the vibration from the vibrating section 260 from propagating to the standing wall section 132 through the base section 200 and the supporting section 150.
図29に示すように、本実施形態に係る第1薬剤供給装置10においては、振動部260はベース部200に設けられており、蓋部126は薬剤供給モジュール100に設けられているため、振動部260は、蓋部126に対して接離可能である。ベース部200には、薬剤供給モジュール100が取り付けられたことを検出する、後述するモジュール検出センサ236が設けられている。
As shown in FIG. 29, in the first drug supply device 10 according to the present embodiment, the vibration part 260 is provided in the base part 200, and the lid part 126 is provided in the drug supply module 100, so that the vibration is generated. The part 260 can be brought into and out of contact with the lid part 126. The base unit 200 is provided with a module detection sensor 236 which will be described later and detects that the medicine supply module 100 is attached.
図30は、本発明の一実施形態に係る薬剤供給装置が備えるベース部に薬剤供給部および薬剤収容容器の各々が取り付けられた状態において、ベース部の一部のカバーを取り外した状態を示す正面図である。図31は、本発明の一実施形態に係る薬剤供給装置から、薬剤収容容器およびベース部の一部のカバーを取り外した状態を示す正面側斜視図である。図32は、本発明の一実施形態に係る薬剤供給装置からベース部の他の一部のカバーを取り外した状態を示す背面側斜視図である。
FIG. 30 is a front view showing a state in which a cover of a part of the base part is removed in a state where each of the drug supply part and the drug storage container is attached to the base part included in the drug supply device according to the embodiment of the present invention. It is a figure. FIG. 31 is a front side perspective view showing a state in which the medicine container and the partial cover of the base portion are removed from the medicine supply device according to the embodiment of the present invention. FIG. 32 is a rear perspective view showing a state in which the other part of the cover of the base part is removed from the drug supply device according to the embodiment of the present invention.
図4および図30に示すように、本発明の一実施形態に係る第1薬剤供給装置10において、薬剤収容容器300は、蓋部340を取り外した状態でベース部200に取り付けられる。ベース部200に取り付けられた状態の薬剤収容容器300は、薬剤供給モジュール100の上方に位置している。薬剤収容容器300がベース部200に取り付けられた状態において、薬剤収容容器300の軸線3は水平面に対して傾斜している。たとえば、薬剤収容容器300がベース部200に取り付けられた状態において、薬剤収容容器300の軸線3は水平面に対して20°傾斜している。
As shown in FIGS. 4 and 30, in the first drug supply device 10 according to the embodiment of the present invention, the drug container 300 is attached to the base part 200 with the lid part 340 removed. The medicine container 300 attached to the base portion 200 is located above the medicine supply module 100. In a state where the medicine container 300 is attached to the base portion 200, the axis 3 of the medicine container 300 is inclined with respect to the horizontal plane. For example, when the medicine container 300 is attached to the base portion 200, the axis 3 of the medicine container 300 is inclined by 20° with respect to the horizontal plane.
図31に示すように、ベース部200には、薬剤収容容器300を軸線3まわりに回転可能に支持する4つのローラ部が設けられている。具体的には、ベース部200に、1対の回転軸が設けられている。1対の回転軸の一方に、互いに間隔をあけて1対のローラ部281が取り付けられている。1対の回転軸の他方に、互いに間隔をあけて1対のローラ部282が取り付けられている。ベース部200には、薬剤収容容器300が取り付けられたことを検出する容器検出センサ233が設けられている。
As shown in FIG. 31, the base portion 200 is provided with four roller portions that support the medicine container 300 so as to be rotatable about the axis 3. Specifically, the base portion 200 is provided with a pair of rotating shafts. A pair of roller portions 281 are attached to one of the pair of rotating shafts with a space therebetween. A pair of roller portions 282 are attached to the other of the pair of rotating shafts with a space therebetween. The base unit 200 is provided with a container detection sensor 233 that detects that the medicine container 300 is attached.
図30および図31に示すように、ベース部200には、薬剤収容容器300の第1開口部313から排出された薬剤を、薬剤供給モジュール100の蓋部材120の薬剤供給孔127に導く接続管路290が設けられている。
As shown in FIGS. 30 and 31, in the base part 200, a connection pipe for guiding the medicine discharged from the first opening 313 of the medicine container 300 to the medicine supply hole 127 of the lid member 120 of the medicine supply module 100. A path 290 is provided.
図30に示すように、ベース部200には、薬剤収容容器300の識別子331を認識する識別センサ234が設けられている。本実施形態においては、識別センサ234は、磁気センサである。なお、識別センサ234は、磁気センサに限られず、識別子331を認識可能なセンサであればよい。また、識別センサ234は、必ずしも設けられていなくてもよい。
As shown in FIG. 30, the base unit 200 is provided with an identification sensor 234 that recognizes the identifier 331 of the drug container 300. In the present embodiment, the identification sensor 234 is a magnetic sensor. The identification sensor 234 is not limited to the magnetic sensor and may be any sensor that can recognize the identifier 331. Further, the identification sensor 234 does not necessarily have to be provided.
図30に示すように、ベース部200には、上記のように、回転体110を駆動する第1駆動源である第1モータ270と、開閉部141を駆動する第2駆動源である第2モータ271とが設けられている。図32に示すように、ベース部200には、上記の1対の回転軸の他方を駆動する第3駆動源である第3モータ272が設けられている。
As shown in FIG. 30, in the base unit 200, as described above, the first motor 270 which is the first drive source for driving the rotating body 110 and the second motor source 270 which is the second drive source for driving the opening/closing unit 141 are provided. A motor 271 is provided. As shown in FIG. 32, the base portion 200 is provided with a third motor 272 that is a third drive source that drives the other of the pair of rotating shafts.
図4および図30に示す薬剤補充部12は、薬剤収容容器300、上記の1対の回転軸、1対のローラ部281、1対のローラ部282、第3モータ272、容器検出センサ233および識別センサ234を含む。薬剤収容容器300は、薬剤を収容し、駆動されることにより薬剤供給モジュール100の薬剤受け位置に薬剤を補充する。すなわち、薬剤補充部12は、薬剤受け位置に薬剤を補充する。
The drug replenishing unit 12 shown in FIGS. 4 and 30 includes a drug container 300, the above-mentioned pair of rotary shafts, a pair of roller units 281, a pair of roller units 282, a third motor 272, a container detection sensor 233, and An identification sensor 234 is included. The drug storage container 300 stores a drug and is driven to refill the drug receiving position of the drug supply module 100 with the drug. That is, the medicine replenishing unit 12 replenishes the medicine at the medicine receiving position.
図4および図31に示すように、ベース部200の正面には、表示部250が設けられている。本実施形態においては、表示部250は、複数の色の中から選択的に1つの色で発光する。また、表示部250は、点滅発光することも可能である。表示部250の発光パターンによって、第1薬剤供給装置10の状態を表すことができる。
As shown in FIGS. 4 and 31, a display unit 250 is provided on the front surface of the base unit 200. In the present embodiment, the display unit 250 selectively emits light of one color from a plurality of colors. Further, the display unit 250 can also emit blinking light. The light emission pattern of the display unit 250 can indicate the state of the first medicine supply device 10.
図33は、本発明の一形態に係る薬剤分包装置の接続系統を示すブロック図である。図33に示すように、本発明の一実施形態に係る薬剤分包装置400は、主制御部41を有している。主制御部41は、薬剤包装装置ユニット440、薬剤供給装置ユニット450および操作パネル50の各々と電気的に接続されている。主制御部41は、操作パネル50を介して、処方情報を受け付ける処方情報受付装置90と電気的に接続されている。
FIG. 33 is a block diagram showing a connection system of the medicine packaging device according to the embodiment of the present invention. As shown in FIG. 33, the medicine packaging device 400 according to the embodiment of the present invention includes a main control unit 41. The main controller 41 is electrically connected to each of the medicine packaging device unit 440, the medicine supply device unit 450, and the operation panel 50. The main controller 41 is electrically connected to a prescription information receiving device 90 that receives prescription information via the operation panel 50.
図34は、本発明の一形態に係る薬剤供給装置の接続系統を示すブロック図である。図34に示すように、本発明の一実施形態に係る第1薬剤供給装置10は、薬剤供給部である薬剤供給モジュール100および薬剤補充部12の各々を制御する制御部11を有している。制御部11は、ベース部200に設けられている。制御部11は、第1センサ231、第2センサ232、容器検出センサ233、識別センサ234、薬剤検出センサ235、モジュール検出センサ236、開閉センサ237、停止スイッチ238、表示部250、第1モータ270、第2モータ271、第3モータ272および偏心モータ273の各々と電気的に接続されている。
FIG. 34 is a block diagram showing a connection system of the drug supply device according to the embodiment of the present invention. As shown in FIG. 34, the first drug supply device 10 according to one embodiment of the present invention has a control unit 11 that controls each of the drug supply module 100, which is a drug supply unit, and the drug replenishment unit 12. .. The control unit 11 is provided in the base unit 200. The control unit 11 includes the first sensor 231, the second sensor 232, the container detection sensor 233, the identification sensor 234, the drug detection sensor 235, the module detection sensor 236, the open/close sensor 237, the stop switch 238, the display unit 250, and the first motor 270. , The second motor 271, the third motor 272, and the eccentric motor 273 are electrically connected.
制御部11は、主制御部41と電気的に接続されている。複数の第1薬剤供給装置10の各々の制御部11と、主制御部41とによって、制御装置ユニット460が構成されている。上記のように、薬剤分包装置400が、制御装置ユニット460を備えている。
The control unit 11 is electrically connected to the main control unit 41. A control device unit 460 is configured by the control unit 11 of each of the plurality of first drug supply devices 10 and the main control unit 41. As described above, the medicine packaging device 400 includes the control device unit 460.
以下、本発明の一実施形態に係る第1薬剤供給装置10の動作について説明する。まず、薬剤供給部である薬剤供給モジュール100の動作について説明する。
The operation of the first drug supply device 10 according to the embodiment of the present invention will be described below. First, the operation of the drug supply module 100, which is a drug supply unit, will be described.
薬剤供給孔127から蓋部材120の内側に供給された薬剤は、斜面110s上の薬剤受け位置にて受け止められ、第1周壁部121によって支持される。第1モータ270によって、第1回転部111および第2回転部112の各々が駆動される。
The medicine supplied from the medicine supply hole 127 to the inside of the lid member 120 is received at the medicine receiving position on the slope 110s and is supported by the first peripheral wall portion 121. Each of the first rotating unit 111 and the second rotating unit 112 is driven by the first motor 270.
第1回転部111が駆動されることにより、第1周壁部121によって支持されている薬剤が第1周壁部121に沿って搬送される。第1周壁部121によって支持されている薬剤は、第1周壁部121に沿って搬送される間に、第1周壁部121に沿って整列させられる。
By driving the first rotating portion 111, the medicine supported by the first peripheral wall portion 121 is conveyed along the first peripheral wall portion 121. The medicines supported by the first peripheral wall portion 121 are aligned along the first peripheral wall portion 121 while being transported along the first peripheral wall portion 121.
第1周壁部121によって支持されている薬剤は、回転方向2の先頭側に位置する薬剤から順次、第1傾斜壁部124に沿って下降しつつ軸線1を中心とする径方向の外側に移動することにより、第2周壁部122によって支持される。
The medicine supported by the first peripheral wall portion 121 sequentially moves downward from the medicine located on the leading side in the rotation direction 2 along the first inclined wall portion 124 and moves outward in the radial direction around the axis 1. By doing so, it is supported by the second peripheral wall portion 122.
第1傾斜壁部124に沿って下降する薬剤は、重力によって加速されるため、第1周壁部121に沿って搬送されている薬剤より移動速度が高くなる。これにより、第1傾斜壁部124に沿って下降した薬剤と、第1傾斜壁部124に沿って下降する前の薬剤との間隔が広くなる。
The medicine that descends along the first inclined wall portion 124 is accelerated by gravity, and thus has a higher moving speed than the medicine that is conveyed along the first peripheral wall portion 121. As a result, the distance between the medicine that has descended along the first inclined wall portion 124 and the medicine that has not yet descended along the first inclined wall portion 124 becomes wider.
第1回転部111が駆動されることにより、第2周壁部122によって支持されている薬剤が第2周壁部122に沿って搬送される。第2周壁部122によって支持されている薬剤は、回転方向2の先頭側に位置する薬剤から順次、第2傾斜壁部125に沿って下降しつつ上記径方向外側に移動することにより、第3周壁部123によって支持される。
By driving the first rotating portion 111, the medicine supported by the second peripheral wall portion 122 is conveyed along the second peripheral wall portion 122. The medicine supported by the second peripheral wall portion 122 sequentially moves downward from the medicine located on the leading side in the rotation direction 2 along the second inclined wall portion 125 and moves to the outer side in the radial direction, thereby the third medicine. It is supported by the peripheral wall portion 123.
第2傾斜壁部125に沿って下降する薬剤は、重力によって加速されるため、第2周壁部122に沿って搬送されている薬剤より移動速度が高くなる。これにより、第2傾斜壁部125に沿って下降した薬剤と、第2傾斜壁部125に沿って下降する前の薬剤との間隔が広くなる。
The medicine that descends along the second inclined wall portion 125 is accelerated by gravity, and therefore has a higher moving speed than the medicine that is conveyed along the second peripheral wall portion 122. As a result, the interval between the medicine that has descended along the second inclined wall portion 125 and the medicine that has not yet descended along the second inclined wall portion 125 becomes wider.
第2回転部112が駆動されることにより、第3周壁部123によって支持されている薬剤が第3周壁部123に沿って搬送される。第2回転部112の回転速度は、第1回転部111の回転速度より高いため、第3周壁部123によって支持されている薬剤と、第2周壁部122によって支持されている薬剤との間隔が広くなる。
By driving the second rotating portion 112, the medicine supported by the third peripheral wall portion 123 is conveyed along the third peripheral wall portion 123. Since the rotation speed of the second rotating portion 112 is higher than the rotation speed of the first rotating portion 111, the distance between the medicine supported by the third peripheral wall portion 123 and the medicine supported by the second peripheral wall portion 122 is small. Get wider
第3周壁部123によって支持されている薬剤は、回転方向2の先頭側に位置する薬剤から順次、立壁部132によって支持される。第2回転部112が駆動されることにより、立壁部132によって支持されている薬剤は、立壁部132に沿って搬送される。
The medicines supported by the third peripheral wall 123 are sequentially supported by the standing wall 132 from the medicine located on the leading side in the rotation direction 2. By driving the second rotating portion 112, the medicine supported by the standing wall portion 132 is conveyed along the standing wall portion 132.
薬剤止め部142が斜面110sに接近している状態においては、立壁部132に沿って搬送される薬剤の排出部131への移動が阻止される。そこで、第2モータ271によって、回動軸140sが回動させられる。
When the medicine stopping portion 142 is close to the slope 110s, the medicine conveyed along the standing wall portion 132 is prevented from moving to the discharging portion 131. Therefore, the rotation shaft 140s is rotated by the second motor 271.
回動軸140sが一方に回動させられることにより、開閉部材140が回動軸140sを中心に回動し、開閉部141によって塞がれていた排出部131が開放され、薬剤止め部142が斜面110sから離間する。これにより、立壁部132によって支持されている薬剤のうち回転方向2の先頭側に位置する薬剤が、1つずつ排出部131から排出される。
When the rotating shaft 140s is rotated to one side, the opening/closing member 140 is rotated around the rotating shaft 140s, the discharging portion 131 closed by the opening/closing portion 141 is opened, and the medicine stopping portion 142 is opened. It is separated from the slope 110s. As a result, among the medicines supported by the standing wall portion 132, the medicines located on the leading side in the rotation direction 2 are discharged one by one from the discharge portion 131.
このとき、第1センサ231が、斜面110s上の薬剤が排出部131から排出されたことを検出する。第2センサ232が、排出部131から排出された薬剤を検出する。
At this time, the first sensor 231 detects that the medicine on the slope 110s is discharged from the discharge portion 131. The second sensor 232 detects the drug discharged from the discharging unit 131.
排出部131から薬剤が排出された後、回動軸140sが他方に回動させられることにより、開閉部材140が回動軸140sを中心に回動し、開閉部141によって排出部131が閉鎖され、薬剤止め部142が斜面110sに接近する。
After the medicine is discharged from the discharge portion 131, the rotating shaft 140s is rotated to the other side, whereby the opening/closing member 140 is rotated around the rotating shaft 140s, and the discharge portion 131 is closed by the opening/closing portion 141. The drug stopper 142 approaches the slope 110s.
これにより、立壁部132によって支持されている薬剤は、薬剤止め部142によって排出部131への移動が阻止されるとともに、開閉部141によって排出部131からの排出が阻止される。上記のように、開閉部141は、薬剤供給部から薬剤を供給するときは開状態となり、薬剤供給部から薬剤を供給しないときは閉状態となる。
Accordingly, the medicine supported by the upright wall portion 132 is prevented from moving to the discharging portion 131 by the medicine stopping portion 142, and is prevented from being discharged from the discharging portion 131 by the opening/closing portion 141. As described above, the opening/closing unit 141 is in the open state when the drug is supplied from the drug supply unit, and is in the closed state when the drug is not supplied from the drug supply unit.
薬剤供給部が筐体410に対して移動するときは、薬剤供給部が停止するとともに開閉部141が閉状態となった後、薬剤供給部の移動が開始される。このようにした場合、薬剤供給部の移動中に、排出部131から不所望の薬剤が排出されることを抑制できる。
When the medicine supply unit moves with respect to the housing 410, the medicine supply unit is stopped and the opening/closing unit 141 is closed, and then the movement of the medicine supply unit is started. In this case, it is possible to suppress the discharge of the undesired drug from the discharge unit 131 during the movement of the drug supply unit.
薬剤供給部からの薬剤の供給を再開させるときは、開閉部141が開状態となるとともに薬剤供給部が再稼働する。このようにした場合、薬剤供給部の再稼働直後から、薬剤を排出部131から排出可能とすることができる。
When resuming the supply of the drug from the drug supply unit, the opening/closing unit 141 is opened and the drug supply unit is restarted. In this case, the drug can be discharged from the discharge unit 131 immediately after the drug supply unit is restarted.
次に、薬剤補充部12の動作について説明する。
第3モータ272によって、1対のローラ部282が回転することにより、薬剤収容容器300が軸線3まわりに回転駆動される。 Next, the operation of themedicine replenishing unit 12 will be described.
By rotating the pair ofroller portions 282 by the third motor 272, the medicine container 300 is rotationally driven around the axis 3.
第3モータ272によって、1対のローラ部282が回転することにより、薬剤収容容器300が軸線3まわりに回転駆動される。 Next, the operation of the
By rotating the pair of
薬剤収容容器300が軸線3まわりに回転駆動されることにより、薬剤収容容器300内の薬剤が螺旋溝312によって薬剤収容容器300の底部330側から第1開口部313側に搬送されて第1開口部313から排出される。
When the medicine container 300 is rotationally driven around the axis 3, the medicine in the medicine container 300 is conveyed from the bottom 330 side of the medicine container 300 to the first opening 313 side by the spiral groove 312, and the first opening 313 is formed. It is discharged from the section 313.
第1開口部313から排出された薬剤は、ベース部200の接続管路290内を通過して、蓋部材120の薬剤供給孔127内に供給される。蓋部材120の薬剤供給孔127内に供給された薬剤は、薬剤供給モジュール100の排出部131から1つずつ排出される。
The medicine discharged from the first opening 313 passes through the connection conduit 290 of the base 200 and is supplied into the medicine supply hole 127 of the lid member 120. The medicines supplied into the medicine supply holes 127 of the lid member 120 are discharged one by one from the discharge portion 131 of the medicine supply module 100.
なお、ベース部200には、複数の薬剤収容容器300の中から順次選択された1つの薬剤収容容器300が取り付けられる。複数の薬剤収容容器300の各々は、識別子331に基づいて設定された互いに異なる駆動条件で駆動される。薬剤供給部は、複数の薬剤収容容器300の各々に対応して駆動される。
Note that the base portion 200 is attached with one medicine container 300 selected in sequence from a plurality of medicine containers 300. Each of the plurality of drug storage containers 300 is driven under different drive conditions set based on the identifier 331. The drug supply unit is driven corresponding to each of the plurality of drug storage containers 300.
具体的には、薬剤の種類は、小粒の錠剤である一般的な薬剤と、カプセル、長細い錠剤、球形の錠剤または三角柱状の錠剤などの特殊な薬剤とがある。複数の薬剤収容容器300の各々には、一般的な薬剤または特殊な薬剤が収容される。ベース部200に薬剤収容容器300が取り付けられた際、識別センサ234からの識別子331の検出信号が入力された制御部11は、ベース部200に取り付けられた薬剤収容容器300の内部に収容されている薬剤の種類を判別する。すなわち、制御部11には、識別センサ234からの識別子331の検出信号に含まれている、薬剤の形状に関する薬剤情報を有する薬剤情報信号が入力される。
Specifically, there are two types of drugs: general drugs, which are small tablets, and special drugs, such as capsules, long and thin tablets, spherical tablets, and triangular column tablets. A general medicine or a special medicine is stored in each of the plurality of medicine storage containers 300. When the medicine container 300 is attached to the base unit 200, the control unit 11 to which the detection signal of the identifier 331 from the identification sensor 234 is input is housed inside the medicine container 300 attached to the base unit 200. Determine the type of drug present. That is, the control unit 11 is input with a drug information signal including drug information regarding the shape of the drug, which is included in the detection signal of the identifier 331 from the identification sensor 234.
以下、本発明の一実施形態に係る薬剤分包装置400が処方情報に応じて薬剤を分包する際の制御フローについて説明する。
Hereinafter, a control flow when the medicine packaging device 400 according to an embodiment of the present invention packages a medicine according to prescription information will be described.
図35は、本発明の一形態に係る薬剤分包装置が処方情報に応じて動作する際のタイムチャートである。図36は、処方情報および分包情報を説明するための図である。
FIG. 35 is a time chart when the medicine packaging device according to an aspect of the present invention operates according to prescription information. FIG. 36 is a diagram for explaining prescription information and packaging information.
図35に示すように、処方情報受付装置90に処方情報が入力される。処方情報には、薬剤の種類、服用時点、服用日数、1日の服用量および各服用時点の服用量などの情報が含まれている。
As shown in FIG. 35, prescription information is input to the prescription information reception device 90. The prescription information includes information such as the type of drug, time of administration, number of days of administration, daily dose, and dose at each time of administration.
図36に示す処方情報の一例においては、一処方において3日分の薬剤が処方されており、一処方におけるA薬剤の必要数は9個であり、一処方におけるB薬剤の必要数は6個である。A薬剤の必要数は、朝食後、昼食後および夕食後の各々において1個である。B薬剤の必要数は、朝食後および夕食後の各々において0個であり、昼食後において2個である。
In the example of the prescription information shown in FIG. 36, the drug for 3 days is prescribed in one prescription, the required number of drug A in one prescription is 9, and the required number of drug B in one prescription is 6 Is. The required number of drug A is one after breakfast, after lunch, and after dinner. The required number of B drugs is 0 after breakfast and after dinner, and 2 after lunch.
本実施形態では、一つの処方情報に基づいて一つの分包情報が作成される場合を想定している。この場合、一処方は、一つの処方情報に基づく一つの分包情報に対応する。
In the present embodiment, it is assumed that one packaging information is created based on one prescription information. In this case, one prescription corresponds to one packaging information based on one prescription information.
他の例としては、一つの処方情報に基づいて複数の分包情報が作成される場合がある。たとえば、一つの処方情報に3種類の薬剤が含まれる場合、3種類の薬剤のうちの2種類の薬剤について第1の分包情報が作成され、残りの1種類について第2の分包情報が作成されることがある。この場合、作成された複数の分包情報の各々が、ここでいう一処方に対応する。
As another example, multiple packaging information may be created based on one prescription information. For example, when one prescription information includes three kinds of medicines, first packaging information is created for two kinds of the three kinds of medicines, and second packaging information for the remaining one kind. May be created. In this case, each of the created plurality of packaging information corresponds to one prescription here.
さらに他の例として、一つの処方情報の一部に基づいて一つの分包情報が作成される場合もある。たとえば、一つの処方情報に3種類の薬剤が含まれる場合、3種類の薬剤のうちの2種類の薬剤について一つの分包情報が作成され、残りの1種類について分包情報が作成されないことがある。この場合、作成された一つの分包情報が、ここでいう一処方に対応する。
As yet another example, one packaging information may be created based on a part of one prescription information. For example, when one prescription information includes three kinds of medicines, one packaging information may be created for two kinds of the three kinds of medicines and the packaging information may not be created for the remaining one kind of medicines. is there. In this case, one piece of created packaging information corresponds to one prescription here.
図35に示すように、処方情報受付装置90は、入力された処方情報に応じた分包情報を操作パネル50に入力する。分包情報には、処方情報に応じて薬剤を分包するための情報が含まれている。
As shown in FIG. 35, the prescription information reception device 90 inputs the packaging information according to the input prescription information into the operation panel 50. The packaging information includes information for packaging the medicine according to the prescription information.
図35に示すように、操作パネル50に処方情報受付装置90から分包情報が入力された後、複数の薬剤供給装置のうちのいずれの薬剤供給装置から薬剤を供給するか選択する選択情報、および、薬剤分包装置400に分包動作を開始させる分包指示が、操作パネル50に設けられている入力部から入力される。
As shown in FIG. 35, after the packaging information is input from the prescription information receiving device 90 to the operation panel 50, the selection information for selecting which drug supply device of the plurality of drug supply devices to supply the drug, A packing instruction for causing the medicine packing apparatus 400 to start the packing operation is input from the input unit provided on the operation panel 50.
図35に示すように、操作パネル50の入力部に分包指示が入力されると、選択情報を含む分包情報が操作パネル50から主制御部41に入力される。選択情報を含む分包情報を入力された主制御部41は、選択情報によって選択された第1薬剤供給装置10の制御部11に、一処方における薬剤の必要数を入力する。上記のように、複数の第1薬剤供給装置10の各々の制御部11と主制御部41とによって構成される制御装置ユニット460には、薬剤の分包情報を有する分包情報信号が入力される。
As shown in FIG. 35, when the packing instruction is input to the input unit of the operation panel 50, the packing information including the selection information is input from the operation panel 50 to the main control unit 41. The main control unit 41, to which the packaging information including the selection information is input, inputs the required number of drugs in one prescription to the control unit 11 of the first drug supply device 10 selected by the selection information. As described above, the packaging information signal having the packaging information of the medicine is input to the control device unit 460 including the control unit 11 and the main control unit 41 of each of the plurality of first drug supply devices 10. It
その後、一包における薬剤の必要数、および、供給動作を開始させる供給指示が、主制御部41から制御部11に、適宜のタイミングで順次、入力される。制御部11は、供給指示が入力されると、一包分の供給動作を実行する。一包分の供給動作が完了すると、その旨を告げる完了通知が、制御部11から主制御部41に入力される。
After that, the required number of medicines in one package and the supply instruction for starting the supply operation are sequentially input from the main control unit 41 to the control unit 11 at appropriate timing. When the supply instruction is input, the control unit 11 executes the supply operation for one package. When the supply operation for one package is completed, a notification of the completion is input from the control unit 11 to the main control unit 41.
一処方分の分包動作が完了すると、その旨を告げる完了通知が、主制御部41から操作パネル50に入力される。
When the packaging operation for one prescription is completed, a completion notification to that effect is input from the main control unit 41 to the operation panel 50.
図37は、主制御部から一処方における薬剤の必要数を入力された薬剤供給装置の制御部における動作を説明するフローチャートである。図37に示すように、主制御部41から一処方における薬剤の必要数を入力された第1薬剤供給装置10の制御部11においては、識別センサ234からの入力信号によって薬剤収容容器300を識別する(工程S11)。薬剤収容容器300を識別した制御部11は、薬剤補充部12に薬剤の補充を開始させる(工程S12)。
FIG. 37 is a flow chart for explaining the operation of the control unit of the drug supply device, in which the required number of drugs in one prescription is input from the main control unit. As shown in FIG. 37, in the control unit 11 of the first drug supply device 10 to which the required number of drugs in one prescription has been input from the main control unit 41, the drug storage container 300 is identified by the input signal from the identification sensor 234. (Step S11). The control unit 11 that has identified the medicine container 300 causes the medicine replenishment unit 12 to start replenishment of the medicine (step S12).
図38は、薬剤補充部によって薬剤を補充する際の制御部における動作を説明するフローチャートである。図38に示すように、制御部11は、薬剤補充部12による薬剤の補充を開始させた(工程S12)後、供給数が一処方における薬剤の必要数未満であるかどうかを判別する(工程S21)。
FIG. 38 is a flow chart for explaining the operation of the control unit when the medicine is replenished by the medicine replenishing unit. As shown in FIG. 38, the control unit 11 determines whether the supply number is less than the required number of medicines in one prescription after starting the medicine replenishment by the medicine replenishment unit 12 (step S12) (step S12). S21).
具体的には、図36に示す分包情報の一例において、A薬剤を収容している薬剤収容容器300が搭載されている第1薬剤供給装置10の制御部11は、A薬剤の供給数が必要数である9未満であるかどうかを判別する。B薬剤を収容している薬剤収容容器300が搭載されている第1薬剤供給装置10の制御部11は、B薬剤の供給数が必要数である6未満であるかどうかを判別する。
Specifically, in the example of the packaging information illustrated in FIG. 36, the control unit 11 of the first drug supply device 10 in which the drug storage container 300 that stores the A drug is mounted indicates that the supply number of the A drug is It is determined whether the required number is less than 9. The control unit 11 of the first drug supply device 10 in which the drug storage container 300 containing the B drug is mounted determines whether the number of supplies of the B drug is less than the required number of 6.
供給数が一処方における薬剤の必要数未満である場合、制御部11は、薬剤検出部である薬剤検出センサ235が薬剤受け位置に薬剤があることを検出しているかどうかを薬剤検出信号から判別する(工程S22)。
When the number of supplies is less than the required number of medicines in one prescription, the control unit 11 determines from the medicine detection signal whether the medicine detection sensor 235, which is a medicine detection unit, detects that there is a medicine at the medicine receiving position. (Step S22).
制御部11は、薬剤検出センサ235が薬剤受け位置に薬剤があることを検出している第1検出状態であるとき、補充用モータである第3モータ272を停止させる(工程S23)。すなわち、制御部11は、薬剤検出部が第1検出状態であるとき、薬剤補充部12による薬剤の補充を停止させる。この後、制御部11は、工程S21に戻る。
The control unit 11 stops the third motor 272, which is a replenishing motor, when the medicine detection sensor 235 is in the first detection state in which the medicine is detected at the medicine receiving position (step S23). That is, the control unit 11 causes the drug replenishment unit 12 to stop refilling the drug when the drug detection unit is in the first detection state. After that, the control unit 11 returns to step S21.
制御部11は、薬剤検出センサ235が薬剤受け位置に薬剤が無いことを検出している第2検出状態であるとき、第3モータ272を正転方向に回転させる(工程S24)。すなわち、制御部11は、薬剤検出部が第2検出状態であるとき、薬剤補充部12に薬剤を補充させる。この後、制御部11は、工程S21に戻る。
The control unit 11 rotates the third motor 272 in the forward rotation direction in the second detection state in which the medicine detection sensor 235 detects that there is no medicine at the medicine receiving position (step S24). That is, the control unit 11 causes the drug replenishment unit 12 to replenish the drug when the drug detection unit is in the second detection state. After that, the control unit 11 returns to step S21.
上記のように、制御部11は、薬剤検出部から薬剤検出信号を入力され、薬剤検出信号に応じて薬剤補充部12を制御する。
As described above, the control unit 11 receives the drug detection signal from the drug detection unit and controls the drug replenishment unit 12 according to the drug detection signal.
制御部11は、薬剤検出部が第1検出状態から第2検出状態になった時点から待機時間の経過後に、薬剤補充部12に薬剤を補充させるように構成されていてもよい。上記のように、制御部11には、識別センサ234からの識別子331の検出信号に含まれている、薬剤の形状に関する薬剤情報を有する薬剤情報信号が入力される。制御部11は、薬剤情報に応じて上記待機時間を設定する。
The control unit 11 may be configured to cause the drug replenishment unit 12 to replenish the drug after a waiting time has elapsed from the time when the drug detection unit changed from the first detection state to the second detection state. As described above, the control unit 11 receives the drug information signal including the drug information regarding the shape of the drug, which is included in the detection signal of the identifier 331 from the identification sensor 234. The control unit 11 sets the waiting time according to the drug information.
供給数が一処方における薬剤の必要数以上である場合、制御部11は、第3モータ272を逆転方向に回転させる(工程S25)。これにより、薬剤収容容器300に収容されている薬剤を、第1開口部313側から薬剤収容容器300の内側に戻すことができる。制御部11は、第3モータ272を逆転方向に回転させてから一定時間経過後に、第3モータ272を停止させる(工程S26)。
When the supplied number is more than the required number of medicines in one prescription, the control unit 11 rotates the third motor 272 in the reverse direction (step S25). Thereby, the medicine contained in the medicine container 300 can be returned to the inside of the medicine container 300 from the first opening 313 side. The control unit 11 stops the third motor 272 after a lapse of a certain time after rotating the third motor 272 in the reverse direction (step S26).
なお、制御部11は、供給数が一処方における薬剤の必要数未満である状態において、薬剤検出部が第2検出状態から第1検出状態になった時点で薬剤補充部12による薬剤の補充を停止させ、第1検出状態になった時点から薬剤供給部の作動量が設定値を超えた時点、および、薬剤検出部が第1検出状態から第2検出状態になった時点、のうちの遅い時点で薬剤補充部12による薬剤の補充を再開させるように構成されていてもよい。この場合、制御部11は、上記薬剤情報に応じて上記設定値を設定する。
Note that the control unit 11 causes the drug replenishment unit 12 to replenish the drug when the drug detection unit changes from the second detection state to the first detection state in a state where the number of supplies is less than the required number of drugs in one prescription. It is the later one of the time when the operation amount of the drug supply unit exceeds the set value from the time of stopping and the first detection state and the time when the drug detection unit changes from the first detection state to the second detection state. The medicine replenishment unit 12 may be configured to restart the medicine replenishment at the time point. In this case, the control unit 11 sets the set value according to the drug information.
上記の薬剤供給部の作動量とは、第1検出状態になった時点からの、薬剤供給部における第1回転部111の回転方向2への累積回転角度、または、第1回転部111の回転方向2への累積駆動時間である。具体的には、上記累積回転角度の設定値は、たとえば60°とする。または、上記累積駆動時間の設定値は、上記累積回転角度がたとえば60°となるのに必要な駆動時間とする。
The operation amount of the drug supply unit is the cumulative rotation angle of the first rotation unit 111 in the rotation direction 2 of the drug supply unit from the time when the first detection state is reached, or the rotation of the first rotation unit 111. It is the cumulative drive time in the direction 2. Specifically, the set value of the cumulative rotation angle is, for example, 60°. Alternatively, the set value of the cumulative drive time is a drive time required for the cumulative rotation angle to be, for example, 60°.
上記の補充動作は、一処方に必要な薬剤を供給する複数の第1薬剤供給装置10の各々において随時行なわれる。本実施形態においては、制御装置ユニット460は、上記分包情報に応じて、薬剤を供給している第1薬剤供給装置10の次に薬剤を供給する第1薬剤供給装置10において、薬剤供給部の最初の作動開始時点より前に、薬剤補充部12による薬剤の補充を開始させる。詳しくは、第1薬剤供給装置10の制御部11は、主制御部41から、一処方における薬剤の必要数を入力されると、薬剤補充部12に薬剤の補充を開始させる。第1薬剤供給装置10の制御部11は、主制御部41から、供給指示を入力されていなくても、薬剤補充部12に薬剤の補充を開始させる。
The above replenishment operation is performed at any time in each of the plurality of first drug supply devices 10 that supplies the drug necessary for one prescription. In the present embodiment, the control device unit 460, in the first drug supply device 10 that supplies the drug next to the first drug supply device 10 that is supplying the drug, according to the packaging information, the drug supply unit. The medicine replenishment unit 12 starts replenishment of the medicine before the first operation start time. Specifically, the control unit 11 of the first medicine supply apparatus 10 causes the medicine replenishment unit 12 to start replenishment of the medicine when the required number of medicines in one prescription is input from the main control unit 41. The control unit 11 of the first medicine supply apparatus 10 causes the medicine replenishment unit 12 to start replenishment of medicines even if the supply instruction is not input from the main control unit 41.
具体的には、制御装置ユニット460は、図36に示す分包情報の一例においては、たとえば、A薬剤を供給する第1薬剤供給装置10が朝食後の1日目から3日目までの3包分のA薬剤を供給している間に、次に昼食後の1日目から3日目までの3包分のB薬剤を供給する第1薬剤供給装置10において、薬剤供給モジュール100の第1モータ270が駆動開始する時点より前に、薬剤補充部12による薬剤の補充を開始させる。
Specifically, in the example of the packaging information illustrated in FIG. 36, the control device unit 460, for example, the first medicine supply device 10 that supplies the medicine A has 3 days from the first day to the third day after breakfast. While supplying the drug A for the package, the first drug supply device 10 for supplying the drug B for the three packages from the first day to the third day after lunch is next tested. The medicine replenishment unit 12 starts the medicine replenishment before the time when the 1-motor 270 starts driving.
より好ましくは、次に薬剤を供給する第1薬剤供給装置10が薬剤の供給を開始する時点において、薬剤補充部12は1回目の補充を完了しており、薬剤受け位置に薬剤がある状態になっている。
More preferably, the medicine replenishing unit 12 has completed the first replenishment at the time when the first medicine supplying apparatus 10 that supplies the medicine next starts to supply the medicine, and the medicine is in the medicine receiving position. Has become.
制御装置ユニット460は、上記分包情報に応じて、一処方における必要数の薬剤を供給し終えた第1薬剤供給装置10から順次、薬剤補充部12による薬剤の補充を停止させる。
The control device unit 460 stops the drug replenishment by the drug replenishment unit 12 sequentially from the first drug supply device 10 which has finished supplying the required number of drugs in one prescription according to the packaging information.
具体的には、制御装置ユニット460は、図36に示す分包情報の一例においては、昼食後の1日目から3日目までの3包分に必要なB薬剤の供給を終えて、一処方における必要数のB薬剤を供給し終えた第1薬剤供給装置10の薬剤補充部12によるB薬剤の補充を停止させる。制御装置ユニット460は、その後、夕食後の1日目から3日目までの3包分に必要なA薬剤の供給を終えて、一処方における必要数のA薬剤を供給し終えた第1薬剤供給装置10の薬剤補充部12によるA薬剤の補充を停止させる。
Specifically, in the example of the packaging information shown in FIG. 36, the control device unit 460 finishes the supply of the B medicine necessary for the three packages from the first day to the third day after lunch, The replenishment of the B medicine by the medicine replenishing unit 12 of the first medicine supplying apparatus 10 which has finished supplying the required number of B medicines in the prescription is stopped. The controller unit 460 then completes the supply of the A drug necessary for the 3 packages from the first day to the third day after dinner, and then supplies the necessary number of A drugs in one prescription. The replenishment of the medicine A by the medicine replenishing unit 12 of the supply device 10 is stopped.
図39は、主制御部から一包における薬剤の必要数および供給指示を入力された薬剤供給装置の制御部における動作を説明するフローチャートである。図39に示すように、主制御部41から一包における薬剤の必要数および供給指示を入力された第1薬剤供給装置10の制御部11においては、開閉部141によって塞がれていた排出部131を開放させる(工程S31)。
FIG. 39 is a flowchart for explaining the operation of the control unit of the drug supply device, which is input with the required number of drugs and the supply instruction of the drug from the main control unit. As shown in FIG. 39, in the control unit 11 of the first drug supply device 10 to which the required number of drugs in one package and the supply instruction have been input from the main control unit 41, the discharge unit that is blocked by the opening/closing unit 141. 131 is opened (step S31).
排出部131を開放させた後、制御部11は、薬剤供給部である薬剤供給モジュール100に一包における薬剤の供給を開始させる(S32)。制御部11は、薬剤供給モジュール100による薬剤の供給を開始させた(工程S32)後、薬剤供給モジュール100から供給された薬剤を計数する(工程S33)。薬剤の供給数が一包における薬剤の必要数以上になった時点で、薬剤供給モジュール100による薬剤の供給を終了させる(工程S34)。
After opening the discharge unit 131, the control unit 11 causes the drug supply module 100, which is a drug supply unit, to start supplying the drug in one package (S32). After starting the supply of the medicine by the medicine supply module 100 (step S32), the control unit 11 counts the medicines supplied from the medicine supply module 100 (step S33). When the number of medicines supplied exceeds the necessary number of medicines in one package, the medicine supply by the medicine supply module 100 is terminated (step S34).
この後、制御部11は、薬剤の供給数が一処方における薬剤の必要数以上であるかどうかを判別する(工程S35)。供給数が一処方における薬剤の必要数以上である場合、開閉部141によって排出部131を閉鎖する(工程S36)。供給数が一処方における薬剤の必要数未満である場合、制御部11は、排出部131を開放した状態を維持しつつ、一包分の薬剤の供給動作を終了させる。
After that, the control unit 11 determines whether or not the number of medicines supplied is equal to or larger than the necessary number of medicines in one prescription (step S35). When the supply number is more than the required number of medicines in one prescription, the opening/closing section 141 closes the discharge section 131 (step S36). When the supply number is less than the required number of medicines in one prescription, the control unit 11 ends the operation of supplying one package of medicine while maintaining the discharge unit 131 in an open state.
図40は、薬剤供給部によって薬剤を供給する際の制御部における動作を説明するフローチャートである。図40に示すように、制御部11は、薬剤供給モジュール100による薬剤の供給を開始させた(工程S32)後、供給数が一包における薬剤の必要数未満であるかどうかを判別する(工程S41)。
FIG. 40 is a flow chart for explaining the operation of the control unit when a drug is supplied by the drug supply unit. As shown in FIG. 40, the control unit 11 determines whether the supply number is less than the required number of drugs in one package after starting the supply of the drug by the drug supply module 100 (step S32) (step S32). S41).
具体的には、図36に示す分包情報の一例において昼食後の1日目の分包をする際、A薬剤を収容している薬剤収容容器300が搭載されている第1薬剤供給装置10の制御部11は、A薬剤の供給数が必要数である1未満であるかどうかを判別する。B薬剤を収容している薬剤収容容器300が搭載されている第1薬剤供給装置10の制御部11は、B薬剤の供給数が必要数である2未満であるかどうかを判別する。
Specifically, in the example of the packaging information shown in FIG. 36, when packaging the first day after lunch, the first drug supply device 10 in which the drug container 300 containing the drug A is mounted The control unit 11 determines whether the supply number of the A medicine is less than the required number of 1. The control unit 11 of the first drug supply device 10 in which the drug storage container 300 that stores the B drug is mounted determines whether the supply number of the B drug is less than the required number of 2.
供給数が一包における薬剤の必要数未満である場合、制御部11は、供給用モータである第1モータ270を正転方向に駆動させるとともに、振動用モータである偏心モータ273を駆動させる(工程S42)。これにより、第1回転部111および第2回転部112の各々が正転方向に回転するとともに振動部260が振動する。
When the supply number is less than the required number of medicines in one package, the control unit 11 drives the first motor 270, which is a supply motor, in the forward rotation direction, and also drives the eccentric motor 273, which is a vibration motor ( Step S42). As a result, each of the first rotating portion 111 and the second rotating portion 112 rotates in the forward rotation direction and the vibrating portion 260 vibrates.
この後、制御部11は、第1検出部である第1センサ231が薬剤を検出したかどうかを第1センサ231からの第1検出信号の入力の有無によって判別する(工程S43)。
After that, the control unit 11 determines whether or not the first sensor 231 which is the first detection unit has detected the drug based on the presence or absence of the input of the first detection signal from the first sensor 231 (step S43).
制御部11は、第1センサ231が薬剤を検出した場合、第1モータ270を停止させるとともに、偏心モータ273を停止させる(工程S44)。このように、制御部11は、第1検出信号が入力されると、薬剤供給部による薬剤の搬送を一時的に停止させる。
When the first sensor 231 detects a drug, the control unit 11 stops the first motor 270 and the eccentric motor 273 (step S44). As described above, when the first detection signal is input, the control unit 11 temporarily stops the drug delivery by the drug supply unit.
この後、制御部11は、第1モータ270を逆転方向に設定量だけ駆動させる(工程S45)。このように、制御部11は、第1検出信号が入力されると、薬剤供給部による薬剤の搬送方向を一時的に逆方向にする。
After that, the control unit 11 drives the first motor 270 in the reverse rotation direction by the set amount (step S45). In this way, when the first detection signal is input, the control unit 11 temporarily reverses the drug transport direction of the drug supply unit to the reverse direction.
制御部11は、第1モータ270を逆転方向に設定量だけ駆動させた後、第1モータ270を停止させ、工程S41に戻る。
The control unit 11 drives the first motor 270 in the reverse rotation direction by the set amount, stops the first motor 270, and returns to step S41.
供給数が一包における薬剤の必要数以上である場合、制御部11は、一包分の薬剤の供給動作を終了させる(工程S34)。
When the supply number is equal to or more than the required number of medicines in one package, the control unit 11 terminates the supply operation of the medicines for one package (step S34).
図41は、薬剤供給部によって供給された薬剤を計数する際の制御部における動作を説明するフローチャートである。図41に示すように、制御部11は、薬剤供給部によって供給された薬剤の計数(工程S33)が開始されると、第1検出部である第1センサ231が薬剤を検出したかどうかを第1センサ231からの第1検出信号の入力の有無によって判別する(工程S51)。
FIG. 41 is a flowchart illustrating the operation of the control unit when counting the medicines supplied by the medicine supply unit. As shown in FIG. 41, when the counting of the drug supplied by the drug supply unit (step S33) is started, the control unit 11 determines whether the first sensor 231 as the first detection unit has detected the drug. The determination is made based on the presence or absence of the input of the first detection signal from the first sensor 231 (step S51).
制御部11は、第1センサ231が薬剤を検出した場合、到達フラグをオンにする(工程S52)。制御部11は、第1センサ231が薬剤を検出していない場合、到達フラグはそのままにする。
When the first sensor 231 detects a drug, the control unit 11 turns on the arrival flag (step S52). When the first sensor 231 does not detect the medicine, the control unit 11 leaves the arrival flag as it is.
この後、制御部11は、第2検出部である第2センサ232が薬剤を検出したかどうかを第2センサ232からの第2検出信号の入力の有無によって判別する(工程S53)。工程S53において、第2センサ232が薬剤を検出している状態においては、薬剤は第2センサ232を構成する投光部と受光部との間の光軸を遮っている状態である。
After that, the control unit 11 determines whether or not the second sensor 232, which is the second detection unit, has detected the drug based on the presence or absence of the input of the second detection signal from the second sensor 232 (step S53). In step S53, when the second sensor 232 is detecting the drug, the drug blocks the optical axis between the light projecting unit and the light receiving unit that configure the second sensor 232.
制御部11は、工程S53において第2センサ232が薬剤を検出した場合、第2検出部である第2センサ232が薬剤を非検出となったかどうかを第2センサ232からの第2検出信号の入力の有無によって判別する(工程S54)。工程S54において、第2センサ232が薬剤を非検出となっている状態においては、薬剤は第2センサ232を構成する投光部と受光部との間の光軸を通過して、当該光軸が元の開通状態に戻った状態である。制御部11は、工程S53において第2センサ232が薬剤を検出していない場合、工程S51に戻る。
When the second sensor 232 detects the drug in step S53, the control unit 11 determines whether the second sensor 232, which is the second detection unit, detects the drug as a second detection signal from the second sensor 232. It is determined whether or not there is an input (step S54). In step S54, in the state where the second sensor 232 is not detecting the medicine, the medicine passes through the optical axis between the light projecting section and the light receiving section which constitute the second sensor 232, and the optical axis concerned. Is the state in which it has returned to the original open state. When the second sensor 232 does not detect the drug in step S53, the control unit 11 returns to step S51.
制御部11は、工程S54において第2センサ232が薬剤を非検出となった場合、到達フラグがオンになっているか確認する(工程S55)。制御部11は、工程S54において第2センサ232が薬剤を非検出となっていない場合、工程S54に戻る。
When the second sensor 232 does not detect the drug in step S54, the control unit 11 confirms whether the arrival flag is on (step S55). When the second sensor 232 does not detect the drug in step S54, the control unit 11 returns to step S54.
制御部11は、工程S54において第2センサ232が薬剤を非検出となって、到達フラグがオンになっている場合、供給数を1加算して(工程S56)、到達フラグをオフにする(工程S57)。
When the second sensor 232 does not detect the drug and the arrival flag is on in step S54, the control unit 11 increments the supply number by 1 (step S56) and turns off the arrival flag (step S56). Step S57).
制御部11は、第2センサ232が薬剤を検出したが、到達フラグがオフである場合、異常と判断し(工程S59)、薬剤の計数を終了する。このように、制御部11は、第1検出信号が入力される入力間隔中に第2検出信号が複数回入力されると、異常と判断する。
When the second sensor 232 detects the drug but the arrival flag is off, the control unit 11 determines that the drug is abnormal (step S59) and ends the drug counting. In this way, the control unit 11 determines that the second detection signal is abnormal when the second detection signal is input a plurality of times during the input interval in which the first detection signal is input.
工程S57において到達フラグをオフにした後、制御部11は、供給数が一包における薬剤の必要数以上であるかどうかを判別する(工程S58)。供給数が一包における薬剤の必要数以上である場合、制御部11は、薬剤の計数を終了する。供給数が一包における薬剤の必要数未満である場合、制御部11は、工程S51に戻る。
After turning off the arrival flag in step S57, the control unit 11 determines whether the supply number is equal to or more than the required number of medicines in one package (step S58). When the supply number is equal to or more than the required number of medicines in one package, the control unit 11 finishes counting the medicines. When the supply number is less than the required number of medicines in one package, the control unit 11 returns to step S51.
上記のように、制御部11は、第1センサ231から第1検出信号を入力され、第1検出信号に応じて薬剤供給部を制御し、かつ、第2センサ232から第2検出信号を入力され、第2検出信号に応じて薬剤供給部から供給された薬剤を計数する。
As described above, the control unit 11 receives the first detection signal from the first sensor 231, controls the medicine supply unit according to the first detection signal, and inputs the second detection signal from the second sensor 232. Then, the medicines supplied from the medicine supply unit are counted according to the second detection signal.
本実施形態においては、制御部11は、第1検出信号が入力されると、薬剤情報に応じた薬剤供給部の制御を行なう。具体的には、薬剤情報から、薬剤収容容器300の内部に収容されている薬剤が一般的な薬剤と判別された場合には、一般的な薬剤は薬剤収容容器300の回転量毎の薬剤供給部への排出量が多いため、制御部11は、薬剤受け位置に薬剤があることを薬剤検出センサ235によって検出した直後に、薬剤収容容器300の回転駆動を停止させる。この後、薬剤検出センサ235によって薬剤が検出されなくなると、薬剤収容容器300の回転駆動を再開する。これによって薬剤供給部に薬剤が過供給されることを防止できる。
In this embodiment, when the first detection signal is input, the control unit 11 controls the drug supply unit according to the drug information. Specifically, when it is determined from the drug information that the drug contained in the drug container 300 is a general drug, the general drug is supplied for each rotation amount of the drug container 300. Since the amount discharged to the portion is large, the control unit 11 stops the rotation drive of the medicine container 300 immediately after the medicine detection sensor 235 detects that there is a medicine at the medicine receiving position. After this, when the drug is no longer detected by the drug detection sensor 235, the rotation of the drug container 300 is restarted. This can prevent the medicine from being excessively supplied to the medicine supply unit.
薬剤情報から、薬剤収容容器300の内部に収容されている薬剤が特殊な薬剤と判別された場合には、特殊な薬剤は薬剤収容容器300の回転量毎の薬剤供給部への排出量が少なくなる傾向にあるため、制御部11は、薬剤受け位置に薬剤があることを薬剤検出センサ235によって検出してから薬剤収容容器300の回転駆動を停止させるまでの時間を、一般的な薬剤の場合に比較して長くする。若しくは、制御部11は、薬剤収容容器300の回転速度を、一般的な薬剤の場合に比較して高くする。さらに、制御部11は、回転体110の回転速度も、一般的な薬剤の場合に比較して高くする。このようにすることにより、回転駆動によって排出しにくい特殊な薬剤の場合においても、薬剤補充に要する時間を一般的な薬剤に近づけるとともに、排出部131から1つずつ薬剤を供給することができる。
When it is determined from the drug information that the drug contained in the drug container 300 is a special drug, the amount of the special drug discharged to the drug supply unit for each rotation amount of the drug container 300 is small. Therefore, the control unit 11 determines the time from the detection of the drug at the drug receiving position by the drug detection sensor 235 until the rotation drive of the drug container 300 is stopped in the case of a general drug. Make it longer than. Alternatively, the control unit 11 increases the rotation speed of the medicine container 300 as compared with a general medicine. Further, the control unit 11 also increases the rotation speed of the rotating body 110 as compared with the case of a general medicine. By doing so, even in the case of a special drug that is difficult to be discharged by rotation drive, the time required for drug replenishment can be made closer to that of a general drug, and the drugs can be supplied one by one from the discharge unit 131.
本実施形態においては、第1薬剤供給装置10において、排出部131から薬剤が排出された際、回転体110および振動部260の各々を一時的に停止させるとともに、回転体110を一時的に逆転させ、次に排出部131から排出される薬剤を斜面110s上に保持する。
In the present embodiment, in the first medicine supply device 10, when the medicine is discharged from the discharge portion 131, each of the rotating body 110 and the vibrating portion 260 is temporarily stopped, and the rotating body 110 is temporarily reversed. Then, the medicine discharged from the discharge portion 131 is held on the slope 110s.
なお、第1薬剤供給装置10において、排出部131から薬剤が排出された際、振動部260を一時的に停止させるとともに、回転体110を一時的に停止させ、次に排出部131から排出される薬剤を斜面110s上に保持するようにしてもよい。
In the first medicine supply device 10, when the medicine is discharged from the discharge portion 131, the vibrating portion 260 is temporarily stopped, the rotating body 110 is temporarily stopped, and then the medicine is discharged from the discharge portion 131. The medicine to be held may be held on the slope 110s.
本発明の一実施形態に係る薬剤分包装置400においては、制御装置ユニット460が、分包情報に応じて、薬剤を供給している第1薬剤供給装置10の次に薬剤を供給する第1薬剤供給装置10において、薬剤供給モジュール100の最初の作動開始時点より前に、薬剤補充部12による薬剤の補充を開始させる。これにより、薬剤供給モジュール100の供給開始後から薬剤が供給されるまでの時間を短縮することができるため、ひいては、分包するための所要時間を短縮することができる。
In the medicine packing apparatus 400 according to the embodiment of the present invention, the control device unit 460 supplies the medicine next to the first medicine supplying apparatus 10 which supplies the medicine according to the packing information. In the medicine supply device 10, before the first operation of the medicine supply module 100 is started, the medicine replenishment unit 12 starts the medicine replenishment. As a result, the time from the start of supply of the medicine supply module 100 to the supply of the medicine can be shortened, and thus the time required for packaging can be shortened.
本発明の一実施形態に係る薬剤分包装置400においては、制御装置ユニット460は、分包情報に応じて、一処方における必要数の薬剤を供給し終えた第1薬剤供給装置10から順次、薬剤補充部12による薬剤の補充を停止させる。これにより、薬剤補充部12から薬剤供給モジュール100に薬剤が過剰に補充されることを抑制することができる。
In the medicine packaging device 400 according to one embodiment of the present invention, the control device unit 460 sequentially supplies the required number of medicines in one prescription from the first medicine supplying device 10 in accordance with the packaging information, The replenishment of the medicine by the medicine replenishing unit 12 is stopped. As a result, it is possible to prevent the medicine replenishment unit 12 from replenishing the medicine supply module 100 with the medicine excessively.
本発明の一実施形態に係る薬剤分包装置400においては、制御装置ユニット460は、薬剤検出センサ235から薬剤検出信号を入力され、薬剤検出信号に応じて、薬剤検出センサ235が第1検出状態であるとき、薬剤補充部12による薬剤の補充を停止させ、薬剤検出センサ235が第2検出状態であるとき、薬剤補充部12に薬剤を補充させる。これにより、簡易な制御によって、薬剤補充部12から薬剤供給モジュール100に薬剤を適度に補充することができる。
In the medicine packaging device 400 according to the embodiment of the present invention, the control device unit 460 receives the medicine detection signal from the medicine detection sensor 235, and the medicine detection sensor 235 receives the medicine detection signal according to the first detection state. When the drug detection sensor 235 is in the second detection state, the drug replenishment unit 12 is caused to replenish the drug. Thereby, the medicine can be appropriately replenished from the medicine replenishing unit 12 to the medicine supply module 100 by a simple control.
本発明の一実施形態に係る第1薬剤供給装置10においては、制御部11は、薬剤検出センサ235から薬剤検出信号を入力され、薬剤検出信号に応じて薬剤補充部12を制御する。これにより、薬剤の補充が必要になったことを早期に検出して、薬剤補充部12から薬剤供給モジュール100に薬剤を適度に補充することができるため、薬剤を供給するための所要時間を短縮することができる。
In the first drug supply device 10 according to the embodiment of the present invention, the control unit 11 receives the drug detection signal from the drug detection sensor 235 and controls the drug replenishment unit 12 according to the drug detection signal. As a result, it is possible to detect the necessity of replenishing the medicine at an early stage and appropriately replenish the medicine from the medicine replenishing unit 12 to the medicine supply module 100, thereby shortening the time required to supply the medicine. can do.
本発明の一実施形態に係る第1薬剤供給装置10においては、制御部11は、薬剤検出センサ235が第1検出状態であるとき、薬剤補充部12による薬剤の補充を停止させ、薬剤検出センサ235が第2検出状態であるとき、薬剤補充部に薬剤を補充させる。これにより、簡易な制御によって、薬剤補充部12から薬剤供給モジュール100に薬剤を適度に補充することができる。
In the first drug supply device 10 according to the embodiment of the present invention, the control unit 11 stops the drug replenishment by the drug replenishment unit 12 when the drug detection sensor 235 is in the first detection state, and the drug detection sensor. When 235 is in the second detection state, the medicine replenishing unit is made to replenish the medicine. Thereby, the medicine can be appropriately replenished from the medicine replenishing unit 12 to the medicine supply module 100 by a simple control.
本発明の一実施形態に係る第1薬剤供給装置10においては、制御部11は、薬剤検出センサ235が第1検出状態から第2検出状態になった時点から待機時間の経過後に、薬剤補充部12に薬剤を補充させる。これにより、薬剤補充部12から薬剤供給モジュール100に薬剤が過剰に補充されることを抑制することができる。
In the first medicine supply device 10 according to the embodiment of the present invention, the control unit 11 controls the medicine replenishment unit after the waiting time has elapsed from the time when the medicine detection sensor 235 changes from the first detection state to the second detection state. Let 12 replenish the drug. As a result, it is possible to prevent the medicine replenishment unit 12 from replenishing the medicine supply module 100 with the medicine excessively.
本発明の一実施形態に係る第1薬剤供給装置10においては、制御部11は、薬剤情報に応じて上記待機時間を設定する。これにより、薬剤の種類に応じて、薬剤補充部12から薬剤供給モジュール100に薬剤を適度に補充することができる。
In the first medicine supply device 10 according to the embodiment of the present invention, the control unit 11 sets the waiting time according to the medicine information. Thereby, the medicine can be appropriately replenished from the medicine replenishing unit 12 to the medicine supply module 100 according to the kind of the medicine.
本発明の一実施形態に係る第1薬剤供給装置10においては、制御部11は、薬剤検出センサ235が第2検出状態から第1検出状態になった時点で薬剤補充部12による薬剤の補充を停止させ、上記時点から薬剤供給モジュール100の作動量が設定値を超えた時点、および、薬剤検出センサ235が第1検出状態から第2検出状態になった時点、のうちの遅い時点で薬剤補充部12による薬剤の補充を再開させる。これにより、薬剤補充部12から薬剤供給モジュール100に薬剤が過剰に補充されることを抑制することができる。
In the first drug supply device 10 according to the embodiment of the present invention, the control unit 11 causes the drug replenishment unit 12 to replenish the drug when the drug detection sensor 235 changes from the second detection state to the first detection state. Stop and stop the above-mentioned time, when the operation amount of the medicine supply module 100 exceeds the set value, and when the medicine detection sensor 235 changes from the first detection state to the second detection state, the medicine is replenished later. Replenishment of the medicine by the section 12 is restarted. As a result, it is possible to prevent the medicine replenishment unit 12 from replenishing the medicine supply module 100 with the medicine excessively.
本発明の一実施形態に係る第1薬剤供給装置10においては、制御部11は、薬剤情報に応じて上記設定値を設定する。薬剤の種類に応じて、薬剤補充部12から薬剤供給モジュール100に薬剤を適度に補充することができる。
In the first drug supply device 10 according to the embodiment of the present invention, the control unit 11 sets the set value according to the drug information. The medicine can be appropriately replenished from the medicine replenishing unit 12 to the medicine supply module 100 according to the kind of the medicine.
本発明の一実施形態に係る第1薬剤供給装置10においては、制御部11は、第1センサ231から第1検出信号を入力され、第1検出信号に応じて薬剤供給モジュール100を制御し、かつ、第2センサ232から第2検出信号を入力され、第2検出信号に応じて薬剤供給モジュール100から供給された薬剤を計数する。これにより、第1センサ231にて複数の薬剤が重なった状態で検出された場合においても、第2センサ232にて複数の薬剤がばらけた状態で検出されるため、排出部131から複数の薬剤が同時に排出されたことを検出することができる。
In the 1st chemical|medical agent supply apparatus 10 which concerns on one Embodiment of this invention, the control part 11 inputs the 1st detection signal from the 1st sensor 231, controls the chemical|medical agent supply module 100 according to a 1st detection signal, In addition, the second detection signal is input from the second sensor 232, and the medicine supplied from the medicine supply module 100 is counted according to the second detection signal. Accordingly, even when the first sensor 231 detects a plurality of medicines in an overlapping state, the second sensor 232 detects a plurality of medicines in a separated state, and thus the plurality of medicines from the discharge unit 131 are detected. It is possible to detect that is discharged at the same time.
本発明の一実施形態に係る第1薬剤供給装置10においては、制御部11は、第1検出信号が入力されると、薬剤供給モジュール100による薬剤の搬送方向を一時的に逆方向にする。これにより、排出部131から複数の薬剤が同時に排出されることを抑制することができる。
In the first drug supply device 10 according to the embodiment of the present invention, when the first detection signal is input, the control unit 11 temporarily causes the drug supply module 100 to reverse the drug transport direction. Accordingly, it is possible to prevent the plurality of medicines from being simultaneously discharged from the discharge unit 131.
本発明の一実施形態に係る第1薬剤供給装置10においては、制御部11は、第1検出信号が入力されると、薬剤供給モジュール100による薬剤の搬送を一時的に停止させる。このようにした場合にも、排出部131から複数の薬剤が同時に排出されることを抑制することができる。
In the first drug supply device 10 according to the embodiment of the present invention, the control unit 11 temporarily stops the drug delivery by the drug supply module 100 when the first detection signal is input. Even in this case, it is possible to prevent the plurality of medicines from being simultaneously discharged from the discharge portion 131.
本発明の一実施形態に係る第1薬剤供給装置10においては、制御部11には、薬剤の形状に関する薬剤情報を有する薬剤情報信号が入力される。制御部11は、第1検出信号が入力されると、薬剤情報に応じた薬剤供給モジュール100の制御を行なう。上記のように、第1検出信号が入力された後、薬剤供給モジュール100による薬剤の搬送を一時的に停止させる、または、薬剤供給モジュール100による薬剤の搬送方向を一時的に逆方向にする、のいずれにするかを、薬剤情報に応じて制御部11が決定する。また、制御部11は、薬剤情報に応じて、一時停止させる時間または一時的に逆方向に搬送する時間を決定する。これにより、薬剤の種類に応じた態様で、排出部131から複数の薬剤が同時に排出されることを抑制することができる。
In the first drug supply device 10 according to the embodiment of the present invention, the control unit 11 receives a drug information signal having drug information related to the shape of the drug. When the first detection signal is input, the control unit 11 controls the medicine supply module 100 according to the medicine information. As described above, after the first detection signal is input, the drug supply module 100 temporarily stops the drug transfer, or the drug supply module 100 temporarily reverses the drug transfer direction. The control unit 11 determines which of the above is selected according to the drug information. In addition, the control unit 11 determines the time to temporarily stop or the time to temporarily convey in the opposite direction according to the drug information. Accordingly, it is possible to prevent a plurality of drugs from being simultaneously discharged from the discharging unit 131 in a mode according to the type of the drug.
本発明の一実施形態に係る第1薬剤供給装置10においては、制御部11は、第1検出信号が入力される入力間隔中に第2検出信号が複数回入力されると、異常と判断する。これにより、排出部131から複数の薬剤が同時に排出された異常を検出することができる。
In the 1st chemical|medical agent supply apparatus 10 which concerns on one Embodiment of this invention, the control part 11 will judge with an abnormality, if a 2nd detection signal is input in multiple times during the input interval which a 1st detection signal is input. .. Accordingly, it is possible to detect an abnormality in which a plurality of drugs are simultaneously discharged from the discharge unit 131.
なお、今回開示した上記実施形態はすべての点で例示であって、限定的な解釈の根拠となるものではない。したがって、本発明の技術的範囲は、上記した実施形態のみによって解釈されるものではなく、請求の範囲の記載に基づいて画定される。また、請求の範囲と均等の意味および範囲内でのすべての変更が含まれる。
The above-described embodiment disclosed this time is an example in all respects, and is not a basis for a limited interpretation. Therefore, the technical scope of the present invention should not be construed only by the embodiments described above, but should be defined based on the claims. Also, the meaning equivalent to the scope of claims and all modifications within the scope are included.
1,3 軸線、2 回転方向、4 垂線、10 第1薬剤供給装置、11 制御部、12 薬剤補充部、20 第2薬剤供給装置、30 第3薬剤供給装置、41 主制御部、50 操作パネル、90 処方情報受付装置、100 薬剤供給モジュール、110 回転体、110s 斜面、111 第1回転部、111c 第1凹条部、111g 第1従動歯車、112 第2回転部、112c 第2凹条部、112g 第2従動歯車、120 蓋部材、121 第1周壁部、122 第2周壁部、123 第3周壁部、124 第1傾斜壁部、125 第2傾斜壁部、126,340 蓋部、127 薬剤供給孔、128 切欠部、129 取付部、130 排出部材、130b 軸受部、131 排出部、132 立壁部、140 開閉部材、140b,341h 係合孔、140s 回動軸、140t 付勢部材、141 開閉部、142 薬剤止め部、150 支持部、151 水平面部、152 立設部、153 台部、160 振動伝達板、170 緩衝部材、200 ベース部、210 第1駆動軸、211g 第1駆動歯車、212g 第2駆動歯車、220 排出シュート、231 第1センサ、232 第2センサ、233 容器検出センサ、234 識別センサ、235 薬剤検出センサ、236 モジュール検出センサ、237 開閉センサ、238 停止スイッチ、240 第2駆動軸、250 表示部、260 振動部、270 第1モータ、271 第2モータ、272 第3モータ、273 偏心モータ、281,282 ローラ部、290 接続管路、300 薬剤収容容器、310 本体筒、312 螺旋溝、312e 終端、313 第1開口部、314 第2開口部、315 周方向溝、320 円筒部、330 底部、330b 底面、330c 環状部、331 識別子、332 円板部、341 外蓋、341a アーム部、342 内蓋、342c 内蓋面、342h 開口部、342p 回動軸部、342s 係合突起、400 薬剤分包装置、410 筐体、420 回転ドラム、421 薬剤搬送路、430 ホッパ、440 薬剤包装装置ユニット、450 薬剤供給装置ユニット、460 制御装置ユニット。
1, 3 axis line, 2 rotation direction, 4 normal line, 10 first drug supply device, 11 control unit, 12 drug replenishment unit, 20 second drug supply device, 30 third drug supply device, 41 main control unit, 50 operation panel , 90 prescription information receiving device, 100 drug supply module, 110 rotating body, 110s slope, 111 first rotating part, 111c first recessed part, 111g first driven gear, 112 second rotating part, 112c second recessed part , 112 g second driven gear, 120 lid member, 121 first peripheral wall portion, 122 second peripheral wall portion, 123 third peripheral wall portion, 124 first inclined wall portion, 125 second inclined wall portion, 126,340 lid portion, 127 Drug supply hole, 128 cutout portion, 129 mounting portion, 130 discharge member, 130b bearing portion, 131 discharge portion, 132 standing wall portion, 140 opening/closing member, 140b, 341h engaging hole, 140s rotating shaft, 140t biasing member, 141 Opening/closing part, 142 drug stopper, 150 support part, 151 horizontal surface part, 152 standing part, 153 stand part, 160 vibration transmission plate, 170 cushioning member, 200 base part, 210 first drive shaft, 211g first drive gear, 212g 2nd drive gear, 220 discharge chute, 231, 1st sensor, 232 2nd sensor, 233 container detection sensor, 234 identification sensor, 235 drug detection sensor, 236 module detection sensor, 237 open/close sensor, 238 stop switch, 240 second Drive shaft, 250 display section, 260 vibrating section, 270 first motor, 271 second motor, 272 third motor, 273 eccentric motor, 281,282 roller section, 290 connection line, 300 drug container, 310 main body cylinder, 312 spiral groove, 312e end, 313 first opening, 314 second opening, 315 circumferential groove, 320 cylindrical part, 330 bottom, 330b bottom, 330c annular part, 331 identifier, 332 disc part, 341 outer lid, 341a arm portion, 342 inner lid, 342c inner lid surface, 342h opening portion, 342p rotating shaft portion, 342s engaging protrusion, 400 drug packaging device, 410 housing, 420 rotating drum, 421 drug transport path, 430 hopper, 440 drug packaging device unit, 450 drug supply device unit, 460 control device unit.
Claims (6)
- 補充された薬剤を受ける薬剤受け位置を有し、該薬剤受け位置から前記薬剤を整列させつつ搬送し、前記薬剤を先頭から順に1つずつ供給する薬剤供給部と、
前記薬剤受け位置に前記薬剤を補充する薬剤補充部と、
前記薬剤受け位置における前記薬剤の有無を検出して薬剤検出信号を出力する薬剤検出部と、
前記薬剤補充部を制御する制御部とを備え、
前記制御部は、前記薬剤検出部から前記薬剤検出信号を入力され、前記薬剤検出信号に応じて前記薬剤補充部を制御する、薬剤供給装置。 A drug supply unit that has a drug receiving position for receiving the refilled drug, transports the drugs while aligning them from the drug receiving position, and supplies the drugs one by one in order from the beginning;
A drug replenishing unit that replenishes the drug at the drug receiving position,
A drug detection unit that detects the presence or absence of the drug at the drug receiving position and outputs a drug detection signal,
A control unit for controlling the drug replenishment unit,
The drug supply device, wherein the control unit receives the drug detection signal from the drug detection unit and controls the drug replenishment unit according to the drug detection signal. - 前記薬剤検出部は、前記薬剤受け位置に前記薬剤が有ることを検出している第1検出状態と、前記薬剤受け位置に前記薬剤が無いことを検出している第2検出状態とを有し、
前記制御部は、前記薬剤検出部が前記第1検出状態であるとき、前記薬剤補充部による前記薬剤の補充を停止させ、前記薬剤検出部が前記第2検出状態であるとき、前記薬剤補充部に前記薬剤を補充させる、請求項1に記載の薬剤供給装置。 The medicine detection unit has a first detection state in which it is detected that the medicine is present at the medicine receiving position, and a second detection state in which it is detected that the medicine is not present at the medicine receiving position. ,
When the drug detection unit is in the first detection state, the control unit stops the drug replenishment by the drug replenishment unit, and when the drug detection unit is in the second detection state, the drug replenishment unit The drug supply device according to claim 1, wherein the drug is replenished with the drug. - 前記制御部は、前記薬剤検出部が前記第1検出状態から前記第2検出状態になった時点から待機時間の経過後に、前記薬剤補充部に前記薬剤を補充させる、請求項2に記載の薬剤供給装置。 The drug according to claim 2, wherein the control unit causes the drug replenishment unit to replenish the drug after a lapse of a waiting time from the time when the drug detection unit changes from the first detection state to the second detection state. Supply device.
- 前記制御部には、薬剤の形状に関する薬剤情報を有する薬剤情報信号が入力され、
前記制御部は、前記薬剤情報に応じて前記待機時間を設定する、請求項3に記載の薬剤供給装置。 A drug information signal having drug information relating to the shape of the drug is input to the control unit,
The medicine supply device according to claim 3, wherein the control unit sets the waiting time according to the medicine information. - 前記制御部は、前記薬剤検出部が前記第2検出状態から前記第1検出状態になった時点で前記薬剤補充部による前記薬剤の補充を停止させ、前記時点から前記薬剤供給部の作動量が設定値を超えた時点、および、前記薬剤検出部が前記第1検出状態から前記第2検出状態になった時点、のうちの遅い時点で前記薬剤補充部による前記薬剤の補充を再開させる、請求項2に記載の薬剤供給装置。 The control unit stops the replenishment of the drug by the drug replenishment unit at the time when the drug detection unit changes from the second detection state to the first detection state, and the operation amount of the drug supply unit from the time point is stopped. Resuming the replenishment of the drug by the drug replenishing unit at a later time point of exceeding a set value and a time point of the drug detection unit changing from the first detection state to the second detection state. Item 4. The drug supply device according to item 2.
- 前記制御部には、薬剤の形状に関する薬剤情報を有する薬剤情報信号が入力され、
前記制御部は、前記薬剤情報に応じて前記設定値を設定する、請求項5に記載の薬剤供給装置。 A drug information signal having drug information relating to the shape of the drug is input to the control unit,
The drug supply device according to claim 5, wherein the control unit sets the set value according to the drug information.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2019-017964 | 2019-02-04 | ||
JP2019017964A JP7479037B2 (en) | 2019-02-04 | 2019-02-04 | Drug Delivery Device |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2020162020A1 true WO2020162020A1 (en) | 2020-08-13 |
Family
ID=71948210
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2019/047821 WO2020162020A1 (en) | 2019-02-04 | 2019-12-06 | Drug supply device |
Country Status (2)
Country | Link |
---|---|
JP (2) | JP7479037B2 (en) |
WO (1) | WO2020162020A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US12036185B2 (en) | 2021-07-19 | 2024-07-16 | Optum, Inc. | System and method to count pills |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001060726A1 (en) * | 2000-02-16 | 2001-08-23 | Sanyo Electric Co., Ltd. | Chemical feeding device |
WO2016013553A1 (en) * | 2014-07-23 | 2016-01-28 | 株式会社湯山製作所 | Medicine cassette |
JP2018500254A (en) * | 2014-12-15 | 2018-01-11 | クリテム・カンパニー・リミテッド | Drug packaging cassette |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102489461B1 (en) | 2016-03-18 | 2023-01-18 | 가부시키가이샤 유야마 세이사쿠쇼 | drug dispensing device, drug dispensing program |
-
2019
- 2019-02-04 JP JP2019017964A patent/JP7479037B2/en active Active
- 2019-12-06 WO PCT/JP2019/047821 patent/WO2020162020A1/en active Application Filing
-
2024
- 2024-02-16 JP JP2024022009A patent/JP7568337B2/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001060726A1 (en) * | 2000-02-16 | 2001-08-23 | Sanyo Electric Co., Ltd. | Chemical feeding device |
WO2016013553A1 (en) * | 2014-07-23 | 2016-01-28 | 株式会社湯山製作所 | Medicine cassette |
JP2018500254A (en) * | 2014-12-15 | 2018-01-11 | クリテム・カンパニー・リミテッド | Drug packaging cassette |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US12036185B2 (en) | 2021-07-19 | 2024-07-16 | Optum, Inc. | System and method to count pills |
Also Published As
Publication number | Publication date |
---|---|
JP7568337B2 (en) | 2024-10-16 |
JP2020124327A (en) | 2020-08-20 |
JP2024040510A (en) | 2024-03-25 |
JP7479037B2 (en) | 2024-05-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP7568337B2 (en) | Drug Delivery Device | |
JP4638793B2 (en) | Tablet supply device and tablet supply method | |
US20170327255A1 (en) | Cassette for drug packaging | |
JP2007314203A (en) | Tablet feeding apparatus | |
WO2020162019A1 (en) | Drug packaging device | |
WO2020162021A1 (en) | Drug supply device | |
JP7398838B2 (en) | drug supply device | |
JP7470451B2 (en) | Drug Delivery Device | |
JP7546317B2 (en) | Drug Delivery Device | |
JP7357406B2 (en) | drug supply device | |
JP7148961B2 (en) | drug supply device | |
US20150196459A1 (en) | Pill Counting and Conveying Apparatus | |
JP7193128B2 (en) | drug supply device | |
WO2020162022A1 (en) | Drug packaging device | |
JP2024033229A (en) | Medicine sub-packaging device | |
JP2009023844A (en) | Approximately cylindrical article put-out device | |
JP2005258969A (en) | Rotational coin paying out method, rotational coin paying out mechanism, coin discharging device and slot machine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 19914685 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 19914685 Country of ref document: EP Kind code of ref document: A1 |